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Summary 
The WHO End TB strategy targets to end the global tuberculosis epidemic by 2035 
with a reduction of 90% new cases, a 95% reduction in deaths, and to ensure that no 
family is burdened by catastrophic costs as a result of tuberculosis. In order to reach 
this ambitious goal, not only strengthening of tuberculosis control programs, 
discovery, development and evaluation of novel and sensitive tuberculosis 
diagnostics tools will be required, but also actions with regard to social determinants 
of tuberculosis and health care seeking, particularly in low-income settings with high 
tuberculosis burden. Furthermore, novel and more sensitive TB diagnostics tools will 
only have an impact at the population-level if the millions of undiagnosed TB cases 
reach health care centres timely for diagnosis and treatment. The low tuberculosis 
case detection observed in Tanzania and elsewhere is not only due to limitations in 
tuberculosis diagnostics, but also in the socio-cultural and economic factors which 
are relevant for tuberculosis healthcare seeking, timely diagnosis and treatment. 
This doctoral thesis therefore aimed to assess the pathways and costs of care from 
the onset of tuberculosis symptoms, to explain patient and diagnostic delays and 
loss to diagnostic follow-up during health care seeking, and finally to explore the role 
of traditional healers in tuberculosis management and control in Tanzania, using 
quantitative and qualitative methods. It firstly makes use of data obtained from the 
on-going tuberculosis cohort study in Dar es Salaam Tanzania, interviewing 100 
confirmed and 100 presumptive tuberculosis patients on pathways to care and on 
direct and indirect costs, with data recording on tablets using the OpenDataKit (ODK) 
application. Secondly, data were collected during an intervention study on intensified 
case findings at pharmacies in Tanzania, administering a semi-structured 
explanatory model interview based on the EMIC framework for cultural epidemiology 
xiv 
to 136 presumptive and confirmed TB patients. It further used data from in-depth 
interviews and structured interviews with 90 traditional healers in urban, peri-urban 
and rural districts of Tanzania.  
Pathways to care in confirmed tuberculosis patients were complex compared 
to the presumptive patients. In confirmed patients, pathways involved several visits 
to health care facilities before diagnosis, while that of the presumptive patients were 
more direct with only one or few visits to healthcare facilities before diagnosis. 
Confirmed and presumptive TB patients spent a median of 31% of their monthly 
household income on health expenditure for all five visits to healthcare facilities. 
Indirect costs were considerably higher than direct costs both in confirmed and 
presumptive TB patients.  
A patient delay of ≥3 weeks was observed in almost two thirds of our 
participants from the intervention study. In addition, loss to diagnostic follow-up was 
observed in 44.1%. Prior consultations with traditional healers were associated with 
patient delay but not with loss to diagnostic follow-up. Gender differences were 
observed in patient delay and LDFU, whereby the odds of patient delay were higher 
in females than in males, and also loss to diagnostic follow-up was higher in females 
than in males.  
Knowledge on cough and tuberculosis related symptoms was limited among 
traditional healers and varied in urban, peri-urban and the rural settings. Costs spent 
for traditional healers for treatment of cough and tuberculosis symptoms were lower 
than costs incurred by patients from the formal healthcare providers. Traditional 
healers in all three study sites referred patients for further treatment. Collaboration 
among the traditional healers, the government (NTLP) and other stakeholders was 
xv 
limited. There was a significant association between collaboration with the 
government and referring patients to hospitals for further treatment. 
The results from this PhD project contribute to our understanding on the pathways 
and costs of care in confirmed and presumptive tuberculosis patients. This study is 
among a few to report costs associated with tuberculosis taking onto account gender 
differences and poverty status. Furthermore, it contributes to open questions 
regarding patient delay and loss to diagnostic follow-up during healthcare seeking. 
Our study is also among the few to address the gap on the role of traditional healers 
in tuberculosis management particularly from sub-Sahara Africa. Given the 
importance of tuberculosis in terms of global disease burden, and the WHO’s 
ambitious goal to end tuberculosis by 2035, planning and specific interventions 
which integrate social and biomedical solutions are needed. 
 
 
  
1 
Introduction 
1.1 Tuberculosis 
1.1.1 A short overview of the disease, its diagnosis and treatment  
Tuberculosis (TB) is an airborne disease caused by bacillus Mycobacterium 
tuberculosis (M.tuberculosis). The bacillus may infect the lungs causing pulmonary 
TB or it might infect other sites such as lymph nodes, bones, and joints leading to 
extrapulmonary TB (EPTB) (Dye C, 2015; WHO, 2016). The bacteria are carried 
through airborne particles (droplets nuclei) and they can remain in the air for several 
hours depending on the environment. Transmission occurs when a person inhales 
the bacillus from an infected individual with active pulmonary TB through sneezing, 
coughing, shouting or talking (Dye C, 2015).  
Risk factors for TB include those associated with exposure to the infectious nuclei 
droplets such as overcrowded environment and migration of individuals from a low 
incidence to an area of high incidence of TB or vice versa (Lienhardt C, 2001) and 
those associated with impaired host immunity as HIV-co infections, furthermore with 
co-morbidities such as diabetes, malnutrition, and with behavioral factors such as 
alcohol abuse as well smoking (Shanmuganathan and Shanmuganathan, 2015).  
Diagnostic tests for TB include molecular tests, sputum smear microscopy and 
culture. Among the molecular tests, Xpert® MTB/RIF assay (Cepheid, USA) is the 
currently recommended test by WHO (WHO, 2017). The assay requires minimal 
technical training to be run, results are available within a short time and the test 
identifies possible multi-drug resistance TB (Center for Disease Control: Division of 
tuberculosis elimination, 2013). Sputum smear microscopy is less sensitive and 
specific compared to the Xpert® MTB/RIF assay (Orina et al., 2017). The culture-
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based method requires more developed laboratory capacities and it can take up to 
twelve weeks to obtain the results (Kadioglu et al., 2014).  
TB treatment involves a combination of several antibiotics. The standard treatment 
regime for new patients with pulmonary TB includes a six-month regime with two 
months of initial treatment, followed by a continuation phase of four months. During 
the initial phase, patients receive a combination of isoniazid, rifampicin, 
pyrazinamide and ethambutol (2HRZE), and isoniazid and rifampicin in the 
continuation phase (4HR) (WHO, 2010a).  
1.1.2 Global burden of disease 
Globally, TB is one of the top ten causes of death and a leading cause from single 
infectious agent ranking above HIV/AIDS (WHO, 2017). Furthermore, TB ranks 
among the top three causes of global burden of disease (GBD 2017 Disease and 
Injury Incidence and Prevalence Collaborators, 2018). In 2017, there were 1.3 million 
deaths among Human Immunodeficiency Virus (HIV) negative people, and 10 million 
new TB cases occurred of which 64%  among males (WHO, 2018). Additionally, TB 
is the single most common cause of death in HIV-infected individuals (WHO, 2015a). 
TB continues to mark as a public health problem particularly in resource-constrained 
settings despite the advancement in biomedical achievement of effective 
chemotherapy and prophylaxis (WHO, 2017). A recent United Nations general 
assembly high-level meeting on TB endorsed an ambitious declaration to accelerate 
progress towards ending TB (United Nations, 2018). It also emphasized that current 
global actions and investments on TB are not enough to end the global epidemic. 
TB global burden of disease is also mostly caused by multi-drug resistant TB (MDR 
TB) as well as extensive drug-resistant TB (X-DR) TB. WHO estimates that 600,000 
people were infected with MDR-TB in 2016 (WHO, 2017). Since MDR-TB and X-DR 
3 
TB are highly expensive to treat and require prolonged treatment duration, they 
contribute substantially to the global burden of disease (Nathanson et al., 2006). 
TB burden in Africa is estimated to be higher compared to other regions due to the 
HIV epidemic (Chaisson and Martinson, 2008). In 2017, 9% of all people affected by 
TB globally were people living with HIV of which 72% were in Africa (WHO, 2018). 
Furthermore, the current estimates of the global burden of TB from Africa may 
represent an underestimate of the actual burden since they are based on 
calculations from reported notification data and expert’s opinions (WHO, 2016). The 
actual magnitude of the problem in Africa remains undefined due to poor diagnostic 
infrastructures, reporting, and recording systems. The high burden in Africa is also 
partly caused by weak healthcare systems, suboptimal laboratories and further 
conditions which increase TB transmission such as overcrowding (WHO, 2015a, 
2016).  
1.1.3 TB in Tanzania 
With a prevalence of 295 cases per 100,000 in the adult population, Tanzania 
remains among the 30 countries with a high burden of TB (Ministry of Health and 
Social Welfare, 2013a; WHO, 2018). A total of 65,902 cases of all forms were 
notified in 2016 which is an increase of 5.6% compared to 2015 (Ministry of Health 
and Social Welfare, 2016a). TB notification rates were higher in males than females 
by 61%, translating into a sex ratio above 1:1.5. The highest number of cases 
notified was observed in the age groups of 25-34 and 35-44 years for both females 
and males.  
The Dar es Salaam region has the highest notification rates, accounting for 20% of 
all cases notified in Tanzania (Ministry of Health and Social Welfare, 2015, 2016a). 
Additionally, based on passive routine case detection (i.e. individuals with TB 
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symptoms present themselves in a healthcare facility for diagnostic services), it is 
estimated that until 2015 the case notification rate was below 50% in Tanzania, 
pointing to a substantial under detection (Ministry of Health and Social Welfare, 
2013a). 
Diagnosis of TB in Tanzania is primarily based on sputum microscopy; however, the 
use of GeneXpert MTB/RIF assay (Cepheid, CA, USA) is becoming a widespread 
technology. In 2016, a total of 71 healthcare facilities used GeneXpert machines (if 
there was no shortage), and the country average utilization was 35% (Ministry of 
Health and Social Welfare, 2016a).  
Treatment success rates in 2016 were 90%, which is an improvement of about 80% 
compared to 2001. Likewise, the death rate has been declining from 8% in 2006 to 
6% in 2014 (Ministry of Health and Social Welfare, 2016a). The high success rates 
result from an early adaptation and implementation of the directly observed 
treatment short course (DOTS) strategy (Egwaga et al., 2009; WHO, 2010a). 
1.2 Determinants of TB 
1.2.1. Socio-cultural determinants of TB 
The way a society is constructed exposes certain populations more often to higher 
risks of TB infection, greater chances of developing active TB, and lower likelihood of 
accessing effective TB treatment (Mason PH, Degeling C, 2015). Furthermore, the 
way people perceive and act towards TB is shaped by social and cultural factors. 
According to WHO, social determinants of health (SDH) originate from structural 
determinants of health which are conditions that reinforce the stratification of 
individuals into different social positions (classes). This stratification of individuals is 
based on individuals’ income, gender, race, ethnicity, education as well as 
occupation. The social positions in turn shape specific determinants of health among 
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the individuals. Subsequently, individuals experience differences in exposure and 
vulnerabilities to health-compromising conditions (WHO, 2010b). Social stratification 
thereby leads to an unequal distribution of SDH such as: living conditions, 
behavioural and biological factors (WHO, 2010b). 
Figure 1 displays the structural and social determinants of TB. The key structural 
determinants of TB epidemiology include: global socio-economic inequalities, rapid 
urbanization, population growth and increased mobility. These conditions enhance 
social determinants of TB, such as poor housing conditions, environmental 
conditions, financial and geographic problems, malnutrition as well as cultural 
barriers to health care access. In turn, the population distribution of TB reflects these 
social determinants that has an impact on TB pathogenesis from the exposure to 
infection, to diagnosis and treatment (Hargreaves et al., 2011; Lönnroth et al., 2009).  
Socio-cultural determinants of TB are among the key risk factors for TB. For 
example, overcrowding in workplaces or homes and poor housing conditions 
increase the likelihood of an exposure to TB infection (Lienhardt C, 2001). Social, 
economic and cultural as well as geographical factors substantially contribute to 
barriers to successful case detection and TB treatment (Mason PH, Degeling C, 
2015). For example, TB patients in Ethiopia could not start TB treatment on time due 
to long travelling time and financial burdens (Tadesse et al., 2013a). 
The socio-cultural determinants of TB are not solely responsible for the persistence 
of TB as a global public health problem. Unmet social challenges as part of social-
cultural determinants are crucial also for TB control (Rubel, 1992). Therefore, 
beyond  understanding of the biology of infection and health systems’ performance, 
a better understanding of the socio-cultural context that affects illness and behaviour 
of people with TB is needed (Weiss MG, Sommerfled J, Uplikar MW, 2008). 
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Solutions for the effective control and treatment so far have largely relied on 
biomedical approaches and neglected socio-cultural approaches. A more 
comprehensive strategy with bio-socio-cultural approaches is needed for an effective 
TB control (Wingfield et al., 2018) 
 
 
Figure 1: Structural and social determinants of TB 
1.2.2 Socio-cultural determinants of TB in Tanzania  
In Tanzania, the different prevalence rates of TB have been observed. It was, for 
example, estimated to be higher in the mainland compared to Tanzania Island 
(Ministry of Health and Social Welfare, 2013a). Tuberculosis notification rates in Dar 
es Salaam were the highest (244 cases per 100,000 population) in the country, while 
Kigoma and Unguja had the lowest notification rates of less than 50 cases per 
100,000 population (Ministry of Health and Social Welfare, 2016a). Though these 
notification rates might be attributable to biological factors, social constructions of 
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these societies might also have a substantial effect on the notification rates. For 
example, in communities where people live in overcrowded conditions, and one of 
the member of the household has TB, we would expect higher TB notification rates. 
Therefore, biological factors are not only associated with high notification rates, but 
also social constructions of the societies such as overcrowding. Likewise, the clinical 
characteristics and helminth co-infections differed among TB patients in the rural and 
urban settings of Tanzania (Sikalengo et al., 2018). These two examples underscore 
that not only the biological and genetic differences play a role for TB susceptibility, 
but also the social constructions and the physical environment.  
A recent study from Tanzania showed that ideas about the spread of TB and its 
association with HIV/AIDS led to the stigmatization among TB patients (Miller et al., 
2017). The effects of stigma may lead to social discrimination, subsequently 
adversely affecting health care seeking of an individual, and consequently the 
treatment outcomes (Miller et al., 2017). Furthermore, cultural understandings and 
perceptions of the individuals sometimes explicitly influence the health-seeking 
behaviour of the individuals. As (Bussey-Jones and Genao, 2003) found, 
understanding the individual perceptions led to effective treatment and eventually 
positive treatment outcomes. 
Another study from Tanzania indicated that individuals with no employment delayed 
seeking health care more than those who were employed (Mfinanga and Mutayoba, 
2008a). This clearly indicates the social determinants of TB as financial hardship 
may influence the health care seeking of the individuals.  
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1. 3 Health care seeking behaviour  
1.3.1. Health care seeking behaviour and pathways to care  
Health care seeking behaviour is largely determined by underlying social and cultural 
practices, the socio-economic status and access to health care (Zyaambo et al., 
2012). Socio-cultural aspects are key factors in understanding health-seeking 
behaviour since TB transmission and progression are also driven by social factors 
(Ali, 2014; Ortblad et al., 2015).  
Globally, about 4 million people are estimated to be missed each year by health 
systems and therefore, many do not get the required health care (WHO, 2017). This 
might furthermore result from seeking health care at facilities with inadequate TB 
diagnostics (dispensaries, pharmacies and traditional healers) which actually is 
common for the health care seeking behaviour of the majority of people in resource-
limited settings (Senkoro et al., 2015a; Ukwaja et al., 2013a). Consequently, this 
leads to on-going transmission in resource-limited settings like Tanzania. 
The main strategy for the identification of TB cases in Tanzania largely depends on 
passive case findings (patient presenting themselves to TB clinics to seek health 
care) (Ministry of Health and Social Welfare, 2013b). Thus, case finding largely 
depends on patient motivation, knowledge in seeking care, and effectiveness of 
diagnostic services (Dujardin and Kegels, 1997). 
There is a significant association between levels of education and the knowledge 
about TB and health care seeking behaviour from onset of symptoms. Patients who 
could not recognize symptoms such as chest pain and night sweats sought care less 
than those who could recognize such symptoms. Likewise, patients who had an 
education background below primary education sought care less than those with 
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primary education and above (Mfinanga and Mutayoba, 2008a; Eliud R. Wandwalo 
and Mørkve, 2000a). Moreover, inequalities in income and access to resources have 
also been documented as factors determining the health care seeking behaviour of 
individuals in resource-limited settings. Results from a recent prevalence survey in 
Tanzania and results from a study in Zimbabwe indicated that lack of money was a 
factor associated with not seeking care (Senkoro et al., 2015a; Zyaambo et al., 
2012).  
Presumptive TB patients (coughing for more than two weeks), particularly from low-
income groups, have long and complex pathways to care. Initiated care for 
presumptive TB patients often starts in the private sector and the consultation of 
three to four care providers before reaching public sector (Said et al., 2017; Shete 
P.B et al., 2015). Complex pathways to care result in treatment delay and therefore 
contribute to worsening patient morbidity and mortality.  
1.3.2 Health care utilization in relation to health care seeking 
The conceptual framework for access to medical care by Andersen (Aday and 
Andersen, 1974) is used for this study and modified for the context of health care 
seeking for TB patients. The model has been conceptualized, proceeding from the 
health policy in relation to the characteristics of population at risk and the health 
delivery system (Figure 2.)  
Health policy is the entry point to the access and healthcare utilization. Health policy 
affects the access and utilization of healthcare services and has a direct relationship 
with the population at risk and the health delivery system. The health delivery system 
is characterized by two elements i.e. resources and organization. Resources include 
labour and capital involved in healthcare. Organization entails what the system does 
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with its resources, how the physicians and the health facilities are organized for 
healthcare utilization.  
For this PhD project, we focus on the population at risk (red box) in relation to the 
utilization of health care services and consumer satisfaction (red arrows). The 
characteristics of the population at risk are defined as the function of three elements 
including: pre-disposing factors, enabling factors and need factors. It describes how 
people`s use of health services are a function of their predisposition (i.e. their 
characteristics). Use further depends on the consumer satisfaction and the utilization 
of health services. Consumer satisfaction refers to the attitudes of the population at 
risk towards care that they have received in terms of quantity and quality. 
Satisfaction also include: the convenience, costs and coordination. Healthcare 
utilization has also a direct relationship with the population at risk.  
The components of utilization include the type of health care received and who 
provided care (example: traditional healer or physician or pharmacist) to the 
population at risk. It further includes the site where the service was provided 
(example: in hospital or at the pharmacy) and the time interval for the visit to the 
healthcare provider. We explain in detail the three elements of the population at risk 
and draw examples from healthcare seeking in TB.  
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Predisposing factors:  
Predisposing factors describe the propensity of individuals to use the health services 
based on factors existing prior to the onset of illness (Aday and Andersen, 1974). 
They include demographic characteristics of the individual such as: age, sex/gender, 
education, occupation, social relationships social compositions, and health beliefs 
(e.g. knowledge related to health and health services) (Babitsch et al., 2012). 
Evidence suggests for example that there is a significant association between 
gender and health care utilization particularly for TB. Women tend to seek health 
care less frequently than men and use healthcare providers with sub-optimal or no 
adequate diagnostic equipment (Eastwood and Hill, 2004a; Krishnan et al., 2014; 
WHO, 2006). These factors are classified as predisposing factors that can shape the 
health seeking behaviour of individuals as well as healthcare utilization. 
The need factors: 
Need factors refer to the illness level which is the immediate cause to use services, 
and may be perceived by the individual or health delivery system (Aday and 
Andersen, 1974). The model differentiates between the perceived need for health 
care services (i.e., how people view and experience their general health, and illness 
symptoms) and the evaluated need (the professionals’ assessment and diagnosis of 
patient’s health status) (Aday and Andersen, 1974; Babitsch et al., 2012). Need 
factors have been shown to account for the differences in health seeking and 
healthcare utilization. In a study from Argentina, individual’s utilization of health care 
services depended on whether they perceived their general health to be poor or 
good. Patients with increased age had the largest associations with utilization of 
health services compared to those in middle and reproductive age (Jahangir et al., 
2012). Furthermore, in Tanzania individuals with additional symptoms other than 
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cough and haemoptysis sought health care, seeking twice as much compared to 
those with no additional symptoms (Senkoro et al., 2015a). Moreover, perceiving TB 
services as being free, doubled the chance of health care seeking in Angola (Luis et 
al., 2011). 
Enabling factors 
Enabling factors describe the means available for the individuals to use health 
services. These include both the individual resources and the attributes of the 
community in which the individual lives for example in a rural or in an urban area 
(Aday and Andersen, 1974). Individual resources include the individual's income and 
wealth to pay for the health services, while the community or organizational factors 
include resources for healthcare available in the community such as: travel time, 
means of transport and waiting time for health care (Babitsch et al., 2012). 
Associations have been found between financial capabilities or individual’s income 
and health care utilization in TB. In Nigeria for example, individuals utilized traditional 
healers (THs) more frequently than any other health provider because the costs of 
care were cheaper compared to other healthcare facilities (Christopher and Bosede, 
2010).  
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Figure 2. Conceptual framework for health care utilization (red box, red arrows) in 
relation to the theoretical framework of access to health care by (Aday and Andersen, 
1974) 
1.4 Healthcare seeking for TB and loss to follow-up in TB 
Early diagnosis and efficacious treatment are important factors for effective TB 
control (WHO, 2009). Timely healthcare seeking is crucial because an untreated TB 
patient can infect an average of 10 contacts annually and more than 20 during the 
natural history of disease until death (Dye C, 2015). Health or healthcare seeking 
behavior has been defined as ‘any action undertaken by individuals who perceive 
themselves to have a health problem or to be ill for the purpose of finding an 
appropriate remedy (Olenja, 2003). Healthcare seeking is preceded by a decision 
making process influenced by cognitive factors of the individual, by household 
behaviour and furthermore by community norms and expectations. Also, provider-
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related characteristics and contextual factors such as availability of services and 
health costs are playing a role, as elaborated by (Olenja 2003). Healthcare seeking 
involves recognition of symptoms, perceived nature of illness, eventually relying on 
home care in a first step, eventually followed by seeking care at a health facility. The 
final choice of a healthcare seeking option is seen as interplay of these factors. It 
furthermore involves also eventual returns to a health facility in case of treatment 
failure, or seeking care at an alternative care provider. 
In this thesis, we focus on two components of healthcare seeking: Delay in 
healthcare seeking and loss to follow-up until TB treatment. 
1.5 Delay in healthcare seeking for TB 
Delay durations have been defined and categorized differently (Sreeramareddy C.T, 
Panduru K.V, Menten J, Ende J.V, 2009a; Storla et al., 2008; WHO, 2009). WHO 
defines patient delay as the interval between the onset of symptoms and the first 
presentation to the healthcare provider (Figure 3) (WHO, 2009). Diagnostic delay is 
the interval between the onset of symptoms and diagnosing the patient as a TB 
patient (Sreeramareddy CT, Oin ZZ, Satyanarayana S, Subbaraman R, 2014; Yimer 
et al., 2005). Treatment delay on the other hand is the time interval between 
tuberculosis diagnosis and initiation of anti-TB treatment (WHO, 2009). Total delay 
defined as the time interval from the onset of TB symptoms until initiation of anti-TB 
drugs. It is the sum of patient delay, diagnostic delay and treatment delay (WHO, 
2009). 
Delay in seeking care is more pronounced in females than in males (Mfinanga and 
Mutayoba, 2008a; Pronyk et al., 2001; Storla et al., 2008). On average, the delay 
before seeking care is eight weeks among women compared to six weeks among 
men (World Health Organization, 2009). This is mainly influenced by women 
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primarily being the family caregiver and the lack of financial autonomy. One of the 
reasons for lack of financial autonomy among women is mostly attributed to women 
remaining at home to take care of their families while men work outside the homes 
and can provide economic substance to the families. Furthermore, stigma also plays 
a major role in shaping the perception of illness and help-seeking behaviour among 
women. As women are dependent on their families or spouses, they are always 
concerned about the social isolation and marital problems that may arise as an 
impact of TB i.e. divorce (Onifade et al., 2010; Somma et al., 2008a; Weiss et al., 
2008a).  
Several factors have been identified to influence delay in diagnosis until treatment 
initiation including: patient knowledge and perception of the causes of disease, older 
age and stigma (Auer et al., 2000a; Ngadaya et al., 2008a; WHO, 2009), distance 
between the patient’s household and the healthcare facility, socio-economic level of 
the patient, severity of the disease and health facility capacities such as the 
availability of the healthcare personnel (Cai et al., 2015; Mfinanga and Mutayoba, 
2008a).  
Delay of treatment is said to be influenced furthermore by the degree of diagnostic 
suspicion from the physician as well as effective diagnostic services (Dujardin and 
Kegels, 1997). While all these factors are crucial in the TB control and management, 
there are always setbacks by delays either with the patient or with the healthcare 
system (the time interval from the first contact with the healthcare services until the 
date of diagnosis) (Sreeramareddy C.T, Panduru K.V, Menten J, Ende J.V, 2009a). 
Delays in TB diagnosis and treatment initiation are not only important prognostic 
factors for poor clinical outcomes, but are also a major public health concern 
because undiagnosed infectious TB patients continue to transmit TB to their 
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household contacts and the community (Sreeramareddy CT, Oin ZZ, Satyanarayana 
S, Subbaraman R, 2014; Yimer et al., 2005). Delay in seeking care may negatively 
impact the decline in TB transmission, which is a crucial factor to meet the ambitious 
WHO targets of TB control and elimination. 
 
Figure 3. Schematic overview of different delay durations contributing to the total 
delay in health care seeking (Adopted and modified from WHO-TDR diagnostic delay 
in TB) 
1.6 Loss to follow-up in TB 
The care pathway for presumptive and TB patients starts with the identification of the 
symptoms that lead to seeking health care. Individuals may drop out of care if they 
are not identified as tuberculosis patient, during diagnosis (i.e. loss to diagnostic 
follow-up, LDFU), before treatment initiation (pre-treatment loss to follow-up) or 
during treatment (i.e. loss to follow-up, LTFU) as shown in figure 4 (MacPherson et 
al., 2014a). Any loss along this pathway poses a great challenge in TB control as 
high mortality rates are reported in this group as was found in South Africa with loss 
of smear-positive patients where mortality rates were substantial (Botha et al., 2008; 
Squire et al., 2005). Furthermore, case identification of smear-positive patients and 
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prompt treatment initiation are key factors in TB control (Dye et al., 2008). These two 
approaches are promoted as parts of DOTS passive case finding by WHO (WHO, 
2010a).  
Several factors have been found to have a direct association with LTFU during the 
diagnostic process or during treatment, falling into two categories: those related to 
the patient and those related to the health system. Factors such as male sex, and 
older age (Gopi et al., 2005a), living in rural residence, perception that TB is 
associated with HIV/AIDS and financial hardships were found to contribute to LTFU 
(Ade et al., 2016; Buu et al., 2003a; Muture et al., 2011).  
Health system related obstacles include dissatisfaction with long waiting time during 
diagnosis and treatment and inappropriate handling of the presumptive or TB 
patients by the healthcare workers. For example, even after recognising the 
symptoms to be suggestive of TB, healthcare workers may refuse to take diagnostic 
measures (i.e, requesting of sputum samples), missing smear results, patient may 
not be informed by the clinic regarding the results as well as under diagnosis of the 
TB patients (Botha et al., 2008; Squire et al., 2005).  
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Figure 4. Schematic overview of pathway to care for TB patients, showing different  
episodes of loss to follow-up until TB treatment (MacPherson et al., 2014a) 
1.7 TB and Gender 
“Gender” refers to distinguishing features of males and females that are socially 
constructed (Uplekar et al., 2001). Gender is distinguished from “sex” as sex entails 
differences in men and women basing on their biological characteristics (WHO, 
2005a). Gender affects TB epidemiology since the risk factors and health care 
seeking pathways for diagnosis and treatment are different among men and women 
(Mason et al., 2016). A cross-site analysis of gender and further socio-cultural 
determinants in India, Bangladesh and Malawi reported that gender influences the 
clinical presentation, illness-related experience, behaviour, and treatment outcomes 
(WHO, 2006).  
1.7.1 TB in men and women 
TB prevalence has been shown to be more than twice as high among men than 
among women in lower middle income countries (LMIC), with strong evidence that 
men are less seeking and/or accessing TB care in many settings (Horton et al, 
2016). TB notification rates are also consistently higher in men than in women 
(Horton et al., 2016; WHO, 2017). The lower infection rates among women 
compared to men have been attributed to socio-cultural factors as women have less 
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social interactions outside the home compared to men. Although more TB cases and 
deaths occur among men worldwide, the burden of disease among women is high in 
countries with a high HIV prevalence (WHO, 2005a, 2014).  
There is an on-going debate as to whether the higher notification rates in men stem 
from sex differences or from socio-cultural or gender differences (Mason 2017). It is 
unlikely that the pronounced variations in the male to female notification data in 
neighbouring countries such as Thailand and Vietnam are explained by biological 
reasons. Similarly, in a recent prevalence survey, the male to female ratio of notified 
TB patients in Tanzania was 1.4 (Ministry of Health and Social Welfare, 2013a), 
while that of Uganda stood at 1.2 (Ministry of Health Uganda, 2014). This difference 
could hardly be explained by biology. It may rather be due to variations in gender-
related risk factors and gender-specific health seeking behaviours(Mason et al., 
2017). As these differences are rarely accounted for in the epidemiology of TB, it is 
possible that sex differences in detection and reporting may be attributed to gender-
specific barriers to health service utilization and diagnosis (Uplekar et al., 2001). 
Evidence suggests that men and women interpret TB symptoms differently. In 
Vietnam, women reported cough and haemoptysis less frequently than men (Long et 
al., 2002). These differences remained significant even after controlling for variables 
as age, sex, family size and area of residence. Additionally, the general symptoms 
as tiredness, headache and fever were significantly more common in women than in 
men (Long et al., 2002). As documented elsewhere such variations may lead to 
clinicians missing out TB diagnosis in women as some may not request sputum 
examination as they request from men (Thorson et al., 2000a). Although these 
differences may partly be explained biological factors, socio-cultural factors also play 
a role. For example, sputum expectoration and coughing are culturally less 
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acceptable for women; therefore, women may expectorate less frequently than men, 
which may result in women producing less likely good quality sputum than men 
(Khan et al., 2004).  
Furthermore, men tend to seek medical help more frequently after the onset of TB 
symptoms compared to women who tend to start treatment with home remedies or 
taking medicines without prescriptions before seeking professional help. Even when 
seeking medical help, women usually consult less qualified healthcare providers 
(Kaur et al., 2013; Weiss et al., 2008a). Both women and men face gender-specific 
barriers to TB diagnosis, care and treatment (Gosoniu et al., 2008a). 
Adherence to TB treatment and treatment outcomes may also be affected by gender 
roles. Evidence suggests that women who are diagnosed and start TB treatment are 
more likely to adhere to treatment, have positive treatment outcomes and missed 
less the DOT appointment compared to men (Chan-Yeung et al., 2002).  
1.7.2 Framework for the study of gender and TB 
A stepwise attrition conceptual framework has been formulated to identify gender 
differentials at each step, as shown in the overview of the framework in figure 5 
(Uplekar et al., 2001). Seven steps are proposed by the model, including awareness 
of symptoms, appropriate help-seeking, utilization of health services, diagnosis, 
treatment initiation, adherence to treatment as well as positive treatment outcomes. 
Gender differences may occur at each of these steps, from the onset of symptoms 
until treatment outcome.  
The health care seeking behaviour of both men and women particularly for TB is 
largely determined by either how she or he and those around her perceive the 
symptoms, regard the diagnosis, accept the treatment and are ready to adhere to the 
treatment. The framework suggests that gender issues influence both the TB patient 
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and also the health care providers and thereby impact on the effectiveness of 
clinicians to diagnose TB while taking into account sex/gender differences.  
The shortening double columns on the framework indicate the attrition that occurs as 
both men and women move through the various steps during healthcare seeking 
until TB treatment. For example, it has been documented that more men are 
diagnosed with TB, however, among those who receive treatment, more women 
adhere to the treatment regimen than men, have positive treatment outcomes and 
women die less often from the disease (Chan-Yeung et al., 2002; E Johansson et al., 
1999).  
The vertical lines indicate barriers during the process that may impair the effective 
efforts to achieve cure (Uplekar et al., 2001). Some of the barriers for cure may 
appear even before the help seeking, i.e. financial barriers for healthcare seeking 
that affect males and females differently. While males face financial barriers as a 
result of limited resources, females on the other hand lack financial autonomy that 
makes them dependent on their spouses and other family members, thereby limiting 
their access to care seeking (Krishnan et al., 2014). Furthermore, the barriers may 
continue even after cure, e.g. stigma that may be faced by both males and females. 
However, it has been documented that women usually report the burden of TB-
related stigma more frequently than men and are afraid that their illness may result in 
marital problems, eventually leading to divorce and social isolation, even after cure 
(Karim et al., 2007; Krishnan et al., 2014). The horizontal arrows cutting through the 
barriers indicate the success pattern in overcoming the barriers.  
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Figure 5. Framework for the study of gender and TB (adopted from Uplekar 2001) 
1.8 Costs of TB care in relation to poverty and gender 
TB is characterized as a result of poverty but also fuels poverty (Benatar and 
Upshur, 2010). People in resource-limited settings live in poor living conditions i.e. 
overcrowded houses with poor ventilation which play a major role in TB transmission 
(Lienhardt et al., 2003). Moreover other risk factors as malnutrition, smoking and 
alcohol abuse which are also characteristics of poverty are more prevalent in 
resource-limited settings. TB which accounts for a considerable global burden of 
diseases also leads to poor health that subsequently lower human productivity which 
in turn aggravates poverty. Universal access to healthcare and reducing the socio-
economic burden of TB is therefore one of the key strategies proposed by WHO-
Stop TB strategy for effective TB control (WHO, 2005b). Although access to free TB 
care has expanded substantially due to global and government efforts (WHO, 2017), 
TB patients in low and middle-income countries still face substantial costs as a result 
of TB (Onazi et al., 2015). Financial risk protection therefore remains a major issue 
on the way to a tuberculosis-free world, as stated by the Lancet Commission on 
tuberculosis (Goosby et al., 2018). 
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Despite the fact that TB treatment in most of the countries is provided for free, 
patients in low and middle-income countries still incur high direct and indirect costs 
that are catastrophic (Kemp et al., 2007; Ukwaja et al., 2013b). The onset of TB 
symptoms can exacerbate poverty as the patient enters into a lengthy period of 
healthcare expenditure and loss of productivity (Benatar and Upshur, 2010).  
TB related costs may not only negatively impact the treatment outcome. High direct 
and indirect costs before and during TB treatment are also a reason why many of the 
TB affected households continue to fall more below the poverty line (Foster et al., 
2015). Additionally, TB patients in resource-limited countries spend a substantial 
amount of their annual household income on TB treatment, particularly in the initial 
phase of health care seeking (Dye et al., 2009; Tanimura et al., 2014). 
Costs for TB treatment are not uniform to all the patients (de Cuevas et al., 2016; 
Ramma et al., 2015): Men incurred higher direct costs and higher opportunity costs 
than women (Kemp et al., 2007). Though the costs of care for women seem to be 
low compared to those of the men, the opportunity costs faced by a household are 
always higher when women get sick compared to men, especially women in the 
reproductive years (WHO, 2014). 
1.9 Traditional healers and TB 
Traditional healers (THs) co-exist together with traditional medicine and are widely 
acknowledged worldwide. They are historically one among the widely used practices 
in the community (Mbwambo et al., 2007) and serve as the primary health care 
providers for a substantial proportion of individuals, especially in African communities 
(Gessler et al., 1995b). THs have been documented to treat a vast number of 
diseases including malaria, TB, diarrhea, sexually transmitted diseases and 
HIV/AIDS (Banerjee et al., 2000; Gessler et al., 1995b; Mbwambo et al., 2007). 
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Although THs are not a homogenous group, they serve as the entry point in health 
care seeking among a majority of people in sub-Saharan Africa (Eliud R. Wandwalo 
and Mørkve, 2000a; Wilkinson et al., 1999). 
In sub-Saharan Africa, scant attention has been given to THs and their practices 
towards TB management. This neglect may lead to an increase in poor health 
outcomes and high mortality rates among patients who visit THs (Barker et al., 
2006). For the diagnosis and treatment, THs use a broad range of different 
treatments such as plant roots, shoots and leaves. Diagnosis and treatment of TB 
and TB related symptoms are usually based on the patient’s history and the cause of 
the disease (Banerjee et al., 2000). 
It has been found that female patients visit THs more often than male patients. 
Strong traditional beliefs, the short time spent for visits to THs compared to visits at 
other healthcare facilities and confidentiality have been mentioned as the underlying 
reasons (Eastwood and Hill, 2004a). 
1.10 Conclusion 
In summary, TB is a major public health problem which contributes substantially to 
the global burden of disease. The socio-cultural determinants of TB are crucial 
factors that can significantly support the global efforts for effective TB control 
(Hargreaves et al., 2011). Gender roles influence the control that men and women 
have with regard to the determinants of their health, particularly for TB (WHO, 
2005a). Gender also influences health-seeking behaviour from the onset of 
symptoms until treatment completion. Evidence shows that men are disadvantaged 
in seeking and accessing TB care (Horton et al, 2016), whereas women tend to visit 
health care providers that have sub-optimal or a lack of diagnostic equipment for TB 
as compared to men (Eastwood and Hill, 2004a). This subsequently leads to delays 
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in health care and treatment, increasing the period of TB infectivity in the 
communities. Additionally, the costs of care before and during TB treatment are 
higher for men than women whereas the opportunistic costs are more pronounced 
for women and their households (Kemp et al., 2007). This underscores the need to 
understand the cycle of TB patients, starting from the onset of symptoms, healthcare 
seeking, and access to health care services, until the end of treatment and post-TB 
treatment impairments.  
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2. Research Questions, Aims and Methods 
2.1 Cohort study  
Part of this PhD project was conducted within the framework of an on-going 
prospective cohort study in Dar es Salam Tanzania (TB-DAR). TB-DAR was initiated 
in 2013 with the overall goal of studying clinical and molecular epidemiology of TB in 
Tanzania. The cohort includes sputum smear positive or Xpert MTB/RIF positive TB 
patients, sputum smear negative or Xpert MTB/RIF negative patients (presumptive 
TB patients) and household contacts of the TB positive patients (household contact 
controls) (Mhimbira et al., 2017). The cohort is funded by Rudolf Geigy Foundation of 
Basel Switzerland, TB.  
For the PhD project, an additional clinical record form with pathways and costs of 
care questions was integrated into the cohort database in 2016 and data were 
collected retrospectively in confirmed and presumptive TB patients. Ethical clearance 
was obtained from the Ifakara Health Institute Institutional Review Board, 
Coordinating Committee of the National Institute for Medical Research in Tanzania 
(NIMR), and Ethics Committee of the Canton of Basel (EKNZ). 
2.2 Intervention study  
The other part of the PhD work was conducted on the platform of an intervention 
study on intensified case findings at pharmacies (TB-PHARM). The overall objective 
was: to develop and evaluate a referral system of presumptive TB cases from 
pharmacies to National Tuberculosis and Leprosy (NTLP) TB clinics; to increase TB 
case detection; to reduce diagnosis delay; and to increase linkage to care (Mhimbira 
et al., 2015). The study undertook a systematic symptom screening for TB among 
pharmacy clients, and referral of the presumptive TB cases to the NTLP diagnostic 
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and treatment center (i.e. intervention center). Five pharmacies were selected based 
on the geographical location to the TB clinic, the ownership (government, private) 
and the size of the pharmacy. Additional data on LDFU was collected through a 
structured questionnaire for all patients who met the inclusion criteria of the LDFU 
study at the TB clinic after the referral from the pharmacies. Ethical clearance was 
obtained from the Ifakara Health Institute Institutional Review Board, Coordinating 
Committee of the National Institute for Medical Research in Tanzania (NIMR). 
2.3 Research Questions & Hypothesis 
As stated in the introduction section, solutions for effective TB control and treatment 
have largely relied on biomedical approaches and less is known on socio-cultural 
and gender differences and social determinants of TB. Furthermore, pathways to 
care and the costs of care during diagnosis for the confirmed and presumptive TB 
patients have insufficiently been addressed specifically in sub- Saharan Africa. 
The PhD project aims to address three questions on socio-cultural determinants and 
gender issues in Tanzania. The questions include:  
i) what are the pathways of care and costs of care among the 
confirmed and presumptive TB patients in Tanzania? Does cost of 
care before diagnosis in confirmed and presumptive TB patients 
differ among females and males?  
ii) what role do socio-cultural aspects and gender have for LTFU 
while seeking care, and what are the reasons for LDFU on the 
pathway to care before TB diagnosis; and  
iii) what is the role of THs in management of TB in Tanzania? 
Does the management of TB and cough related symptoms done 
by THs differ among the urban, peri-urban and rural settings of 
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Tanzania? Is there any collaboration among the healers and the 
government particularly on TB?  
We hypothesize that gender and socio-cultural factors have an effect on health 
seeking behaviour of presumptive and confirmed TB cases, on costs of care before 
treatment initiation as well as on LTFU during the diagnostic period. We further 
hypothesize that THs play a role in healthcare of the confirmed and presumptive TB 
patients in urban, peri-urban and rural settings of Tanzania. 
2.4 Aims 
The PhD project specifically aims to: 
1. Assess pathways and associated costs of seeking care from the onset of 
symptoms until TB diagnosis in confirmed and presumptive TB patients taking 
into account gender and poverty status 
2 Study LTFU before TB diagnosis and its determinants (gender, socio-cultural 
factors) among presumptive TB cases in the community during an intervention 
study on intensified case finding; and 
3. Explore the role of THs in TB control and management in comparison of 
urban, per-urban and rural Tanzania. 
2.5 Methods 
2.5.1 Study settings and study design 
The study areas for the PhD project are described in details below (Figure 5). These 
included Temeke, an urban area (objective 1 and 3), Buguruni, an urban area 
(objective 2), Bagamoyo, a peri-urban area (part of objective 3), and Ifakara a rural 
area (part of objective 3). 
29 
2.5.1.1 Temeke district, Dar es Salaam (urban) 
Temeke district is one among the three districts of Dar es Salaam, a business capital 
with approximately 5 million people and about 10% of the country’s population (The 
United Republic of Tanzania, 2014a). Dar es Salaam region has the highest 
notification rates of TB, contributing 20% of all notified TB cases in the country 
(Ministry of Health and Social Welfare, 2016a). Temeke district is densely populated 
with a population of at least 1.4 million per person (The United Republic of Tanzania, 
2013a). In 2016, 4,495 TB cases (all forms) were notified  in the district (Ministry of 
Health and Social Welfare, 2016a). 
2.5.1.2 Buguruni, Ilala district, Dar es Salaam (urban) 
Buguruni is in the Ilala district of Dar es Salaam Tanzania, a metropolitan area with 
high TB burden. Ilala has a population of at least 1.3 million people with an average 
of 4.0 persons per household (The United Republic of Tanzania, 2013a). The study 
area was a residential area within the Buguruni sub-district with a population of 
70,585 and 559 notified TB cases in 2012. The area is characterized with one registered 
TB diagnostic and treatment centre. 
2.5.1.3  Bagamoyo, Pwani region (peri-urban) 
The remaining part of the study was conducted in Bagamoyo. Bagamoyo is located 
in Pwani region of Tanzania. The region is characterized by few health care facilities 
and notifies < 5% of the TB cases per year (Ministry of Health and Social Welfare, 
2016a; Tanzania National Bureau of Statistics, 2016a). 
2.5.1.4 Ifakara, Morogoro region (rural) 
Ifakara is located in the rural area of Kilombero district in the Morogoro region of 
Tanzania. The district is also characterized by few health care facilities and notified 
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about 5.4% TB cases in 2016 (Ministry of Health and Social Welfare, 2016a; 
Tanzania National Bureau of Statistics, 2016b). 
 
Figure 6. Study settings of the PhD project 
2.5.1.5 Study design 
We used a cross-sectional study design. For the first and second study objectives, 
we took advantage of the on-going cohort and intervention study on intensified case 
findings and conducted a survey among presumptive and confirmed TB cases. For 
our last objective, we conducted a survey in urban, peri-urban and rural settings of 
Tanzania.  
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2.6 Definition of main outcomes  
2.6.1 Delay in seeking health care  
Throughout the following chapters, we use the definitions of patient delay and 
diagnostic delay according to the framework of WHO on diagnostic and treatment 
delay (WHO, 2009). Diagnostic delay was defined as the interval between the onset 
of TB symptoms and the time of diagnosis of more than three weeks. Patient delay 
was defined as the interval from the onset of TB symptoms and consultation with the 
healthcare facility of more than three weeks. The interval of three weeks for both 
patient and diagnostic delay were considered sufficient based on previous studies 
(Said et al., 2017; Shete P.B et al., 2015). 
2.6.2 Costs of care  
Definitions for the direct and indirect costs of care were based on the WHO tool to 
estimate patient costs (WHO, 2008). Direct costs were defined as out of pocket costs 
linked to seeking diagnosis including medical expenses, transport, fees and food. 
Indirect costs were defined as the cost of foregone income due to inability to work 
and loss of time due to visits to health facilities. 
2.6.3 LDFU  
LDFU was defined as failure to present after referral from the recruitment pharmacy 
to the TB clinic (pharmacy LDFU) within two months, or failure to return for all three 
required diagnostic visits after recruitment in the TB clinic (clinic LDFU). More details 
on LDFU are described in chapter three. 
2.7 Definition of exposures 
2.7.1 Gender  
In the quantitative analysis, gender was defined based on the self-report of being 
male/female, and the analytic approach included stratification by gender and by 
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poverty status. Furthermore, the analysis of the qualitative in-depth interviews paid 
attention to gender issues as an emerging theme. For further details on the definition 
see section 1.5. 
2.7.2 Socio-cultural factors 
We define patients as poor if their wealth fell in the lowest or second-lowest wealth 
quintile. The non-poor were defined as persons in the remaining middle, fourth and 
highest wealth quintiles as indicated in our first objective.  
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2.8 Statistical and qualitative analysis 
The analytic approach for the three research questions are outlined below and 
described in detail in the respective papers of the result section. 
Research question 1): What are the pathways of care and costs of care among the 
confirmed and presumptive TB patients in Tanzania? Does cost of care before 
diagnosis in confirmed and presumptive TB patients differ among females and 
males?  
Pathways to care including the distance that confirmed and presumptive patients 
took and the costs of care were analysed by logistic regression as well as quintile 
regression models. All analyses were conducted using STATA version 14 (StataCorp 
College Station TX, USA). The specific covariates used and additional analyses are 
described in more details in chapter three. 
Research question 2): What role do socio-cultural aspects and gender have for 
LTFU while seeking care, and what are the reasons for LDFU on the pathway to care 
before TB diagnosis. 
LDFU and delay in seeking healthcare and their association with gender (chapter 
three) were analysed with univariate and multivariate logistic regressions. Variables 
of perceived causes of TB (i.e water, food, dust alchohol and smoking) and were first 
summarized by univariate statistics. Subsequently, multivariate logistic regression 
models were run for delay and LDFU.  
To explain identified differences and associations of the variables delay and LDFU, 
we analysed narrative data. Narratives from the EMIC interviews were coded 
thematically and imported in MAXQDA version 12 (VERBI Software, Berlin, 
Germany). We further used the framework method of Gale to analyse the data. 
34 
Research question 3): What is the role of THs in management of TB in Tanzania? 
Does the management of TB and cough related symptoms done by THs differ 
among the urban, peri-urban and rural settings of Tanzania? Is there any 
collaboration among the healers and the government particularly on TB?  
We used qualitative and quantitative approach to explore the role of THs healers. 
The qualitative analysis was preceded by verbatim transcription of the interviews. 
We developed codes that were checked for inter-coder-reliability and analysed the 
data focusing on emerging themes, patterns, similarities and differences. All 
qualitative analyses were performed using MAXQDA version 12 (Verbi Software, 
Berlin, Germany). We further performed quantitative analysis to assess THs 
knowledge on symptoms and causes of TB, traditional management of cough and 
TB related symptoms as well as distance from the TH to a near healthcare facility. 
We used chi square test of association to assess differences between groups All 
analyses were conducted using STATA version 14 (StataCorp College Station TX, 
USA).  
2.9. Relevance of the research 
Different patient pathways to care are an important part in recognition of public 
health interventions in TB control. So far, most studies have been focusing on 
patients who have already been diagnosed and on treatment, rather than the large 
presumptive population seeking care once they are aware of TB symptoms. 
Furthermore, studies on cost of TB have also predominantly focused on TB patients 
during TB treatment and little is known about cost of care not only before treatment 
initiation but also in presumptive TB patients (Shete P.B et al., 2015). Additionally, 
assessment of costs of care taking into account gender differences is understudied 
especially in sub- Saharan Africa. To our knowledge, the study by (Kemp et al., 
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2007) is so far the only study that assessed cost of TB care taking into account 
gender differences and poverty status in sub-Saharan Africa. In this PhD project, we 
assess pathways and costs of care before TB treatment in confirmed and 
presumptive TB patients, taking into account gender differences and poverty status. 
Our study in chapter 3 contributes more on assessing costs of TB care before 
treatment initiation comparing the presumptive and confirmed TB patients. 
Despite recent advances in molecular TB diagnostics such as Xpert MTB/RIF, the 
effect at population-level is relatively modest (Creswell et al., 2015) because 
presumptive TB patients do not reach the healthcare system on time for effective 
diagnosis and treatment. Studies on health seeking behaviour have predominantly 
focused on patients who have already been diagnosed within the health care system 
rather than presumptive cases with TB symptoms (Fatima et al., 2015a; Senkoro et 
al., 2015a). Novel and more sensitive TB diagnostics will only have an impact at the 
population-level if the undiagnosed TB cases reach health care centres in a timely 
manner for diagnosis and treatment (Creswell et al., 2015). This PhD project 
contributes to knowledge in this area where we investigate the reasons for patient 
delay, diagnostic delay and LDFU among the presumptive and confirmed TB 
patients in an urban setting of Tanzania. 
Finally, It has been documented that most of the presumptive and TB patients in 
sub-Saharan Africa start treatment seeking from THs before reaching healthcare 
facilities for diagnosis and effective treatment (Brouwer et al., 1998; Wilkinson et al., 
1999). However, the role of THs in TB management and control is largely unknown. 
Most of the studies on THs have only focused on how the patient utilizes services 
offered by a TH and not on how the THs manage TB patients. Therefore, there is a 
gap in addressing the role of THs particularly from sub-Saharan Africa. We again 
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contribute to the body of knowledge by assessing the role of THs in TB management 
in comparison of urban, peri-, urban and rural areas of Tanzania. 
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Abstract  
Objective: To assess pathways and associated costs of seeking care from the onset 
of symptoms to diagnosis in confirmed and presumptive tuberculosis (TB) patients. 
Design: Cross-sectional study. 
Setting: District hospital in Dar es Salaam, Tanzania. 
Participants: Bacteriologically confirmed TB and presumptive TB patients. 
Primary and secondary outcome measures: We calculated distance in meters 
and visualized pathways to healthcare up to five visits for the current episode of 
sickness. Costs were described by medians and interquartile ranges (IQR), with 
comparisons by gender and poverty status. 
Results: Of 100 confirmed and 100 presumptive TB patients, 44% of confirmed patients 
sought care first at pharmacies after the onset of symptoms, and 42% of presumptive 
patients did so at hospitals. The median visits made by confirmed patients was 2 (range 1-
5), and 2 (range 1-3) by presumptive patients. Patients spent a median of 31% of their 
monthly household income on health expenditures for all visits. The median total direct 
costs were higher in confirmed compared to presumptive patients (USD 27.4 [IQR 
18.7-48.4] vs. USD 19.8 [IQR 13.8-34.0], p=0.02), as were the indirect costs (USD 
66.9 [IQR 35.5-150.0] vs. USD 46.8 [IQR 20.1-115.3], p<0.001). The indirect costs 
were higher in men compared to women (USD 64.6 [IQR 31.8-159.1] vs. USD 55.6 
[IQR 25.1-141.1], p<0.001). The median total distance from patients’ household to 
healthcare facilities for confirmed and presumptive TB patients was 2,338 meters 
(IQR 1,373-4,122) and 2,009 meters (IQR 986-2,976) respectively. 
Conclusions: Confirmed TB patients have complex pathways and higher costs of 
care compared to presumptive TB patients, but their costs are also substantial. 
Improved access to healthcare is needed for effective patient-centred care. This 
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underscores the need for strengthening the healthcare sector and identifying 
strategies for diagnostic procedures that are cost-effective and patient-centred, 
particularly in the light of the introduction of new TB diagnostics 
Strengths and limitation of the study 
  We present data on pathways to care and assess costs of care in confirmed 
and presumptive TB patients in Tanzania 
 We estimate costs of care by stratifying costs according to poverty status and 
gender 
 Estimated costs for TB diagnosis did not account for HIV and other 
comorbidities. 
 The accuracy of reported costs may have been compromised by recall bias 
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3.1 Introduction 
Confirmed and presumptive tuberculosis (TB) patients follow complex pathways to 
healthcare. Pathways to healthcare are the steps/ways the confirmed and 
presumptive patients take from the initial point of seeking healthcare to the point of 
diagnosis and treatment (Hanson et al., 2017; WHO Stop TB partnership, 2016). 
Many patients consult various healthcare providers before being diagnosed with TB 
(Said et al., 2017; Shete P.B et al., 2015). These pathways are usually complex and 
delayed diagnosis and treatment may increase morbidity and mortality (Kapoor et al., 
2012). The World Health Organisation estimated an incidence of 10.4 million TB 
cases in 2016, yet only 6.3 million new TB cases were notified to national authorities 
and reported to WHO (WHO, 2017). Although many factors contribute to this 
notification shortfall, the complexity of pathways to TB care may substantially 
contribute to low notification rates.  
TB is widely regarded as a disease of poverty due to its disproportionate effects on 
the marginalized populations (Ali, 2014; Lönnroth et al., 2009). To help socially and 
economically marginalized groups fight the disease, healthcare facilities diagnose 
and treat TB free of charge in countries with a high TB burden (WHO, 2016). 
However, patients with symptoms of TB face high direct and indirect costs for 
diagnosis and treatment (de Cuevas et al., 2016; Kemp et al., 2007; Ramma et al., 
2015; Tanimura et al., 2014), and these costs are usually higher for patients with 
confirmed TB than presumptive cases (Shete P.B et al., 2015; Veesa et al., 2018).  
Prior to diagnosis, the pathways to care of presumptive TB in Tanzania are complex. 
They usually involve consultations with more than one healthcare provider with 
suboptimal or no means for diagnosing TB (Said et al., 2017; Senkoro et al., 2015b). 
The complex pathways to care may begin at pharmacies and basic health care 
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facilities with no TB diagnostics before reaching healthcare facilities with TB 
diagnostic capacity (Veesa et al., 2018). 
A national TB prevalence survey indicated that the case detection rate of TB was 
below 50% (Ministry of health and Social welfare, 2013). This result may not only be 
due to the complexity but also the high cost of care (Mfinanga and Mutayoba, 2008a; 
Senkoro et al., 2015b; Eliud R. Wandwalo and Mørkve, 2000a). The recommended 
pathway to care for TB patients is to present themselves to the appropriate 
healthcare facilities for TB diagnosis after recognition of TB symptoms (Ministry of 
health and social welfare, 2006a; Ngadaya et al., 2008a; WHO, 2016). 
Research has focused predominantly on patients who have already been diagnosed 
within the healthcare system, rather than costs for presumptive TB cases prior to 
diagnosis (Onazi et al., 2015). Costs for presumptive cases are not well understood, 
especially in sub-Saharan Africa (Alobu et al., 2013; Shete P.B et al., 2015). In 
addition to financial costs, sociocultural and gender-related factors can shape how 
patients seek healthcare (WHO, 2005c), yet such studies of the influence of these 
factors are scarce (Somma et al., 2008a). Finally, only few studies have examined 
pathways and costs of seeking health care by comparing confirmed and presumptive 
TB patients (de Cuevas et al., 2016; Laokri et al., 2014; Shete P.B et al., 2015). 
Objective 
We aimed to assess the pathways to care and associated costs of seeking care from 
the onset of symptoms until TB diagnosis in confirmed and presumptive TB patients 
in Dar es Salaam, Tanzania.  
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3.2 Methods 
Study setting and study population 
The study was conducted within the framework of an on-going TB cohort study 
among the adult population in the Temeke district of Dar es Salaam, Tanzania (Said 
et al., 2017). The district is densely populated with a population of 1,369,000 persons 
(The United Republic of Tanzania, 2013a). It ranks as the poorest in the region with 
29% of the households living below the poverty line, resulting in 295 poor persons 
per square kilometre (The United Republic of Tanzania, 2005). The number of health 
facilities in Temeke district is low compared to other districts in the region. There are 
six public or private hospitals, eight health centers, and 121 dispensaries (The 
United Republic of Tanzania, 2014a). In 2011, a total of 4,112 TB cases of all forms 
were notified in the Temeke district, of which 1,760 (43%) were smear-positive 
(Ministry of Health and Social Welfare, 2014a). 
We included adult, sputum smear-positive TB patients and presumptive TB cases 
who were consecutively enrolled in the TB-DAR study (Mhimbira et al., 2017; Said et 
al., 2017) between August 2016 and January 2017, until the target sample size of 
100 patients in each category was reached (Figure 6). Based on power calculation 
and previous studies (Laokri et al., 2014; Shete P.B et al., 2015) we included 100 
confirmed TB patients and 100 presumptive TB patients allowing to detect a 
statistically significant difference in the prevalence of diagnostic delay between the 
two groups of patients with a power of 80%  in case of a true difference of at least 
20%. Inclusion criteria were, (i) ≥18 years of age at recruitment; (ii) bacteriologically 
confirmed TB diagnosis, or with presumptive TB, and (iii) residency in the Wailes I or 
II sub-districts of Temeke. Additionally, patients in both groups were screened for TB 
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using sputum smear microscopy and Xpert MTB/RIF. We excluded patients who did 
not provide consent and those with incomplete data. 
 
 
 
 
 
 
 
 
 
Figure 7.Flowchart of the study population 
Data collection  
Interviews 
We interviewed patients, reconstructed retrospectively visits to healthcare facilities 
and collected data on direct and indirect costs using a standardized questionnaire at 
the TB clinic. The data collected included patient socio-demographic and 
socioeconomic characteristics, TB symptoms, the duration of the time from the onset 
of symptoms until the first help seeking in a healthcare facility, and the number of 
health care facilities that confirmed and presumptive TB patients had visited. Data 
were recorded on tablets using the OpenDataKit (ODK) application (Steiner et al., 
2016).  
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Pathways to care 
Visualization charts were used to reconstruct the pathways to care for each patient 
from the onset of symptoms until TB diagnosis up to five visits. We assessed all 
visits to the healthcare facilities made, including transport used and approximate 
distance from the household to the respective healthcare facilities. Healthcare 
facilities included pharmacies, dispensaries, health centres, traditional and religious 
healers, and private and government hospitals.  
Geographical information system data 
We collected geo-coordinates of health care facilities, including all pharmacies, 
dispensaries, private and governmental hospitals, health centres as well as 
traditional healers identified in the study area. We also collected geo-coordinates of 
households of all patients who participated in the study. 
Costs of care 
We asked patients to estimate direct and indirect costs associated with each visit 
from the onset of symptoms until TB diagnosis, using a standardized questionnaire 
(WHO, 2008). Direct costs included costs for diagnosis (such as costs for X-rays), 
medical costs (as costs for drugs that excluded TB drugs), food, transport, and other 
costs that included special supplements and vitamins. Indirect costs included income 
reduction, decreased  
production costs, coping costs (including the use of savings or selling of household 
assets to cater for sickness), and reduced payment for labour. Calculation of patient 
costs relied upon the 2008 WHO tool (WHO, 2008). We report costs as US Dollars 
(USD), converted from Tanzania shillings using the exchange rate from the Bank of 
Tanzania of USD/TZS 2167.84 as of August 2016.   
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Definitions 
A new TB patient was defined by bacteriological confirmation with sputum smear 
microscopy and/or Xpert MTB/RIF in the absence of prior TB treatment during 
screening (WHO, 2013). A presumptive TB patient was defined by presentation with 
TB symptoms, including coughing for longer than two weeks, fever, night sweats, or 
unexplained weight loss, and who tested negative on sputum smear or Xpert 
MTB/RIF (WHO, 2013). Diagnostic delay was defined according to the framework of 
WHO (29) and used in previous studies (Sreeramareddy CT, Oin ZZ, Satyanarayana 
S, Subbaraman R, 2014; Storla et al., 2008) as the interval between the onset of any 
TB-related symptom and the time of TB diagnosis of more than 3 weeks. Healthcare 
provider was defined as a person or facility that could provide healthcare, this 
included hospitals, pharmacies, and dispensaries, as well as traditional healers. Prior 
medication was defined as the use of any prescribed or self-prescribed medication 
prior to TB diagnosis (Said et al., 2017). We defined patients as poor if their wealth 
fell in the lowest or second-lowest wealth quintile. The non-poor were defined as 
persons in the remaining middle, fourth, and highest wealth quintiles (Ministry of 
Health and Social Welfare, 2016b). 
Statistical and geographical analysis 
We performed descriptive analyses to summarize the data and used χ2 or Fisher`s 
test to assess differences between groups in categorical variables. “A cut off point of 
300 USD was used as a threshold for the monthly household income as indicated in 
another similar study (Said et al., 2017). Cost distributions were described by their 
medians and interquartile ranges (IQR). Costs were further calculated stratifying by 
gender and poverty status. Wealth quintiles were generated following a principal 
component analysis of standard household assets as indicated in the Tanzania 
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household survey (The United Republic of Tanzania, 2013a). To stratify among the 
poor and non-poor, we used wealth indicators relating to household characteristics 
(e.g., roofing type, cooking fuel and nature of flooring) and ownership of assets (e.g., 
radio and mobile phone) to create wealth ranking as used in other studies 
(Kuwawenaruwa et al., 2015; Vyas and Kumaranayake, 2006). Patients in the first 
and second quintiles were considered poor and in the remaining quintiles as non-
poor. We used the nonparametric Kruskal-Wallis test to assess the statistical 
significance of the differences in estimated costs between groups. All significance 
tests were two-sided with a confidence level of 95%. Quintile regression models 
were performed for median costs to examine the association of patient factors with 
the different types of costs. Factors considered in these models included male vs 
female, age in years, unskilled and semi-skilled labour, level of education, and 
diagnostic delay. Statistical analyses were performed using Stata version 14.0 (Stata 
Corporation, College Station, TX, USA). 
We mapped and visualized the pathways of patients to health care providers up to a 
maximum of five visits for the current episode of sickness as described elsewhere 
(Shete P.B et al., 2015; Veesa et al., 2018). We calculated distances in meters as 
the straight-line distance between the patient's household and the nearest health 
facility. The resulting distances were imported into Stata for further analyses. All 
geographical analyses were performed using ArcGIS (version 10.5, Esri, Redlands, 
CA, USA). 
Ethics approval and consent to participate 
The study was approved by Ifakara Health Institute Institutional Review Board 
(IHI/reference no IHI/IRB /09-2016), the Medical Research Coordinating Committee 
of the National Institute for Medical Research in Tanzania (NIMR reference no 
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NIMR/HQ/R.8c/Vol. I/357), and the Ethics Committee of the Canton of Basel (EKNZ 
reference no BASEC UBE-2016-00260). Written informed consent was obtained 
from all study participants.  
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3.3 Results 
Patient characteristics 
The study population includes 100 confirmed and 100 presumptive TB patients 
(Table 1). Patients' median age was 34 years, with presumptive TB patients being 
slightly older than the confirmed patients. Men slightly predominated (55.5%) and 
accounted for almost two thirds of the confirmed patients. Compared to presumptive 
TB patients, confirmed patients had a somewhat higher education, were less likely to 
own a house and use a car transport for their first point of care. They more frequently 
used medication after the onset of symptoms and prior to seeking care at the health 
facilities (71% vs. 44%, p<0.001). The proportion of patients with a monthly 
household income of less than USD 300 was 63% in confirmed and 75% in 
presumptive patients (p=0.06). 
First point of care and diagnostic delay 
Among confirmed patients, 44% first sought care at pharmacies after the onset of 
symptoms, whereas 42% of presumptive patients first sought care at hospitals 
(Table 1). Fewer than 10% of patients in both groups reported visits to traditional 
healers as the first point of care. Confirmed patients frequently indicated more than 2 
visits at health facilities (33% vs. 9%, p<0.001).  
The average time for first seeking healthcare after the onset of symptoms was two 
weeks. Overall, 45.5% sought care within one week after the onset of TB symptoms. 
For 30%, the diagnostic was established within 2-3 weeks. For around every tenth 
there was a diagnostic delay of six weeks or more. The diagnostic delay differed 
significantly between confirmed and presumptive patients, with 41% of confirmed 
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versus 50% of presumptive patients having a short delay (of <1 week). Higher 
proportion of confirmed patients had a diagnostic delay of 4-5 and of ≥6 week  
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Table 1. Socio-demographic characteristics and diagnostic delay for the 
confirmed and presumptive tuberculosis (TB) patients 
Variable 
n (%) 
All 
n=200 
Confirmed 
n=100 
Presumptive 
n=100 
P-value 
Age in years (median, IQR) 34 (27-41.5) 32.5 (26-39) 34 (29-43) 0.055
* 
Age groups    0.22 
18-27 years 52 (26) 30 (30) 22 (22)  
28-37 years 75 (37.5) 39 (39) 36 (36)  
>38 years 73 (36.5) 31 (31) 42 (42)  
Sex    0.016 
Male 111 (55.5) 64 (64) 47 (47)  
Female 89 (44.5) 36 (36) 53 (53)  
Education    0.023 
No education 34 (17) 12 (12) 22 (22)  
Primary education 122 (61) 59 (59) 63 (63)  
Secondary/university 44 (22) 29 (29) 15 (15)  
Occupation    0.081 
Unemployed/housewife 59 (29.5) 30 (30) 29 (29)  
Unskilled labour 49 (24.5) 18 (18) 31 (31)  
Semiskilled labour 92 (46) 52 (52) 40 (40)  
Household size     
<4 93 (46.5) 45 (45) 48 (48) 0.67 
≥4 107 (53.5) 55 (55) 52 (52)  
House ownership    0.050 
Rented 135 (67.5) 74 (74) 61 (61)  
Own 65 (32.5) 26 (26) 39 (39)  
Household income    0.067 
≤300 USD per month 138 (69.0) 63 (63) 75 (75)  
>300 USD per month 62 (31.0) 37 (37) 25 (25)  
Wealth quintile     
Poor -households 47 (23.5) 21 (21) 26 (26) 0.54 
Second 33 (16.5) 16 (16) 17.0 (17)  
Middle 41 (20.5) 19 (19) 22 (22)  
Fourth 44 (22.0) 27 (27) 17 (17)  
Non-poor households  35 (17.5) 17 (17) 18 (18)  
Prior Medication    <0.001 
Yes 115 (57.5) 71 (71) 44 (44)  
No 85 (42.5) 29 (29) 56 (56)  
First point of care    0.004 
Hospitals 70 (35.0) 28 (28) 42 (42)  
Dispensaries 49 (24.5) 19 (19) 30 (30)  
Pharmacies 66 (33.0) 44 (44) 22 (22)  
Traditional healers 15 (7.5) 9 (9) 6 (6)  
HC facility visits    <0.001 
≤2  158 (79.0) 67 (67) 91 (91)  
>2  42 (21.0) 33 (33) 9 (9)  
Transport used for first point of 
care 
    
Car 70 (35.5) 22 (22) 48 (48) <0.001 
On foot 95 (47.5) 65 (65) 30 (30)  
Motorcycle/tricycle 35 (17.5) 13 (13) 22 (22)  
Diagnostic delay (weeks)     
0-1  91 (45.5 41 (41) 50 (50) 0.04 
2-3 60 (30) 26 (26) 34 (34)  
4-5 27 (13.5) 19 (19) 8 (8)  
6+ 22 (11) 14 (14) 8 (8)  
 
HC, health facility; IQR, interquartile range; USD, United States Dollar 
* 
Wilcoxon-rank sum test  
P-values provided by Chi-square tests and Fisher's exact test 
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Pathways to care 
The spatial distribution of healthcare facilities in the study area show pharmacies and 
dispensaries are distributed over the whole area Figure 8A. Hospitals are situated 
mainly in the urban centres and traditional healers predominantly in the peripheral 
area. Figures (8B) and (8C) offer examples of pathways to care until TB diagnosis in 
confirmed and presumptive patients. Pathways in confirmed patients involved 
several visits to the healthcare facilities before TB diagnosis. Pathways in 
presumptive patients were more direct with only one or few visits to healthcare 
facilities before TB diagnosis.  
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Figure 8. Geographical analyses of health care facilities and pathways to care of 
confirmed and presumptive TB patients in Temeke District Dar es Salaam Tanzania. 
Panel A: Spatial distribution of healthcare facilities in the study area. Panel B: Possible 
pathways to care of confirmed TB patients while seeking healthcare. Various types of 
healthcare facilities as the entry point into the healthcare system until final diagnosis at the 
TB clinic are shown. Panel C: Possible pathways to care of presumptive TB patients while 
seeking healthcare. Various types of healthcare facilities as the entry point into the 
healthcare system until final diagnosis at the TB clinic are shown.  
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The median total distance from patients' households to healthcare facilities including 
hospitals, pharmacies, dispensaries, and traditional healers was 2,338 meters (IQR 
1,373-4,122) for confirmed patients, and 2,009 meters (IQR 986-2,976) for 
presumptive patients (p=0.25). Among confirmed patients, 37% lived within 500 
meters near a pharmacy, as did 42% of presumptive patients. Eighty-three per cent 
of confirmed patients and 72% of presumptive patients lived within 1,000 meters 
from the nearest hospital. We did not find an association of the distance from 
patients’ household to the nearest possible healthcare facility with patient 
characteristics such as being poor (defined as being in the lowest wealth quintile), 
prior use of medication, or having more than two healthcare visits in multivariate 
analysis. 
While seeking care at pharmacies was prominent for the first visit in confirmed 
patients and also reported by a fifth of the presumptive patients, subsequent visits at 
pharmacies were mentioned much less (Figure 9). The second visit was 
characterised by a large proportion of both patients seeking healthcare at hospitals. 
Confirmed patients had more visits to healthcare facilities compared to presumptive 
patients (none of the presumptive patient’s indicated a fourth and fifth visit).  
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Figure 9. Margin plots showing associations between total costs and diagnostic delay 
in confirmed TB patients (panel A) and presumptive TB patients (panel B). 
Associations between median total costs and diagnostic delay were modelled by quadratic 
polynomials. The p-values are from Wald test of the linear and quadratic terms of the 
diagnostic delay (p<0.001 for panel A, p=0.08 for panel B) 
Costs associated with seeking care 
Patients spent a median of 31% (IQR 15.0-56.3%) of their monthly household 
income for health expenditures for all visits for TB diagnosis. For the first visit 
confirmed patients had lower median costs than presumptive patients (USD 8.3 [IQR 
4.6-17.5] vs. 13.8 [IQR 6.0-20.5]), but their costs were comparatively higher with 
increasing number of visits (Supplementary Table 1). 
55 
Overall, indirect costs were considerably higher than direct costs, both in confirmed 
and presumptive patients from the onset of symptoms until confirmation/exclusion of 
TB (Table 2). Confirmed patients had higher diagnostic costs than presumptive 
patients (USD 7.0 [IQR 5.8-9.2] and 5.3 [IQR 1.4-7.0), higher food costs, and higher 
informal payments. Among the indirect costs, income reduction was considerably 
higher for confirmed TB patients than presumptive patients. (USD 23.1 [IQR 6.9-
55.4] vs. 9.2 [IQR 1.4-25.4]). 
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Table 2. Direct and indirect costs (in USD) from the onset of symptoms until confirmation/exclusion of TB among confirmed and 
presumptive TB patients. 
Costs 
 
All 
(n=200) 
Confirmed TB patients 
(n=100) 
Presumptive TB patients 
(n=100) 
P-value  
Average number of visits (range) 1.2 (1-5) 1.3 (1-5) 1.1 (1-3) 
 
Direct costs  Median, (IQR) Median, (IQR) Median, (IQR)  
Diagnostic costs 7.0 (2.3-8.8) 7.0 (5.8-9.2) 5.3 (1.4-7.0) <0.001 
Medication costs 2.8 (1.4-8.0) 2.8 (1.4-9.2) 2.8 (1.4-7.4) 0.873 
Food costs 2.3 (1.4-4.2) 3.2 (1.8-5.3) 1.8 (1.0-2.5) <0.001 
Transport costs 3.2 (1.8-5.5) 3.2 (1.4-5.5) 3.7 (1.8-6.00) 0.154 
Informal payments 2.3 (1.4-4.2) 2.8 (2.3-7.4) 2.1 (1.0-2.8) <0.001 
Other direct costs 4.6 (2.3-9.7) 4.6 (2.3-9.5) 4.4 (2.3-9.7) 0.567 
Sub-total direct costs 24.7 (16.1-42.4) 27.4 (18.7-48.4) 19.8 (13.8-33.9) 0.02 
     
Indirect costs (median, (IQR)     
Coping costs  11.3 (4.6-23.1) 11.5 (4.61-20.98) 9.2 (4.6-27.7) 0.765 
Income reduction 15.7 (3.7-36.9) 23.1 (6.9-55.4) 9.2 (1.4-25.4) 0.001 
Decreased production 9.2 (1.4-23.06) 10.0 (3.2-26.3) 9.2 (0-16.8) 0.137 
Less paid labour 4.61 (0-12.0) 5.07 (0-15.22) 4.61 (0-9.2) 0.467 
Other indirect costs 8.5 (1.8-19.4) 11.8 (1.4-23.1) 6.5 (2.3-13.8) 0.056 
Sub-total indirect costs 60.0 (25.1-141.1) 66.9 (35.1-149.9) 46.8 (20.1-115.3) 0.006 
Total costs 83.0 (46.4-173.9) 99.2 (64.3-190.0) 67.11 (37.1-161.0) 
0.003 
IQR, interquartile range; TB, tuberculosis; USD United States Dollar (1 USD=2168 Tanzania shillings, exchange rates as of August 2016). P-values provided by Wilcoxon rank sum test. 
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Gender, poverty status and costs 
Costs for different patients groups differed significantly. Overall, the median total 
direct costs were similar for men, USD 24.9 (IQR 17.5-41.9), and women, USD 24.6 
(IQR 16.1-42.4 p=0.66). Indirect costs for men, USD 64.6 (IQR 31.8-159.1), were 
significantly higher than those for women, at USD 55.6 (IQR 25.1-141.1, p<0.001). 
Analyses stratified by sex and poverty status indicate that poor men with confirmed 
TB had lower total direct costs compared to poor women (USD 24.4 [IQR 18.9-47.9] 
vs. 30.0 [IQR 18.68.5-49.58.]) (Table 3). For the presumptive TB patients total direct 
costs for poor men differed slightly from those of poor women (USD 22.6 [IQR 17.5-
29.1] vs. 20.5 [IQR 14.3-35.1]). Among the non-poor men and women, direct costs 
varied only little in confirmed and presumptive patients. In confirmed patients, 
diagnostic costs were lower among poor men compared to poor women (USD 6.91 
[IQR 4.61-9.22] vs. 7.61 [IQR 1.38-10.14]), whereas for the presumptive patients, 
diagnostic costs were the same among poor men and women 
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Table 3. Direct costs (in USD) of seeking healthcare among confirmed and presumptive TB patients, according sex and 
poverty status  
IQR, interquartile range; USD, United States Dollar (1 USD=2168 Tanzania shillings, exchange rates as of August 2016) Other direct costs including costs of special supplements and vitamins 
required due to illness or additional direct costs due to chronic illness for which patients were receiving treatment for besides the costs for TB diagnosis.  
1 
Poor or second lowest wealth quintile 
2 
Non-poor middle, fourth and highest wealth quintile. 
Variable All 
 
Confirmed  Presumptive 
   
Men Women  Men Women 
Median (IQR)  
 
Poor
1 
n=21 
Non-poor
2
 
n=43 
Poor 
n=16 
Non-poor 
n=20 
 
Poor 
n=15 
Non-poor 
n=32 
Poor 
n=28 
Non-poor n=25 
Diagnostic costs 
6.92 
(3.22-9.23) 
 
6.91 
4.61-9.22 
6.91 
(6.91-9.22 
7.61 
(1.38-10.14) 
7.61 
1.84-11.53 
 
4.61 
(0.92-6.91) 
6.91 
(2.07-9.68) 
4.61 
(1.84-6.91) 
6.91 
(3.22-9.22) 
Medication costs 3.69 
(1.84 -8.99) 
 5.53 
(2.30-16.14) 
2.30 
(1.38-6.91) 
3.45 
(0.92-8.76) 
3.92 
(2.07-13.60) 
 4.15 
(1.38-9.22) 
5.30 
(2.30-8.76) 
3.45 
(1.84-8.99) 
3.69 
(2.30-6.91) 
Food costs 2.31 
(1.38-4.61) 
 3.22 
(1.84-6.45) 
4.15 
(1.84-5.07) 
2.53 
(1.84-6.68) 
3.45 
(2.30-6.22) 
 1.38 
(0.92-2.30) 
2.07 
(1.15-2.99) 
1.84 
(0.92-2.53) 
2.30 
(0.92-2.76) 
Transport costs 3.69 
(1.84-5.76) 
 3.69 
(1.84-5.53) 
2.76 
(1.38-5.53) 
3.00 
(0.69-4.84) 
3.69 
(2.07-5.53) 
 3.22 
(1.38-5.07) 
4.38 
(2.53-6.91) 
3.69 
(2.07-6.45) 
4.61 
(2.30-6.00) 
Informal payments 2.30 
(1.38-4.61) 
 2.30 
(2.30-6.45) 
2.30 
(2.30-9.68) 
3.22 
(2.30-12.91) 
3.92 
(1.61-7.38) 
 1.84 
(0.92-2.30) 
2.30 
(1.61-3.69) 
1.16 
(0.92-3.22) 
2.30 
(0.92-2.77) 
Other direct costs 5.53 
(2.77-10.61) 
 5.07 
(2.30-6.45) 
6.45 
(3.69-10.60) 
6.91 
(4.84-8.30) 
9.91 
(4.84-15.00) 
 5.07 
(1.38-9.68) 
5.30 
(2.07-12.00) 
3.45 
(2.30-10.60) 
5.53 
(3.69-10.60) 
Total direct costs 27.21 
(18.45-43.12) 
 24.44 
(18.91-47.97) 
29.98 
(22.60-43.35) 
30.00 
(18.68-49.58) 
32.51 
(17.98-55.81) 
 22.60 
(17.52-29.05) 
25.13 
(15.91-44.28) 
20.52 
(14.29-35.05) 
26.75 
(17.98-37.82) 
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Total indirect costs, (Table 4) among poor confirmed TB patients were higher in men 
than women, (USD 84.4 [IQR 55.3-125] vs. 51.7 [IQR 27.6-73.4]), while this gender 
difference was absent in non-poor confirmed patients. Among presumptive TB 
patients, poor men faced higher total indirect costs than poor women (USD 50.2 
[IQR 27.6-83.4]) vs. 39.2 [IQR 18.6-116.0]). 
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Table 4 Indirect costs (in USD) of seeking health care among confirmed and presumptive TB patients, according to sex 
and poverty status 
Variable All  Confirmed  Presumptive 
   Men Women  Men Women 
Median (IQR)  
 Poor 
n=21 
Non-poor n=43 
Poor 
n=16 
Non-poor 
n=20 
 Poor 
n=15 
Non-poor n=32 
Poor 
n=28 
Non-poor 
n=25 
Coping costs 
13.37 
(6.91-25.36) 
 
10.60 
(4.61-18.45) 
13.83 
(6.91-20.75) 
13.53 
(8.53-17-75) 
23.06 
(9.22-34.59) 
 
9.22 
(6.91-13.83) 
13.37 
(4.61-27.67) 
15.91 
(6.22-140-35) 
9.22 
(0-18.45) 
Income reduction 
18.45 
(4.61-35.51) 
 
29.98 
(23.06-46.12) 
23.06 
(11.53-59.96) 
14.52 
(5.76-28.13) 
23.06 
(0-53.04) 
 
9.22 
(3.69-36.90) 
15.22 
(6.68-29.98) 
4.61 
(0.69-11.53) 
11.53 
(0-23.06) 
Decreased production 
9.22 
(2.30-23.06) 
 16.14 
(7.38-23.06) 
12.00 
(4.61-31.36) 
6.91 
(2.30-13.37) 
9.45 
(0-32.51) 
 9.22 
(4.61-20.75) 
13.14 
(4.61-31.13) 
4.61 
(0-13.14) 
9.22 
(0-14.76) 
            
Less paid labour 
4.61 
(0-12.0) 
 
6.91 
(0-17.52) 
6.91 
(0-18.45) 
0 
(0-6.45) 
1.61 
(0-18.45) 
 
 
5.53 
(0-13.83) 
5.75 
(0-13.37) 
4.61 
(0-10.37) 
1.38 
(0-6.91) 
Other indirect costs 
8.53 
(1.38-19.37) 
 11.53 
(1.38-26.29) 
12.0 
(0-23.06) 
11.53 
(2.53-18.45) 
11.53 
(3.69-26.06) 
 9.68 
(3.22-13.83) 
8.53 
(4.38-21.90) 
5.76 
(0.69-11.07) 
3.22 
(0.92-9.22) 
Total indirect costs 
61.34 
(27.90-128) 
 
84.40 
(55.35-125) 
71.03 
(51.66156.36) 
51.66 
(27.67-73.80) 
70.80 
(31.82-148.52) 
 
50.27 
(27.67-83.48) 
55.11 
(30.21-166.28) 
39.20 
(18.68-116.00) 
39.20 
(21.67-65.95) 
IQR, interquartile range; USD, United States Dollar (1 USD=2168 Tanzania shillings, exchange rates as of August 2016)  
Other indirect costs including costs that were not treated as direct labour or additional indirect costs due to chronic illness for which patients were receiving treatment for besides the costs for TB 
diagnosis 
1 
Poor or second lowest wealth quintile 
2 
Non-poor middle, fourth and highest wealth quintile
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Determinants of cost differences 
On average, each week of diagnostic delay was associated with an increase in 
median total costs (direct and indirect costs) among confirmed patients by 1.44 USD 
(95%CI: (-19.56, -6.63), p <0.001), but no significant association was seen in 
presumptive patients (Table 5). Diagnostic delay was associated with an increase in 
total direct costs in confirmed patients (USD 0.52 per week, 95%CI: (0.34, 0.70), 
p<0.001), but with a decrease in presumptive patients (USD -0.84 per week, 95%CI: 
(-1.32,-0.35), p=0.001). For total indirect costs, the pattern was similar, but neither of 
the two associations reached statistical significance. 
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Table 5. Estimates of effects of different factors on median direct, indirect and total costs in USD among confirmed and 
presumptive TB patients 
Variable All 
   
Confirmed 
    
Presumptive 
  
*Difference 
 
95% CI 
 
P-value 
  
*Difference 
 
95% CI 
  
P-value 
  
*Difference 
 
95% CI 
 
P-value 
             
Total direct costs             
Males vs females -1.71 -11.80, 8.38 0.73  -2.31 -20.29, 15.67  0.79  -3.58 -9.80-2.63 0.25 
Age (per year) -0.01 -0.48, 0.46 0.97  0.28 -0.70, 1.26  0.57  0.06 -0.19, 0.31 0.31 
Unskilled labour
1
 1.80 -11.40, 15.01 0.78  -7.55 -33.38, 18.26  0.56  2.20 -5.18, 9.59 0.55 
Semi-skilled labour
1
 2.87- -8.75, 14.48 0.62  5.01 -14.66, 24.69  0.61  1.87 -5.49, 9.23 0.61 
Poor vs non-poor -2.34 -12.19, 7.51 0.63  19.73 --56.98, 96.46  0.61  -2.40 -8.07, 3.27 0.40 
Primary education
2
 3.18 -10.21, 16.56 0.64  8.96 -17.83, 35.76  0.66  0.66 -6.47 7.78 0.85 
Secondary education 6.12 -11.16, 23.40 0.48  20.86 -11.40, 53.12  0.20  4.22 -5.88, 14.32 0.40 
University
2
 9.36 -19.07, 37.84 0.51  10.53 -35.17, 56.25  0.46  -0.59 -21.14, 19.95 0.95 
Diagnostic delay  0.04 -0.08,0.16 0.52  0.52 0.34, 0.70  <0.001  -0.84 -1.32,-0.35 0.001 
Total indirect costs             
Males vs females 11.63 -11.37, 34.63 0.32  6.60 -33.93, 47.14  0.74  1.85 -34.74, 38.44 0.92 
Age (per year) 0.38 -0.69-1.45 0.48  0.07 -2.14, 2.29  0.94  0.75 -0.74, 2.24 0.32 
Unskilled labour 12.68 -17.41, 42.78 0.40  14.47 -43.74, 72.700  0.62  19.13 -24.32, 62.11 0.38 
Semi-skilled labour 20.90 -5.58, 47.38 0.12  37.24 -7.11, 81.60  0.09  22.94 -20.38, 66.27 0.29 
Poor vs non-poor 6.29 -16.15, 28.75 0.58  6.92 -33.36, 47.20  0.73  5.82 -27.53, 39.18 0.72 
Primary education 21.24 -9.27, 51.75 0.17  8.96 -51.46, 69.37  0.76  20.0 -20.34, 60.34 0.32 
Secondary/ University 70.14 9.47, 130.80 0.02  56.88 11.71, 125.47  0.10  -38.5 16.52, 93.52 0.16 
Diagnostic delay 0.46 0.18-0.74 0.001  0.57 0.16, 0.97  0.07  -1.25 -4.11, 1.60 0.38 
Total costs             
Males vs females 9.87 -26.39, 46.14 0.59  -4.98 -58.90, 48.93  0.85  -0.62 -44.96, 43.71 0.97 
Age (per year) 0.34 -1.34, 2.03 0.68  -0.56 -3.50, 2.38  0.70  0.74 -1.06, 2.55 0.41 
Unskilled labour 11.95 -35.50, 59.40 0.62  8.25 -69.18, 85.69  0.83  16.02 36.64, 68.69 0.54 
Semi-skilled labour 30.47 -11.28, 72.23 0.15  58.81 -0.18, 117.81  0.05  26.64 -25.86, 79.14 0.31 
Poor vs non-poor 0.89 -34.50, 36.31 0.96  8.39 -45.18, 61.98  0.75  2.39 -38.01, 42.81 0.90 
Primary education 24.87 -23.25, 72.98 0.31  19.73 -60.62, 100.09  0.62  18.06 -32.75, 68.88 0.48 
Secondary  education 69.54 7.43, 131.16 0.02  69.45 -27.29, 166.19  0.15  46.10 -25.86, 79.14 0.20 
University 108.89 6.63, 211.16 0.03  69.20 -67.87, 206.28  0.31  -15.74 -162.23, 130.73 0.83 
Diagnostic delay 1.29 0.84.1.73 <0.001  1.44 -19.56, -6.63  <0.001  -2.40 -5.86,1.06 0.17 
*Estimated differences in median costs are presented with the corresponding 95% confidence intervals (95% CI); Diagnostic delay was defined as delay in seeking care three weeks or more after 
the onset of symptoms. Multivariable quintile regression was performed for median costs to examine the association of patient factors with different types of costs. Separate models were run for 
direct, indirect and total costs. 
1 
Reference: Unemployed 
2
Reference: no educatio
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Overall, having a university degree was significantly associated with higher indirect 
costs (USD 70.14, 95%CI: (9.47, 130.80), p=0.02). None of other factors of the 
model were significantly associated with median costs. The pattern of positive 
association between diagnostic delay and total costs among confirmed patients and 
negative association among presumptive patients was further supported by analyses 
using linear and quadratic terms (Figure 10).  
 
 
 
 
 
Figure 10. Margin plots showing associations between total costs and diagnostic 
delay in confirmed TB patients (panel A) and presumptive TB patients (panel B). 
Associations between median total costs and diagnostic delay were modelled by quadratic 
polynomials. The p-values are from Wald test of the linear and quadratic terms of the 
diagnostic delay (p<0.001 for panel A, p=0.08 for panel B) 
Furthermore, we conducted regression analyses separately for different types of 
costs (Supplementary table 2 and Supplementary table 3). Medication costs in 
confirmed patients increased with the number of weeks of delay (USD 0.13 per 
week, 95%CI: (0.06, 0.19), p<0.001), but not in presumptive patients. Transport 
costs were significantly lower among men and women with presumptive TB (USD -
1.54, 95%CI: (-3.12, -0.03), p < 0.05). We further observed an increase in coping 
costs with the length of diagnostic delay in both confirmed and presumptive patients 
(Supplementary Table 3). Finally, in patients with presumptive TB, costs due to 
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decreased production were significantly higher among unskilled labourers (USD 
8.71, 95%CI: (0.53, 16.89), p=0.03).  
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3.3 Discussion 
This study indicates that pathways to care of the confirmed TB patients are more 
complex compared to those of presumptive patients, involving visits at several 
healthcare providers among whom not all have necessary diagnostic equipment. A 
diagnostic delay of six weeks or more after the onset of symptoms was reported by 
10% of the patients. Fifty percent of the patients visited healthcare facilities within 
one week after onset of symptoms. In seeking care, patients incur substantial direct 
and indirect costs. The costs of care were higher in confirmed patients than in 
presumptive patients. For half of the confirmed patients, direct costs account for 
more than 30% of the monthly household income. Total costs were associated with 
diagnostic delay among confirmed patients only. The indirect costs were higher for 
men than for women whereas direct costs did not differ. Among the poor, direct costs 
were higher in women and indirect costs higher in men. 
Almost half of the confirmed TB patients began their search for care at pharmacies, 
and patients in both groups sought care from more than one healthcare provider 
before a diagnosis. This highlights a diagnostic shortfall in some healthcare facilities 
and poor management of patients as documented elsewhere (Laokri, 2017), and 
partially explains the diagnostic delay. Compared to findings of other studies (Getnet 
et al., 2017a; Ngadaya et al., 2008a) the observed diagnostic delay in our study was 
lower. However, a delay of at least 6 weeks observed in 10% of our study population 
still requires attention. Most patients lived near healthcare facilities, and only 9% of 
the confirmed TB patients and 6% of the presumptive TB patients reported visiting 
traditional healers. Living near healthcare facilities might have an impact on 
treatment seeking (Lake et al., 2011). We investigated the impact of geographical 
distance between household and health facility on health-seeking behaviour, but 
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found no associations between distance and patient characteristics such as being 
poor, prior use of medication and having more than two visits to the healthcare 
facility. This is contrary to some other results that found distance to have an impact 
on patient characteristics such as treatment completion and diagnostic delay (Cai et 
al., 2015; Ibrahim et al., 2014; Sreeramareddy CT, Oin ZZ, Satyanarayana S, 
Subbaraman R, 2014). Diagnostic delay was significantly associated with direct 
costs, indirect costs (borderline significance) and total costs in confirmed patients. 
The most likely explanation for this finding is that diagnostic delay worsens patients’ 
morbidity, especially in confirmed TB patients, thus increasing costs of healthcare 
(Cai et al., 2015).  
Patients in both groups spent a median proportion of around 30% of their monthly 
household income on health expenditures for up to five visits. The economic burden 
of direct and particularly indirect costs of seeking TB care for patients and their 
households are high for the marginalized population, which is most at risk of 
acquiring TB. These findings are consistent with other studies that show patients in 
low-and-middle income countries face a very high economic burden of seeking TB 
care (Tanimura et al., 2014), and expenditures for seeking healthcare for TB can 
cause or exacerbate poverty (Barter et al., 2012a). The total costs for presumptive 
TB patients were lower compared to confirmed cases in our study. These results are 
also consistent with those reported in other settings where half of the total costs for 
seeking healthcare are pre-treatment costs which disproportionately affect poor TB 
patients (Tanimura et al., 2014) 
While direct costs were relatively low, they may be catastrophic for patients who are 
semiskilled labourers reporting monthly household income of less than 300 USD. 
Their situations can further be worsened by employment in the informal sector that 
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lacks sickness benefits (Barter et al., 2012a). Confirmed TB patients encountered 
higher indirect costs compared to presumptive patients, which may be due to the 
prolonged time required for diagnosis leading to their substantially higher income 
reduction as shown in our study. 
We found higher indirect costs among poor men compared to poor women. This was 
mainly due to their more pronounced income reduction and decreased production. 
Although the direct and indirect costs were higher for men than for women, the costs 
of ill health are usually more profound for women and their households than for men. 
When women get sick the impact of the disease on their children and their families is 
stronger than when men get sick (Kemp et al., 2007). Furthermore, financial burden 
may limit access to care for both confirmed and presumptive female TB patients 
since most of them lack financial autonomy. Moreover, their lower status in 
households deprioritizes their health. 
Article summary 
Strengths and limitations of this study 
Our study is the first to look at pathways to care and assess costs of care before the 
start of treatment in confirmed and presumptive TB patients in an urban Tanzania 
setting. Studies have focused on pathways and costs of care in confirmed TB 
patients and ignore the effects on presumptive cases. Furthermore, it’s the first study 
to estimate costs by stratifying according to poverty status and gender in sub-
Saharan Africa. However, this study has some limitations. First, recall bias is a 
concern when inquiring about the costs incurred during health-care seeking. This 
might influence the accuracy of the reported costs and pathways to care. However, 
we attempted to limit the recall bias by linking questions about costs with memorable 
events such as the onset of symptoms or first care seeking. Our interviews were also 
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conducted by well-trained personnel who spent enough time with the respondents so 
as to obtain answers that were as accurate as possible. Furthermore, we only 
addressed pathways and costs of care until TB diagnosis to the public healthcare 
facilities. Therefore, we might have left out costs of care for the patients who had 
their final diagnosis at the private and faith based healthcare facilities. Finally, we 
only estimated the costs for TB diagnosis. However, comorbidities may have caused 
higher costs, but this is equally true for confirmed as well as presumptive TB 
patients.  
3.4.1 Conclusions 
This study demonstrates the complexity of pathways until diagnosis in confirmed TB 
patients. It also highlights the high financial burden for the period between symptom 
onset and diagnosis for confirmed and presumptive TB patients, and points to 
different direct and indirect costs among poor men and women. This underscores the 
need to strengthen the healthcare sector to ensure early diagnosis of TB. Ensuring 
integration of different healthcare providers including private, public health 
practitioners and patients themselves could help not only in reducing the complex 
pathways during healthcare seeking, but also effective health care utilization (Laokri, 
2017). Reducing the direct and indirect costs associated with treatment seeking is 
likely to support confirmed and presumptive TB patients in timely accessing health 
care for TB diagnosis and treatment. Decreasing or removing user fees and further 
decentralization of TB care could reduce diagnostic delay and lower expenditures. 
Additionally, strengthening of health systems policies including protection of patients 
against the catastrophic direct and indirect costs, as well as ensuring universal 
access to healthcare must be interpreted into actions for a better TB control 
(Lienhardt et al., 2012). These interventions are central for reaching the ambitious 
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WHO targets of zero deaths, disease, and suffering due to TB by 2035 (WHO, 
2015b).  
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Supporting Information 
Supplementary Table 1. Direct costs associated with first, second and >2 visits 
for patients with confirmed and presumptive TB 
IOR, interquartile range; USD, United States Dollar (1 USD=2168 Tanzania shillings, exchange rates as of August 2016); 
MMHI, median monthly household income
Visit 
All 
n (%) 
 
Cost of visit/patient in USD 
Median (IQR) 
 
Costs as a % of MMHI 
Median (IQR) 
   Confirmed Presumptive  Confirmed Presumptive 
First visit 200 (100)  8.30 (4.6-17.5) 13.8 (6.0-20.5)  9.1 (3.7-18.3) 15.1 (8.0-34.8) 
Second visit 90 (45)  15.2 (11.0-24.0) 14.3 (12.0-22.1)  14.5 (8.7-28.5) 19.7 (10.0-32.0) 
Third to fifth 
visit 
42 (21)  27.2 (14.8-38.7) 13.4 (12.9-20.3)  24.6 (13-42) 
 
13.3 (12.0-14.3) 
 
Total direct costs  27.4 (18.7-48.4) 19.8 (13.8-34.0)  30.5 (16.5-53.5 29.0 (14.1-52.1 
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Supplementary Table 2. Estimates of effects of different factors on median types of direct costs in USD among confirmed 
and presumptive TB patients. 
Variable All  Confirmed  Presumptive 
 Difference* 95% CI P-value  Difference* 95% CI P-value  Difference* 95% CI P-value 
 
Diagnostic costs 
           
Males vs females 0.29 -1.33, 1.93 0.71  -0.17 -2.85, 2.52 0.90  -0.95 -3.45, 1.54 0.45 
Age (in years) 0.03 -2.67,0.51 0.18  -0.05 -0.20, 0.01 0.45  0.07 -0.03, 0.17 0.18 
Unskilled labour1 1.71 -0.42,.84 0.11  1.32 -2.53, 5.19 0.49  1.99 -0.97, 4.96 0.18 
Semi-skilled1 1.22 -0.65,3.10 0.20  1.77 -1.17, 4.71 0.34  2.66 -0.29, 5.62 0.07 
Poor vs non-poor -1.08 -2.67,0.51 0.18  -0.16 2.83, 2.50 0.90  -1.80 -4.08, 0.48 0.12 
Primary education2 1.14 -1.03, 3.30 0.30  3.03 -0.98, 7.03 0.13  -0.27 -3.12, 2.59 0.85 
Secondary education 2.49 0.29, 5.29 0.08  3.80 -1.02, 8.62 0.12  0.89 -3.17, 4.95 0.85 
University2 6.16 1.56, 10.76 0.09  3.30 -3.53, 10.14 0.34  3.72 -4.54, 11.97 0.37 
Diagnostic delay -0.02 -0.02, 0.19 0.97  0.01 -0.01, 0.04 0.49  -0.07 -0.03, 0.12 0.45 
Medication costs            
Males vs females -0.31 -3.65, 3.09 0.85  -0.69 -7.40, 6.01 0.83  0.45 -2.23-3.13 0.73 
Age (in years) -0.03 0.18, 0.13 0.74  -0.01 -0.38-, 0.35 0.95  -0.05 -0.16, 0.06 0.36 
Unskilled labour 0.13 -4.23, 4.49 0.95  -0.03 -9.67, 9.61 0.99  -0.68 -3.86-2.49 0.67 
Semi-skilled labour -0.03 -3.86, 3.81 0.99  0.92 -6.41, 8.27 0.80  -2.01 -5.17, 1.16 0.21 
Poor vs non-poor 0.62 -2.64, 3.87 0.71  0.77 -5.90, 7.43 0.82  0.31 -2.12, 2.75 0.80 
Primary education 1.26 -3.16-5.68 0.57  2.04 -7.95, 2.04 0.68  0.88 -2.18, 3.95 0.56 
Secondary education 1.54 -4.17, 7.25 0.59  4.28 -7.75, 16.32 0.48  0.58 -3.76, 4.93 0.79 
University 0.24 9.16, 9.64 0.95  1.98 -15.08, 
19.03 
0.81  4.24 -4.60, 13.08 0.34 
Diagnostic delay 0.06 0.02, 0.10 0.002  0.13 0.06, 0.19 <0.001  -0.17 -0.38, 0.04 0.11 
Transport costs            
Males vs females -1.02 -2.19, 0.13 0.08  -0.52 -2.25, 1.21 0.55  -1.54 -3.12, 0.03 0.05 
Age (in years) 0.02 -0.03, 0.74 0.45  0.02 -0.07, 0.12 0.66  -0.01 -0.71, 0.06 0.84 
Unskilled labour 1.39 -0.12, 2.90 0.07  -0.29 -2.78, 2.20 0.81  2.36 0.49, 4.24 0.01 
Semi-skilled 0.35 -0.98, 1.68 0.60  0.49 -1.41, 2.39 0.61  0.94 -0.92, 2.81 0.31 
Poor vs non-poor -0.36 -1.48-0.76 0.53  0.92 -0.80, 2.64 0.29  -0.32 -1.76, 1.11 0.65 
Primary 1.17 -0.36-2.71 0.13  1.16 -1.41, 3.75 0.37  0.84 -0.96, 2.65 0.35 
Secondary education 1.41 -0.56-3.39 0.16  2.20 -0.91, 5.31 0.16  -0.13 -2.70, 2.42 0.91 
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University 1.48 -1.78-4.74 0.37  0.99 -0.80, 2.64 0.65  0.32 -4.89-5.53 0.90 
Diagnostic delay 0.01 -0.04-0.24 0.16  0.03 0.01, 0.05 0.002  -0.01 -0.22, 0.30 0.13 
Total direct cots            
Males vs females -1.71 -11.80, 8.38 0.73  -2.31 -20.29, 
15.67 
0.79  -3.58 -9.80, 2.63 0.25 
Age (per year) -0.01 -0.48,  0.46 0.97  0.28 -0.70,1.26 0.57  0.06 -0.19 0.31 
Unskilled labour 1.80 -11.40, 
15.01 
0.78  -7.55 -33.38, 
18.26 
0.56  2.20 -5.18, 9.59 0.55 
Semi-skilled labour 2.87- -8.75,14.48 0.62  5.01 -14.66, 
24.69 
0.61  1.87 -5.49, 9.23 0.61 
Poor vs non-poor -2.34 -12.19,7.51 0.63  7.44 -10.42, 
25.31 
0.41  -2.40 -8.07, 3.27 0.40 
Primary education 3.18 -10.21,16.56 0.47  8.96 -17.83, 
35.76 
0.66  0.66 -6.47, 7.78 0.85 
Secondary education 6.12 -11.16, 
23.40 
0.48  20.86 -11.40, 
53.12 
0.20  4.22 -5.88, 14.32 0.40 
University 9.36 -19.07, 
37.84 
0.51  10.53 -35.17, 
56.25 
0.64  -0.59 -21.14, 19.95 0.95 
Diagnostic delay 0.04 -0.08, 0.16 0.52  0.52 0.34, 0.70 <0.001  -0.84 -1.32, -0.35 0.001 
Total costs            
Males vs females 9.87 -26.39, 
46.14 
0.59  -4.98 -58.90, 
48.93 
0.85  -0.62 -44.96, 43.71 0.97 
Age (per year) 0.34 -1.34, 2.03 0.68  -0.56 -3.50, 2.38 0.70  0.74 -1.06, 2.55 0.41 
Unskilled labour 11.95 -35.50, 
59.40 
0.62  8.25 -69.18, 
85.69 
0.83  16.02 36.64, 68.69 0.54 
Semi-skilled labour 30.47 -11.28, 
72.23 
0.15  58.81 -0.18, -
117.81 
0.05  26.64 -25.86, 79.14 0.31 
Poor vs non-poor 0.89 -34.50, 
36.31 
0.96  8.39 -45.18, 
61.98 
0.75  2.39 -38.01, 42.81 0.90 
Primary education 24.87 -23.25-72.98 0.31  19.73 -60.62, 
100.09 
0.62  18.06 -32.75, 68.88 0.48 
Secondary education 69.54 7.43-131.65 0.02  69.45 -27.29, 
166.19 
0.15  46.10 -25.86, 79.14 0.20 
University 108.89 6.6, 211.16 0.03  69.20 -67.87, 
206.28 
0.31  -15.74 -162.23, 130.73 0.83 
Diagnostic delay 1.29  0.84, 1.73 <0.001  1.44 -19.56, -6.63 <0.001  -2.40 -5.86, 1.06 0.17 
*Estimated differences in median costs are presented with the corresponding 95% confidence intervals (95% CI); Diagnostic delay was defined as delay in seeking care three weeks or more after 
the onset of symptoms 
Multivariable quintile regression was performed for median costs to examine the association of patient factors with the different types of costs. Separate models were run for direct, indirect and total 
costs. 
1 
Reference: Unemployed 
2 
Reference: no education. 
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Supplementary Table 3. Estimates of effects of different factors on median  types of indirect and costs in USD among 
confirmed and presumptive TB patients. 
Variable All  Confirmed  Presumptive 
 Difference* 95% CI P-value  Difference* 95% CI P-value  Difference* 95% CI P-value 
Coping costs            
Males vs females -0.24 -6.12,5.64 0.93  -3.86 -11.45, 3.71 0.31  -1.39 -12.58, 9.79 0.80 
Age (in years) 0.02 -0.25,0.29 0.88  -0.25 -0.66, 0.16 0.23  0.15 -0.30, 0.61 0.51 
Unskilled labour1 -2.38 -5.71,9.90 0.59  -8.56 -19.45, 2.33 0.12  -0.49 -13.78, 12.79 0.94 
Semi-skilled1 -4.63 -11.41,2.14 0.17  -2.64 -10.94, 5.66 0.52  -5.01 -18.25, 8.24 0.45 
Poor vs non-poor 0.30 -5.43,6.05 0.91  -2.56 -10.09, 4.98 0.50  2.09 -8.10, 12.28 0.68 
Primary education2 2.09 -5.71,9.90 0.59  -2.89 -14.20, 8.40 0.61  5.92 -6.89, 18.74 0.36 
Secondary education2 5.79 -4.28,15.86 0.25  -4.85 -18.46, 8.76 0.48  9.23 -8.94, 27.41 0.31 
University2 -6.65 -23.24, 9.93 0.43  5.09 -14.19-24.37 0.60  -4.09 -41.05, 32.85 0.82 
Diagnostic delay 2.47 0.87, 4.07 0.003  -0.04 -0.12, 0.03 0.26  -0.39 -1.27, 0.47 0.36 
Less paid labour            
Males vs females 1.32 -2.69,5.33 0.51  3.78 -3.78, 11.35 0.32  0.74 -2.99, 4.46 0.69 
Age (in years) 0.17 -0.01,0.35 0.07  0.19 -0.21, 0.60 0.34  0.15 -0.01, 0.30 0.05 
Unskilled labour 2.80 -2.45,8.06 0.29  3.16 -7.71, 14.02 0.56  3.59 -0.83, 8.02 0.11 
Semi-skilled labour 3.43 -1.18,8.06 0.14  1.44 -6.83, 9.72 0.36  4.63 0.22, 9.05 0.04 
Poor vs non-poor 1.54 -2.37,5.57 0.43  -2.33 -9.85, 5.18 0.53  2.10 -1.29, 5.50 0.22 
Primary education 3.15 -2.16,8.48 0.24  -2.51 -13.79, 8.77 0.65  4.38 0.11, 8.65 0.04 
Secondary education 4.69 -2.17,11.57 0.17  -1.64 -15.22, 11.93 0.80  8.03 1.97, 14.08 0.01 
University  3.88 -7.43,15.20 0.49  8.84 -10.40, 28.07 0.36  3.93 -8.37, 16.24 0.52 
Diagnostic delay 0.09 0.05,0.15 <0.001  0.09 0.02, 0.17 0.01  -0.27 -0.56, 0.02 0.06 
Decreased production            
Males vs females 3.12 -1.67,7.91 0.20  3.31 -4.73, 11.35 0.41  2.48 -4.39, 9.37 0.47 
Age (in years) 0.11 -0.11,0.33 0.33  0.18 -0.25, 0.62 0.42  0.09 -0.19, 0.37 0.51 
Unskilled labour 7.38 1.11,13.65 0.02  1.37 -10.19, 12.62 0.19  8.71 0.53, 16.89 0.03 
Semi-skilled labour 6.40 0.89,11.92 0.02  5.16 -3.64, 13.97 0.24  7.25 -0.90, 15.40 0.08 
Poor vs non-poor -0.07 -4.75-4.60 0.97  0.08 -7.90, 8.09 0.98  -0.79 -7.07, 5.48 0.80 
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Primary education 2.25 -4.10,8.61 0.48  0.63 -11.36, 12.63 0.91  3.40 -4.49, 11.29 0.39 
Secondary education 6.53 -1.67-,4.73 0.11  5.94 -8.49, 20.38 0.41  5.76 -5.42, 16.95 0.39 
University 21.51 7.99,35.02 0.002  21.39 0.93,41.85 0.04  -4.33 -27.07, 18.42 18.41 
Diagnostic delay 0.04 -0.02,0.09 0.20  0.05 -0.02,0.13 0.21  -0.17 -0.71, 0.36 0.51 
Total indirect costs            
Males vs females 11.63 -11.37,34.63 0.32  6.60 -33.93,47.14 0.74  1.85 -34.74, 38.44 0.92 
Age (per year) 0.38 -0.69,1.45 0.48  0.07 -2.14, 2.29 0.94  0.75 -0.74, 2.24 0.32 
Unskilled labour 12.68 -17.41,42.78 0.40  14.47 -43.74,72.700 0.62  19.13 -24.32, 62.11 0.38 
Semi-skilled labour 20.90 -5.58,47.38 0.12  37.24 -7.11, 81.60 0.09  22.94 -20.38, 66.27 0.29 
Poor vs non-poor 6.29 -16.15,28.75 0.58  6.92 -33.36,47.20 0.73  5.82 -27.53, 39.18 0.72 
Primary education 21.24 -9.27,51.75 0.17  8.96 -51.46, 69.37 0.76  20.17 -21.76, 62.11 0.34 
Secondary education 61.52 22.14,100.92 0.002  54.24 -18.48,126.99 0.73  38.79 -20.65, 98.25 0.19 
University 108.74 43.89,173.60 0.001  85.66 -17-40,188.72 0.10  -7.79 -128.66, 113.09 0.89 
Diagnostic delay 0.46 0.12,0.74 0.001  0.56 0.16,0.98 0.007  -1.25 -4.09, 1.62 0.39 
Total costs            
Males vs females 9.87 -26.39,46.14 0.59  -4.98 -58.90,48.93 0.85  -0.62 -44.96, 43.71 0.97 
Age (per year) 0.34 -1.34,2.03 0.68  -0.56 -3.50,2.38 0.70  0.74 -1.06, 2.55 0.41 
Unskilled labour 11.95 -35.50,59.40 0.62  8.25 -69.18,85.69 0.83  16.02 36.64, 68.69 0.54 
Semi-skilled labour 30.47 -11.28,72.23 0.15  58.81 -0.18,117.81 0.05  26.64 -25.86-79.14 0.31 
Poor vs non-poor 0.89 -34.50,36.31 0.96  8.39 -45.18,61.98 0.75  2.39 -38.01, 42.81 0.90 
Primary education 24.87 -23.25,72.98 0.31  19.73 -60.62,100.09 0.62  18.06 -32.75, 68.88 0.48 
Secondary education 69.54 7.43,131.65 0.02  69.45 -27.29,166.19 0.15  46.10 -25.86, 79.14 0.20 
University 108.89 6.63,211.161 0.03  69.20 -67.87,206.28 0.31  -15.74 -162.23, 130.73 0.83 
Diagnostic delay 1.29 0.84,1.73 <0.001  1.44 -19.56,6.63 <0.001  -2.40 -5.86, 1.06 0.17 
 *Estimated differences in median costs of are presented with the corresponding 95% confidence intervals (95% CI); Diagnostic delay was defined as delay in seeking care three weeks or more 
after the onset of symptoms. Multivariable quintile regression was performed for median costs to examine the association of patient factors with the different types of costs. Separate models were 
run for direct, indirect and total costs. 
1 
Reference: Unemployed 
2 
Reference: no education 
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Abstract  
Background: Delay in healthcare seeking and loss to diagnostic follow-up (LDFU) 
contribute to substantial increase in tuberculosis (TB) morbidity and mortality. We 
examined factors, including perceived causes and prior help seeking, contributing to 
delay and LDFU during referral to a TB clinic among patients with presumptive TB 
initially seeking help at the pharmacies in Dar es Salaam Tanzania. 
Methods: In a TB clinic, a semi-structured interview based on the explanatory model 
interview catalogue (EMIC) framework for cultural epidemiology was administered to 
presumptive TB patients enrolled at pharmacies during an intervention study. We 
assessed delay in seeking care at any medical care provider for a period of ≥3 
weeks after the onset of symptoms, LDFU during referral (not reaching the TB clinic), 
and LDFU for three required TB clinic visits among the presumptive and confirmed 
TB patients. Logistic regression models were used to assess factors associated with 
delay and LDFU. 
Results: Among 136 interviewed patients, 88 (64.7%) had delayed seeking care of 
which 59 (67%) were females. Eighty six patients (63.2%) were LDFU. Among the 
50 (36.8%) non-LDFU, 26 (52.0%) had also delayed seeking care. Prior consultation 
with a traditional healer (aOR 2.84, 95% CI 1.08-7.40), perceived causes as 
ingestion (water and food) (aOR 0.38 CI 0.16-0.89), and substance use (smoking 
and alcohol) (aOR 1.45 CI 0.98-2.14) were all associated with patient delay. Female 
gender was associated with LDFU (aOR 3.80, 95% CI 1.62-8.87) but not with delay. 
Other conditions as prior illness and heredity were also associated with LDFU but 
not delay (aOR 1.48 CI 1.01-2.17). 
Conclusion: Delay and LDFU after referral from the pharmacies were substantial. 
Notable effects of female gender indicate a need for more attention to women’s 
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health to promote timely and sustained TB treatment. Public awareness to counter 
misconceptions about the causes of TB is needed.  
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4.1 Introduction 
Tuberculosis (TB) ranks above HIV/AIDS as the number one infectious-disease killer 
worldwide accounting for 1.7 million TB deaths and 10.4 million new cases in 2016 
(WHO, 2017). Tanzania is among the 30 countries with a high TB burden where TB 
case detection relies on passive case findings. Although Individuals with TB 
symptoms may present themselves to healthcare facilities for TB diagnosis (Ministry 
of health and social welfare, 2006b; Senkoro M, Hinderaker SG, Mfinanga SG, 2015; 
WHO, 2015c) the problem of delayed appropriate help seeking for people with TB 
symptoms is widespread in sub-Saharan African countries (Sreeramareddy C.T, 
Panduru K.V, Menten J, Ende J.V, 2009b). The problem of diagnosis and starting 
appropriate treatment is further complicated by early loss to diagnostic follow up (E. 
Botha et al., 2008). In view of good prospects for cure with timely diagnosis and 
treatment, these are serious problems [2, 6].  
Diagnosis and treatment of TB patients require recognition of symptoms and both 
prompt presentation for diagnosis and treatment in a competent healthcare facility. 
Furthermore, healthcare must be sustained to limit morbidity and mortality 
(MacPherson et al., 2014b; Shete et al., 2015). People with symptoms of TB usually 
follow a complex pathway to care, typically including prior consultation with two or 
three healthcare providers before reaching specialized healthcare facilities capable 
of diagnosing and treating TB (Mfinanga and Mutayoba, 2008b; Mhalu et al., n.d.; 
Eliud R. Wandwalo and Mørkve, 2000b). Research suggests that factors contributing 
to delay in reaching specialized healthcare facilities and loss to diagnostic follow-up 
(LDFU) include dissatisfaction with health services, use of self-prescribed medication 
and initial help seeking with traditional healers (Hinderaker et al., 2011a; Khan et al., 
2009; Rabin et al., 2013). LDFU leads to poor health outcomes for the individuals 
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such as increased morbidity, decreasing the quality of life and increasing mortality 
(Fatima et al., 2015b). It also enables further spread of TB. 
Most studies addressing loss to follow-up (LTFU) consider TB patients in treatment, 
but little is known about LDFU for the larger group of people with presumptive TB 
symptoms who have not yet been diagnosed and not yet started treatment (Fatima 
et al., 2015b; Wali A, Kumar A.M.V, Hinderaker S.G, Heldal E, Qaader E, Fatima R, 
2015). To explain delayed healthcare seeking and LDFU that complicates diagnosis 
and initiating TB treatment, we examined the role of selected features of patients’ 
own illness explanatory models, including patient-perceived TB causes and prior 
healthcare seeking (Gosoniu et al., 2008b). We interviewed people with symptoms of 
TB who were referred for diagnosis but did not come for the three recommended 
follow-up visits and assessed patient delay in seeking care, and we compared them 
with TB patients who completed recommended diagnostic follow-up in a TB referral 
clinic in Dar es Salaam Tanzania, to identify factors associated with delay and LDFU.  
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4.2 Methods 
Study setting 
Intervention study: Tuberculosis case findings at the pharmacies 
A study of TB case finding at pharmacies (TB-PHARM) was conducted in 2015 in the 
Ilala district of Dar es Salaam, Tanzania. Trained pharmacists who used an 
electronically monitored referral system participated in the study (Mhimbira F, Hella 
J, Mutayoba B, Mahongo E, Minde J, n.d.). The study aimed at developing and 
evaluating referrals of presumptive TB patients from pharmacies to TB clinics of the 
National Tuberculosis and Leprosy Programme (NTLP). Selection of the pharmacies 
was based on the geographical location to the TB clinic, the ownership (government, 
private) and the size of the pharmacy to obtain a representative mix. The intervention 
study included all pharmacy clients aged 18 years or older visiting selected 
pharmacies in the Ilala district with TB symptoms (coughing of any duration) as well 
as pharmacy clients who bought antibiotics for patients with cough symptoms at 
home. Identified presumptive TB patients were counseled and referred to a TB 
diagnostic centre with a referral card. The patient flow of the intervention study is 
schematically shown in Figure 11. Individuals who were currently investigated for TB, 
as well as TB patients on treatment or who had completed treatment within the last 
three months were excluded from the intervention study.  
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Figure 11. Intervention study (TB-PHARM) patient referral flowchart 
Short overview of LDFU sub-study 
The LDFU sub-study included a fraction of the presumptive and confirmed patients 
that participated in the big TB-PHARM study. This was an exploratory study that 
aimed at exploring factors associated with patient delay and loss to diagnostic follow-
up in the intervention study (TB-PHARM). 
LDFU-study setting 
The LDFU sub-study was conducted in Ilala district (Buguruni hospital) in Dar es 
Salaam Tanzania. Ilala has a population of 1,220,611 with an average household 
size of 4.0 persons (Tanzania census of 2012). The district notified 4,582 TB cases 
(all forms) in 2012. The study setting was a residential area in Buguruni sub-district 
with a population of 70,585 and 559 notified TB cases in 2012. There is one 
registered TB diagnostic and treatment centre in the study area.  
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Study population  
We established a patient tracing system that included community health workers, Ex-
TB patient’s organisations and clinical workers. We traced all presumptive and 
confirmed TB patients who did not visit the TB clinic after referral from the 
pharmacies or those who did not complete their required three visits at the clinic after 
treatment initiation. The list of all LDFU was obtained from the main database of the 
intervention study. We further included confirmed TB patients from the main 
database of the intervention study who were not LDFU and completed all the 
required three visits at the TB clinic. Patient delay was assessed in all the LDFU and 
non-LDFU patients and was defined as delay to visit a healthcare provider including 
pharmacies, hospitals, dispensaries and primary healthcare centers of three weeks 
or more after the onset of symptoms. 
Instrument 
We used a mixed method approach in a semi-structured explanatory model interview 
based on the framework of the explanatory model interview catalogue (EMIC) for 
cultural epidemiology to study patients’ illness explanatory models (Weiss, 2001; 
Weiss MG, 1997). The interview and coding categories were adopted from an EMIC 
interview developed and used in a WHO/TDR-supported multi-country study of 
gender and tuberculosis in India, Bangladesh, Malawi and Colombia (Weiss et al., 
2006). The various sections of the interview inquired about priority symptoms, 
perceived causes (PCs) and place and timing of help seeking including delay.  Open 
questions were asked first, and responses were coded according to coding options. 
Spontaneously reported categories in response to open questions were 
distinguished from elicited responses to probed categories that had not been 
mentioned spontaneously. Narrative elaboration was included as a qualitative 
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component of the data set. Additional questions were asked about the most 
important categories of perceived causes and health-seeking. Patient delay was 
assessed by asking the patients regarding the interval between the onset of 
symptoms to consultation with any healthcare provider. 
Each section of the EMIC began with a short introduction to help the respondents 
understand the study interests and questions and to encourage them to respond 
candid and to speak freely (Weiss MG, 1997). The instrument was prepared in 
English and translated into the local language (Swahili). Patients’ narrative interview 
data were translated into English for analysis. 
Variables 
Outcome variables 
Delay in seeking health care was regarded as an outcome variable. Patient delay 
was defined as a duration of three weeks or more between onset of any TB-related 
symptom (such as coughing, chest pain, fever, weight loss, and hemoptysis) and 
presentation to any healthcare facility including pharmacies, hospitals, primary 
healthcare facilities as well as dispensaries.(World Health Organization, 2009). The 
cutoff point for patient delay of three weeks was considered sufficient as described in 
previous studies (Said et al., 2017).  
Furthermore, LDFU was regarded as outcome variable. LDFU was defined as failure 
to present after referral from the recruitment pharmacy to the TB clinic (pharmacy 
LDFU) within two months or failure to return for all three required diagnostic visits 
after recruitment in the TB clinic (clinic LDFU). Negative and confirmed TB patients 
who came for timely assessment to all three diagnostic visits were classified as non-
LDFU. LDFU was dichotomized as 1 (non-LDFU) or 0 (LDFU).  
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Explanatory variables 
Socio-cultural variables specifying features of illness explanatory models included 
perceived causes that encompass locally held beliefs regarding the common causes 
of TB. Treatment-seeking referred to the type of healthcare provider patients may 
consult, including traditional medical practitioners, pharmacies and hospitals (Weiss 
et al., 2008b). Additionally, sex, age, and socio-economic variables (e.g., education 
and occupation) were considered as explanatory variables. 
A prominence score was assigned to each of the EMIC variables denoting perceived 
causes and help-seeking options. Prominence was based on whether and how a 
respondent reported each category. We assigned a value of 2 for a spontaneous 
response, a value of 1 for a positive response only after probing the category and a 
value of 0 if the category was still not reported by the respondent when probing. 
Furthermore, a value of 3 was assigned to those categories that were identified as 
most important perceived cause or treatment seeking option. This value of 3 was 
added to the value for how a category was reported (0, 1 or 2). Thus, the values of 
the prominence score variable had a theoretical range of 0 to 5.  
Data collection 
Clinical officers with research experience administered the interviews after two 
weeks of training. Two clinical officers were present for each interview; one 
interviewed the patient and the other served as scribe, taking notes. They changed 
roles in successive interviews. Interviews required 30 to 60 minutes, and data were 
collected on paper interview forms.  
Data analysis 
Categorical and numerical variables from the EMIC interviews were double entered 
using Epi Info (Centre for Disease Control and Prevention, Atlanta GA, USA, version 
85 
7). We cleaned the data and performed statistical analysis using Stata version 14.2 
(StataCorp, College Station, TX, USA). We calculated the frequencies of response 
options and of the derived prominence score values of categories of perceived 
causes of TB and categories of treatment seeking (Weiss MG, 1997), analysing 
mean prominence for the comparison groups.  
In a separate analysis, we grouped categories representing details of a common 
theme as in previous studies (Merten et al., 2013). For example, perceived cause 
(PC) response variables for water and food as perceived causes were grouped 
under ‘ingestion’, a PC group variable. PC response variables for alcohol and 
smoking were grouped under ‘substance use’. Interview-coded response variables 
for climate, dust, contamination and airborne illness were all grouped under 
‘environmental causes’. Response categories including evil eye/sorcery, demons 
and the will of god were included in a PC group labeled ‘magico-religious’. A PC 
group variable labelled ‘contact’ referred to both sexual contact and casual contact 
with an infected person. A PC group ‘other’ included response categories for 
heredity, conditions such as fatigue, working too hard and carrying heavy loads 
(these were explained by some as possibly causing chest pain which later develops 
into TB). Prominence score values for PC group variables were derived by 
computing the maximum prominence for each PC response variable in the PC group 
(0=not mentioned, 1=mentioned on probe, 2=mentioned spontaneously, additional 
value of 3 if any category in the group had been identified as most important 
perceived cause). In case of non-linear associations with the outcome the variable 
was transformed into a categorical variable and included as such in the logistic 
regression model. To assess the statistical significance of differences between PC 
response variables, PC group variables and help seeking (HS) response variables 
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for the two sets of comparison groups, i.e., for patient delay and LDFU, we used the 
Wilcoxon rank sum statistical test. 
To examine the factors associated with delay and LDFU, we conducted univariate 
and multivariate logistic regressions. Variables for categories of PC, treatment 
seeking, and socio-economic factors were summarized with univariate statistics. 
Multivariate logistic regression models were first run for each subcategory of 
questions about perceived causes and treatment seeking while adjusting for socio-
economic variables. Prominence scores were treated as covariates and linearity of 
their association with the logit of delay and LDFU was tested by including a quadratic 
term. Significant non-linearity was only found for ingestion and this variable was then 
dichotomized into 0 vs. 1-5. Only variables which were associated with the outcome 
variable with a p-value <0.2 were retained in the final multivariate model except for 
the variables of perceived causes. We then tested each retained variable for 
interaction with sex and presented the respective gender-specific estimates.  
Qualitative data for the integrated analysis 
To explain identified differences and associations of the explanatory variables, we 
analysed narrative data. Narratives from the EMIC interviews were coded and 
imported in MAXQDA version 12 (VERBI Software, Berlin, Germany). The narratives 
from EMIC were initially thematically coded with reference to interview questions 
eliciting the narrative. We used the framework method of Gale et al (Gale KN, Heath 
G, Cameron E, Rashid S, 2013a) for analysis of the qualitative data. The analysis 
identified emerging themes, patterns, similarities and differences.  
Open coding to label concepts were used to define and develop categories, based 
on properties and dimensions of the respondent’s description (Strauss A, 1998). We 
developed and assigned a list of thematic codes that correspond to each separate 
87 
section of the EMIC interview (PC, HS, as well as study-specific issues) (Weiss et 
al., 2006).  
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4.3 Results 
Sample characteristics 
The study population includes 136 presumptive and confirmed TB patients. Out of 
these, patients delay of three weeks and more after the onset of symptoms was 
present in 88 (64.7%) patients, of which 59 (67%) were females. Overall, 86 (63.2%) 
were LDFU from pharmacies and TB clinic, and 50 (36.8%) were non-LDFU 
(confirmed or negative TB patients) (Table 6). Among the 86 patients who were 
LDFU, 26 (30.2%) did not complete all of the three diagnostic visits at the TB clinic 
(clinic LDFU). Furthermore, 34 patients in the LDFU group could not be traced and 
included in the study (Figure 12). Additionally, in the LDFU group patient delay of 
three weeks and above was present in 62 (72.1%) patients. The median age was 32 
years (Interquartile range [IQR]: 27-40 years). 82 (60.3%) of the respondents were 
females.  
89 
Table 6. Baseline characteristics of the respondents 
     
Characteristic n (%) All  
n=136 
Non-LDFU
a
 
n=50 
Delay
b
 
n=88 
LDFU
c
  
n=86 
     
Age in years, median (IQR) 32 (27-40) 32 (26-36) 32 (26-40) 33 (28-40) 
Age group, years     
18-27 35 (25.7) 14 (28.0) 24 (27.2) 21 (24.4) 
28-37 57 (42.0) 24 (48.0) 35 (39.8) 33 (38.4) 
≥ 38 44 (32.3) 12 (24.0) 29 (33.0) 32 (37.2) 
Sex     
Male 54 (39.7) 28 (56.0) 29 (33) 26 (30.2) 
Female 82 (60.3) 22 (44.0) 59 (67) 60 (69.8) 
Level of education     
Primary/Secondary 118 (86.8) 46 (92.0) 74 (84.1) 72 (83.7) 
No formal education 18 (13.2) 4 (8.0) 14 (15.9) 14 (16.3) 
Religion     
Muslim 88 (64.7) 32 (64.0) 59 (67) 56 (65.1) 
Christian 48 (35.3) 18 (36) 29 (33) 30 (34.9) 
Employment status     
Unemployed 36 (26.5) 15 (30) 27 (30.7) 21 (24.4) 
Employed 100 (73.5) 35 (70) 61 (69.3) 65 (75.6) 
Monthly household income      
Low income 46 (33.3) 17 (34.0) 34 (38.6) 35 (40.7) 
Middle income 50 (36.7) 18 (36.0) 29 (32.9) 25 (29.1) 
High income 40 (29.4) 15 (30.0) 25 (28.4) 26 (30.2) 
Household size     
≤4 75 (55.2) 27 (54) 45 (51.1) 48 (55.8) 
>4 61 (44.8) 23 (46) 43 (48.9) 38 (44.2) 
IQR: Interquartile Range; LDFU: loss to diagnostic follow-up; Non-LDFU: non- loss to diagnostic 
follow-up; 1 US $=2,190 Tanzanian Shillings 
a 
Including negative and confirmed TB patients who attended the clinic and completed all the visits; 
b 
Patients who delayed seeking health for ≥3 weeks after onset of symptoms in both LDFU and 
non-LDFU groups; 
c 
Including patients who did not visit the clinic after referral from pharmacy and those who did not 
complete their visits after treatment initiation  
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Figure 12. Flowchart of the patient selection ( LDFU sub-study) 
Most of the study participants had primary education (86.8%) and were Muslims 
(64.7%). Patients who had a middle monthly household income were slightly more 
frequent (36.8%) than those who had low (33.3%) and upper (29.4%) household 
income. 
Perceived causes 
Dust was considered to be a main cause of TB symptoms. 47.7% in the LDFU group 
and 54.0% in the non-LDFU group spontaneously mentioned dust as the cause of 
TB symptoms (Table 7).  
“I work in the marketplace. My working environment is full of dust; I think this is what 
caused me to develop TB symptoms.” (male, 41 years). 
This was followed by evil eyes and sorcery, 45.3% and 28.0%, respectively. Other 
common explanations mentioned of TB symptoms were climate, demons or gods.  
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 “My illness might have been caused by the environment at my previous work. 
As a cook, I was exposed to a lot of smoke and heat. Moreover, my workplace was 
near a dusty road. Therefore, I was exposed to dust as well. I strongly believe that 
was the cause of my illness”. (male, 27years). 
“I work at the market where I often generate more profit than most of my 
surrounding neighbours. I began coughing blood and became very fragile, I thought 
my neighbours were jealous of my success and bewitched me. I visited a traditional 
healer”. (female, 44 years). 
In contrast; alcohol was rarely mentioned spontaneously as a cause of TB 
symptoms. 51.2% and 36% in LDFU and the non-LDFU group mentioned alcohol as 
a perceived cause of the disease after probing. This was followed by smoking in both 
groups (48.8% and 46.0%). Prior illness and contaminated water were reported as 
the main causes of the disease after probing 
. 
92 
Table 7. Perceived causes for TB symptoms among LDFU and non-LDFU patients 
LDFU n=86 Non-LDFU n=50 
How reported
a
 How reported
a
 
  
Category
a
 
Total 
reported % 
Spont 
% 
 
Probe 
% 
 
Most 
important 
% 
 
Mean 
Prominence
b 
 
Total 
reported % 
Spont 
% 
Probe 
% 
Most 
important % 
 
Mean 
Prominence
b 
 
            
Ingestion 36.0 5.8 30.2 4.6 0.6 58.0 12.0 50.0 8.0 0.9  
Food 24.4 4.7 19.8 3.5 0.4 44.0 6.0 38.0 6.0 0.6  
Water 27.9 1.2 26.7 1.2 0.3 32.0 6.0 26.0 2.0 0.4  
Substance use 88.3 24.4 63.9 16.3 1.6 84.0 22.0 62.0 10.0 1.3  
Alcohol 56.9 5.8 51.2 4.7 0.8 44.0 8.0 36.0 2.0 0.6  
Smoking 69.7 20.9 48.8 11.6 1.3 66.0 20.0 46.0 8.0 1.1  
Environmental 
causes 
97.7 82.6 15.1 45.4 3.2 98.0 84.0 14.0 44.0 3.1  
Climate 74.4 38.4 36.1 6.9 1.3 86.0 46.0 40.0 4.0 1.4  
Dust 75.6 47.7 27.9 18.6 1.8 86.0 54.0 32.0 28.0 2.2  
Contamination 69.8 27.9 41.8 5.8 1.1 56.0 10.0 46.0 2.0 0.7  
Airborne illness 48.8 19.8 29.1 13.9 1.1 40.0 6.0 34.0 10.0 0.8  
Magico-religious 
courses 
93.0 70.9 22.0 15.1 2.1 98.0 62.0 36.0 14.0 2.0  
Evil eye/sorcery 80.2 45.3 34.9 13.9 1.6 70.0 28.0 42.0 12.0 1.3  
Demons or Gods 80.2 45.4 34.9 1.2 1.2 78.0 48.0 30.0 2.0 1.3  
Contact 68.6 24.4 44.2 5.8 1.1 62.0 14.0 48.0 8.0 1.0  
Casual sexual contact 22.1 5.8 16.3 2.3 0.3 34.0 2.0 32.0 2.0 0.4  
Contact with infected 
person 
62.8 20.9 41.9 3.5 0.9 50.0 12.0 38.0 6.0 0.8  
 
Other conditions  68.6 24.4 44.2 10.5 1.2 78.0 24.0 54.0 8.0 1.3  
Prior illness 27.9 1.2 26.7 5.8 0.4 38.0 4.0 34.0 4.0 0.5  
Heredity 51.2 19.7 31.4 3.5 0.8 60.0 20.0 40.0 4.0 0.9  
Others 17.4 3.5 13.9 1.2 0.2 34.0 2.0 32.0 0 0.4  
LDFU: loss to diagnostic follow-up; Non-LDFU: non- loss to diagnostic follow-up,
 a 
Columns indicate percentage of reported categories and whether a 
category was identified as most troubling; 
b 
Mean prominence based on values assigned to each reported category (0 = not reported, 1= reported after 
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probing, 2=reported spontaneously 3 = identified as most troubling 4= most troubling and reported after probing 5= most troubling and reported 
spontaneously
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Treatment seeking  
Respondents were asked about their healthcare seeking after onset of symptoms. 
Seeking help from the pharmacies was considered the most important choice after 
the onset of symptoms for both females and males in LDFU (Table 8) and non-LDFU 
groups (Table 9). 
“I belived that the pharmacist would understand what is my problem .She gave me 
some tablets to relieve pain and informed me it would be best to go to the clinic”. 
(female 57 years). 
Furthermore, among help-seeking options, use of traditional healers was mentioned 
in both groups, including 21.7% of women and 23.1% of men in the LDFU group and 
22.7% women and 32.1% men in the non-LDFU group. Seeking help from religious 
healers was reported as most important choice among men in the LDFU group 
compared to women (11.5% vs 6.7%) while in non-LDFU group women reported 
help-seeking from religious leaders more often as the most important choice 
compared to men (9.1% vs 3.6%). Furthermore, the majority of those who used 
religious healers in both groups were Muslims. Narrative elaboration suggests 
psychological comfort was valued from visiting a traditional healer, especially among 
women. Other health-seeking practices, such as seeking care at dispensaries and 
TB clinics, were mentioned less often by both groups of respondents. 
 “I feel safer to visit a traditional healer. I will rather go to a traditional healer 
than to the hospital. Doctors at the hospital sometimes mismanage patients”. 
(female, 27 years).
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Table 8.Treatment seeking for TB symptoms among women and men in the LDFU group 
LDFU women n=60 LDFU men n=26 
How reported
a
 How reported
a
 
Category
a
 
Total 
reported 
% 
Spont 
% 
Probe 
% 
Most 
important 
% 
Mean 
Prominence
b 
%
 
Total 
reported% 
Spont 
% 
Probe 
% 
Most 
Important 
% 
Mean 
Prominence
b 
Home remedies 
83.3 45.0 38.3 15.0 1.7 80.7 23.1 57.6 3.8 1.1 
 
Pharmacy 96.7 86.7 10.0 36.7 2.9 92.3 65.4 26.9 38.5 2.7  
Hospital 48.3 15.0 33.3 11.7 0.9 46.1 11.5 34.6 3.9 0.6  
Traditional healer 76.6 53.3 23.3 21.7 1.9 76.9 42.3 34.6 23.1 1.9  
Religious healer 40.0 11.7 28.3 6.7 0.7 42.3 11.5 30.8 11.5 0.8  
Dispensary 33.3 8.3 25.0 0 0.4 34.6 23.1 11.5 7.7 0.6  
TB clinic 10.0 6.7 3.3 6.7 0.4 23.1 3.8 19.2 3.8 0.3 * 
LDFU: loss to diagnostic follow-up; 
a 
Columns indicate percentage of reported categories and whether a category was identified as most troubling; 
b 
Mean 
prominence based on values assigned to each reported category (0 = not reported, 1= reported after probing, 2=reported spontaneously 3 = identified as 
most troubling 4= most troubling and reported after probing 5= most troubling and reported spontaneously
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Table 9. Treatment seeking for TB symptoms among women and men in Non-LDFU group 
Non-LDFU women n = 22 Non-LDFU men n = 28 
How reported
a
 How reported
a
 
Category
a
 
Total 
reported 
% 
Spont 
% 
Probe 
% 
Most 
important 
% 
Mean 
Prominence
b 
Total 
reported% 
Spont 
% 
Probe 
% 
Most 
Important % 
Mean 
Prominence
b 
Home remedies 
86.3 54.5 31.8 9.1 1.6 75.0 32.1 43.0 14.3 1.5 
 
Pharmacy 81.8 40.9 40.9 27.3 2.0 96.4 75.0 21.4 28.6 2.6 * 
Hospital 68.2 36.4 31.8 4.6 1.2 71.4 50.0 21.4 7.1 1.4  
Traditional healer 81.8 36.4 45.5 22.7 1.7 67.9 39.3 28.6 32.1 2.0  
Religious healer 59.1 13.6 45.5 9.1 1.0 39.3 3.6 35.7 3.6 0.5  
Dispensary 40.9 18.1 22.7 0 0.5 42.8 7.1 35.7 3.6 0.6  
TB clinic 22.8 4.6 18.2 9.1 0.5 21.4 3.6 18.0 0 0.3  
Non-LDFU: non- loss to diagnostic follow-up,
 a 
Columns indicate percentage of reported categories and whether a category was identified as most troubling; 
b 
Mean prominence based on values assigned to each reported category (0 = not reported, 1= reported after probing, 2=reported spontaneously 3 = identified 
as most troubling 4= most troubling and reported after probing 5= most troubling and reported spontaneously
 
 
Patterns of distress 
Coughing was reported by 89.5% vs 88% of patients of the LDFU and non-LDFU as 
a major distress associated with the experience of having TB, followed by fever 73% 
vs 58% respectively. Respondents in both groups rarely mentioned other symptoms 
such as weight loss, breathlessness, and chest pain. 
The narratives suggested that coughing blood (hemoptysis) was a pattern of distress 
that led to eventually seeking help at the pharmacies and other healthcare facilities.  
“I had a low fever and mild cough for a week. I purchased some antibiotics at 
the pharmacy. Yet I did not feel better and later I started noticing blood in my 
sputum. I thought it was serious and decided to visit the hospital for more check-
ups". (male, 40 years). 
Additionally, coughing blood was associated with socially enacted stigma. Several 
narratives indicated the manifestation of stigma to the presumptive TB cases as a 
result of their symptoms. 
 “My colleagues were frightened with my condition which included fever and 
coughing blood. One day they explicitly mentioned that they no longer wanted to 
stay with me because I was coughing blood” (female, 51 years). 
Factors associated with delay in seeking healthcare 
We examined which categories of PC and HS were associated with delay in seeking 
care after adjusting for socio-demographic and socio-economic variables. In the 
multivariate analysis, diagnostic delay of ≥3 weeks was positively associated with a 
mid-range household monthly income (compared to low income) (aoR 3.35 95% CI 
1.21-9.21), unemployment (aoR 2.81 95% CI 1.00-7.90), and seeking help from a 
traditional healer (aOR 2.66 95% CI 1.03-6.84) (Table 10). Additionally, the odds of 
patient delay for females were higher than for males, (aoR 2.16 95% CI 0.96-4.84). 
We also observed a positive association with perceived substance use as a cause of 
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TB, which was however not statistically significant. (aoR 1.41 95% CI 0.96-2.06). 
The association with perceived cause ingestion was not linear, with a significantly 
reduced risk of delay among patients with prominence scores between 1 and 5 
compared to those with a score of 0 (aOR=0.41; 95% CI: 0.18-0.93). This is 
underscored by the following quotes: 
"I described my symptoms to my colleague. His advice was to consult a 
traditional healer. The traditional healer prescribed some medications to use for a 
month and re-visit him after completion. My condition worsened after using the 
traditional medicines for more than two weeks. I decided to visit the pharmacy". 
(female, 35 years). 
Financial hardship was also mentioned as a reason for diagnostic delay and seeking 
help at the traditional healers. 
“I am from a less privileged family. I could not afford the treatment expenses 
at the hospital. Traditional healers are cheaper compared to hospitals and other 
health facilities. (male, 29 years). 
“I stayed for two months before going to the pharmacy. I just used grinded 
ginger for my symptoms. The reason was I did not have enough money. If I had 
enoughn money I would have gone earlier to the pharmacy.” (female 26 years). 
Another factor mentioned by the respondents for the diagnostic delay was substance 
use example smoking. 
 “I used to smoke a lot. I stopped because my wife did not like the behaviour. 
When I started coughing, I thought it was the aftermath of my behavior. I thought 
since I stopped, the cough will also disappear however it did not. My condition 
worsened then I decided to visit the traditional healer” (male 27 years). 
Another factor commonly mentioned by the respondents for the diagnostic delay was 
the perception of coughing as a ‘normal’ cough. A female respondent said: 
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“My experience of coughing frequently made me feel it was a normal cough that will 
eventually disappear with some antibiotics. I took antibiotics for almost a month 
nevertheless my condition worsened. I visited the pharmacy” (female, 39 years). 
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Table 10. Multivariate analysis of factors associated with delay after onset of 
symptoms for presumptive and confirmed TB patients, n=136 
    
Variable aOR   P-value 95% CI 
 
Sex 
   
Male 1 (Ref)   
Female 2.16  0.06 0.96-4.84 
Monthly household income    
Low income 1 (Ref)   
Middle Income 3.35  0.01 1.21-9.21 
High Income 2.18  0.14 0.77-6.17 
Occupation    
Employed 1 (Ref)   
Unemployed 2.81  0.05 1.00-7.90 
Perceived causes    
Ingestion    
0 1 (Ref)   
1-5 0.41 0.03 0.18,0.93 
Magico-religious 1.11  0.56 0.76-1.63 
Environmental causes 1.09 0.57 0.79-1.50 
Substance use 1.41 0.07 0.96-2.06 
Person to person contact 0.93 0.73 0.64-1.36 
Other conditions 1.01 0.94 0.70-1.45 
Help-seeking    
Traditional healers 2.66  0.04 1.03-6.84 
Religious healer 1.67  0.23 0.71-3.87 
CI=95% Confidence Interval; Delay was defined as three weeks or more after onset of symptoms up 
to the visit of the TB clinic, OR, Odds ratio. Odds ratio associated with variables of perceived causes 
refer to a unit increment in the respective variable except for ingestion which showed a non-linear 
association with delay and was therefore categorized. All the variables listed were included 
simultaneously in the model.  
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Factors associated with LDFU 
Women were significantly more likely to be lost to diagnostic follow-up (aoR 4.12, 
95% CI: 1.78-9.50). The perceived cause “other conditions”, including prior illness, 
was positively associated also with LDFU (aoR 1.39 95% CI 0.96-2.02) (Table 11). 
The association between LDFU and perceived cause ingestion was also non-linear, 
with a significantly reduced risk of LDFU among patients with prominence scores 
between 1 and 5 compared to those with a score of 0 (aOR=0.31; 95%.CI: 0.14, 
0.70). When stratifying analyses by gender, all odds ratios were larger among 
women but none of the differences between the gender-specific estimates was 
statistically significant (Table 12). 
Variations in the profile of men and women on reason for LDFU were apparent in the 
narratives. While women were more concerned with the financial burden to their 
spouses and family members, men were worried about financial burden resulting 
from missing work. 
“The pharmacist advised me to seek further help for my symptoms at the 
hospital. I decided not to. I did not want to impose more financial burden to my 
husband and family as a result of my condition”. (female, 44 years). 
 “I was not concerned with the costs of treatment at the hospital. I was more 
worried that my boss will not understand me if I ask permission to visit the hospital” 
(male 41 years). 
Fear of being diagnosed with TB in relation to HIV was recurring from the narratives 
as well as fear of isolation if diagnosed with TB, although it was not statistically 
significant in the quantitative analysis.  
"The pharmacist gave me a small card to come for further check-ups. I was afraid to 
be asked to test for HIV. I was not ready to know my HIV status”. (male 25 years). 
102 
“My friend was diagnosed with TB and people were afraid to even eat with 
him. I thought it would be the same with me that’s why I did not visit the hospital as 
advised at the pharmacy.” (female 21 years).   
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Table 11. Multivariate analysis of factors associated with LDFU for 
presumptive and TB patients, n=136 
    
Variable aOR  P-value 95% CI 
 
Sex 
   
Male 1 (Ref)   
Female 4.12 0.001 1.78-9.50 
Perceived causes    
Ingestion    
0 1 (Ref)   
1-5 0.31 0.005 0.14, 0.70 
Magico-religious 1.29 0.18 0.88-1.91 
Environmental causes 1.06 0.68 0.78-1.43 
Substance use 1.26 0.19 0.88-1.80 
Person to person contact 1.13 0.51 0.77-1.66 
Other conditions 1.39 0.08 0.96-2.02 
Help-seeking    
Traditional healers 1.39 0.48 0.54-3.59 
Religious healer 0.51 0.11 0.22-1.17 
Hospital 0.54 0.15 0.23-1.24 
CI=95% Confidence Interval; OR, Odds ratio LDFU: loss to diagnostic follow-up. Odds ratio associated 
with variables of perceived causes refer to a unit increment in the respective variable except for 
ingestion, which showed a non-linear association with LDFU and was therefore categorized. All the 
variables listed were included simultaneously in the model  
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Table 12 Multivariate analysis of factors associated with LDFU for presumptive 
and TB patients with gender specific estimates, n=136 
 
Variable 
 Females 
 aOR (95% CI) 
Males 
aOR (95% CI) 
P-Value 
(Interaction) 
    
Perceived causes    
Ingestion 0.50 0.16 0.54 
Environmental causes 1.17 0.84 0.24 
Magico-religious 1.96 0.97 0.14 
Substance use 1.48 1.02 0.29 
Person to person contact 1.46 0.76 0.99 
Other conditions 2.14 0.80 0.14 
Help-seeking    
Traditional healers 2.55 0.63 0.40 
Religious healer 0.84 0.14 0.14 
Hospital 1.47 0.14 0.11 
OR, Odds ratio; 95% CI= 95% Confidence Interval. LDFU: loss to diagnostic follow-up; Gender-specific 
odds ratios were obtained from model including gender-specific terms for the respective variable in 
addition to the other variables listed in the table.  
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4.4 Discussion 
Results from this study indicate that patient delay of ≥3 weeks after the onset of 
symptoms was observed in almost two third, of the respondents. LDFU from the 
pharmacies to the TB clinic was observed in 44.1% of the presumptive patients, and 
a third of the patients who did reach the centre, did not complete all required visits. 
Pharmacies and traditional healers were main healthcare facilities for treatment 
seeking after the onset of symptoms. 
Seeking care at healthcare facilities with absence or sub-optimal TB diagnostics 
before reaching TB centers was associated with patient delay. This finding indicates 
that presumptive TB patients follow a complex pathway to care before reaching 
suitable healthcare facilities for TB diagnosis and treatment. Undoubtedly, this 
suggests that a substantial number of presumptive TB patients delay seeking 
appropriate care as a result of visiting non-professional healthcare providers before 
TB diagnosis (Auer et al., 2000b; Getnet et al., 2017b; Eliud R. Wandwalo and 
Mørkve, 2000b). Consequently, this leads to delay in seeking healthcare after the 
onset of symptoms. 
Women reported being comfortable with the care provided by the traditional healers 
and that healthcare workers would sometimes mistreat patients in the hospitals. This 
might indicate abuse and low quality of care in public health facilities in addition to a 
client’s need for psychological comfort. This finding is in line with research 
documenting that women reach clinical treatment services through a circuitous route 
and prefer seeking healthcare from traditional healers and private practitioners 
(Eastwood and Hill, 2004b; Johansson et al., 2000a) instead of directly seeking care 
at healthcare facilities. 
Presumptive patients with middle monthly household income delayed more 
compared to those with low and high incomes. Possibly, presumptive patients who 
106 
fell in this group had a higher preference for visiting non-professional healthcare 
professionals than those with upper and low monthly household income. 
Furthermore, we believe that these patients used self-medication more frequently 
after the onset of symptoms which is among determinants of delay as reported 
elsewhere (Bonadonna et al., 2017). Moreover, financial limitations resulting from 
unemployment were related to patient delay. The economic burden associated with 
treatment seeking is high for the poor population, which is most at risk of acquiring 
TB, which has already been noted in other settings (Nissen et al., 2012; Tadesse et 
al., 2013b; Thorson et al., 2000b). This highlights the need for poverty reduction in 
marginalized communities that will consequently contribute to the reduction of TB in 
low-resource settings especially in sub-Saharan countries (Barter et al., 2012b; 
WHO, 2004).  
Furthermore, non-reporting of food or water as potential cause of TB was associated 
with an increased risk of patient delay. This finding may indicate a tendency of 
presumptive and TB patients to attribute their TB symptoms to other causes than 
food and water which in turn lead to early health-care seeking. Our findings 
contradict findings from a recent study in India that found that attribution of TB 
symptoms to factors such as water, pollution and cold favoured diagnostic delay in 
the TB patients (Mistry et al., 2016). 
Our results show that seeking help at the traditional healers was associated with 
delay. One of the factors associated with seeking care at traditional healers was 
financial constraint. Patients claimed that traditional healers are cheaper than other 
healthcare provider’s example hospitals. This underscores the need to improve 
health care services by reducing the costs for diagnosis and treatment while 
considering the marginalized population. Our results are in line with findings from 
studies in Tanzania that documented patients consulting traditional healers due to 
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financial constraints before reaching other healthcare facilities (Hinderaker et al., 
2011a; Verhagen et al., 2010). 
We observed a higher risk of delay among those who prioritized substance use, 
such as smoking and alcohol, as a cause of TB. These patients may have attributed 
their TB symptoms to coughing as a result of smoking and alcohol consumption and 
therefore delayed seeking help in proper heath care facilities. Educating patients on 
the risk factors for TB could potentially decrease patient as well as diagnostic delay 
while seeking health care. 
LDFU in our study was massive. 44% of the respondents did not show up in the 
diagnostic centre after referral from the pharmacies and every third patient who did 
reach the centre, did not complete all required visits. Dropouts at the TB clinic did 
not differ from patients who did not attend any visit at the clinic at all. Although we 
could not trace whether these patients had completed TB treatment in other areas, 
we believe this to be partly the case as supported by other studies which 
documented tendencies of TB patients to continue with TB treatment elsewhere 
(Babu et al., 2008; Buu et al., 2003b; Rao et al., 2009). 
The odds of LDFU among women were higher than those of males. Absence of 
financial autonomy made women miss diagnostic follow-up in healthcare facilities as 
indicated in the narratives. Furthermore women might have simultaneously used 
traditional methods and medical services instead of directly visiting healthcare 
facilities for proper diagnosis and treatment (Eastwood and Hill, 2004b). The 
association between female sex and LDFU in our study is contrary to other studies 
on adherence and loss to follow-up that found men to be more likely to be lost to 
follow-up (Gopi et al., 2005b; E. Johansson et al., 1999).  
The category of perceived causes “other conditions”, such as prior illness and 
heredity, showed a marginally significant positive association with LDFU. Although 
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this finding was not well supported by the narratives, possible explanations for such 
results might be that patients with prior illness and who were previously treated for 
TB might have had unpleasant memories (Munro Salla, Lewin Simon, Smith Hellen, 
Engel Mark, Freitheim Atle, 2007) and did not want to make the same experiences 
again. This finding highlights the need for educating patients with regards to the 
importance of adherence and treatment completion so as to reduce loss to follow-up 
during treatment. 
We found that dust exposures followed by sorcery were considered to be the main 
causes of TB symptoms in LDFU and non-LDFU. Alcohol and smoking were 
acknowledged as causes of TB after probing. Since ideas and perceptions about TB 
influence health-seeking behavior, the mentioned perceived causes influenced delay 
and diagnostic loss to follow-up. Clearly, this highlights the need for clarification on 
the perceived causes in the community that might help in shortening delay and 
LDFU and influencing the right help-seeking behaviour. 
Findings from the narratives indicate that respondents often started seeking 
healthcare after coughing up blood (hemoptysis). Additionally, the absence of blood 
in sputum was interpreted as a ‘normal’ cough which would not be associated with 
TB. This suggests that there was a tendency among presumptive and TB patients to 
minimize the importance of their health conditions and discount the need for further 
treatment until they experienced some specific symptoms like hemoptysis, 
subsequently leading to patient delay and LDFU. Our findings are in line with 
findings from the study on health seeking behaviour among people with cough in 
Tanzania that showed patients with additional TB symptoms sought care earlier than 
those with no additional symptoms (Senkoro M, Hinderaker SG, Mfinanga SG, 
2015). 
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Psychosocial distresses such as fear of being diagnosed with TB or HIV were 
recurring themes in the narratives. TB patients often experience considerable 
psychological and emotional distress as a result of their condition (Somma et al., 
2008b; Weiss et al., 2006; World Health Organization, 2009), and presumptive TB 
patients anticipate the emotional burden of TB and of stigma eventually after being 
diagnosed with HIV that might lead to delay in seeking health care. Thus, this aspect 
requires some attention in case finding efforts.  
Our study is the first to look at patient delay and loss to diagnostic follow-up among 
presumptive and confirmed TB patients within an intervention study in Tanzania. 
However, this study has some limitations. We included a small fraction of the 
presumptive and confirmed TB cases that participated in the big TB-PHARM 
intervention study to explore the factors associated with delay and LDFU in-depth. 
Due to the small sample, our analyses have provided few statistically significant 
results. However, the quantitative and qualitative findings of the study seemed to be 
coherent. 
Furthermore, we relied on patient’s recall of the duration of the delay in treatment 
seeking that might have introduced inaccuracy. However, our interviews were 
conducted with well-trained clinical workers who spent considerable time with the 
patients to obtain as accurate answers as possible. We attempted to limit 
inaccuracies by linking questions about delay with memorable events such as onset 
of symptoms until the first care seeking to a healthcare facility. 
4.4.1 Conclusions 
In conclusion, this study highlights that delay after the onset of symptoms and LDFU 
after referral from the pharmacies is substantial, especially for women. It also 
confirms the high proportion of patients consulting traditional practitioners and that 
this behavior is related to delay but not LDFU. This underscores the need for 
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interventions to ensure that more attention is paid to women’s health needs for 
timely and sustained TB treatment and improved public awareness to reduce 
misperceptions of the cause and value for medical treatment. These findings also 
highlight the need to train and educate traditional healers on TB symptoms so they 
refer patients to the healthcare facilities for further treatment. The preference of the 
presumptive and confirmed TB patients to visit sub-optimal and unequipped 
healthcare facilities for treatment of TB-related symptoms as traditional healers may 
lead to diagnostic delay and LDFU as indicated in our study. These findings 
underscore the importance of strengthening the health sector to ensure that these 
patients are traced and linked to the healthcare facilities assuring early detection and 
effective treatment.  
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Supporting Information 
Supplementary Table 4. Univariate analysis of factors associated with patient 
delay for presumptive and TB patients, n=136 
 
Variable 
 
OR  
 
95% CI 
 
P-value 
 
Socio-demographics 
   
Sex   0.03 
Male 1 (Ref)   
Female 2.21 1.07-4.54  
Age groups    
18-27 1 (Ref)   
28-37 0.72 0.29-1.77 0.48 
≥38 0.88 0.34-2.28 0.80 
Level of education   0.22 
No formal education 1 (Ref)   
Primary/secondary 0.48 0.14-1.55  
Monthly household income     
Low income 1 (Ref)   
Middle income 2.18 0.92-5.17 0.07 
High income 1.28 0.53-3.04 0.57 
Perceived causes    
Ingestion 0.75 0.53-1.07 0.12 
Magico-religious 1.15 0.84-1.56 0.35 
Environmental causes 0.94 0.76-1.17 0.61 
Substance Use 1.21 0.90-1.65 0.20 
Person to person contact 0.97 0.71-1.34 0.89 
Other conditions 1.0 0.73-1.35 1.0 
Help-seeking    
Traditional healers 2.46 1.10-5.50 0.02 
Religious healer 1.27 0.62-2.59 0.50 
Hospital 0.85 0.42-1.74 0.67 
Home remedies 1.28 0.52-3.12 0.58 
Dispensaries 1.09 0.52-2.27 0.81 
OR, Odds ratio; 95% CI= 95% Confidence Interval.  
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Supplementary Table 5. Univariate analysis of factors associated with LDFU 
for presumptive and TB patients, n=136 
 
Variable 
 
OR  
 
95% CI 
 
P-value 
 
Socio-demographics 
   
Sex    
Male 1 (Ref)   
Female 3.51  1.70-7.23) 0.001 
Age groups    
18-27 1 (Ref)   
28-37 1.07  0.46-2.51 0.86 
≥38 1.62  0.65-4.05 0.29 
Level of education    
No formal education 1 (Ref)   
Primary/secondary 0.68 0.23-1.93 0.47 
Monthly household income     
Low income 1 (Ref)   
Middle income 1.24 0.54-2.86 0.60 
High income 0.58 0.24-1.37 0.2 
Perceived causes    
Ingestion 0.68 0.47, 0.98 0.04 
Magico-religious 1.26 0.93-1.72 0.12 
Environmental causes  0.92 0.75-1.14 0.49 
Substance use 1.08 0.82-1.43 0.12 
Person to person contact 1.09 0.80-1.50 0.56 
Other conditions  1.15 0.84-1.56 0.36 
Help-seeking    
Traditional healers 1.74 0.79-3.84 0.16 
Religious healer 0.55 0.27-1.11 0.09 
Hospitals 0.48 0.24-0.98 0.04 
Home remedies 1.71 0.71-4.09 0.22 
Dispensaries 0.64 0.31-1.30 0.21 
OR, Odds ratio; 95% CI= 95% Confidence Interval  
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Abstract  
Background: Traditional medicine practitioners (TPs) are significant health care 
resources outside of the formal health services. They are widely used in Tanzania. 
However, the documentation of their understanding and practices towards 
tuberculosis (TB) management is limited. We explore the role of TPs in the 
management of cough and TB related symptoms in Tanzania. 
Methods: In-depth interviews were used to investigate knowledge about TB and 
TPs practices related to the management of cough and TB related symptoms. We 
collected qualitative data from 30 TPs in three districts of urban, peri-urban and rural 
Tanzania. Open coding was used for labelling concepts, defining and developing 
categories based on participant’s descriptions. We analysed data focusing on 
emerging themes, patterns, similarities and differences in the 3 districts.  
Results: The age of TPs (19 males, 11 females) ranged from 30 to 65 years. More 
than half of the respondents knew how TB is transmitted. Diagnosis of cough and TB 
related symptoms were reported to be based on divinations, laboratory tests 
obtained from the hospital and patient-reported symptoms. Traditional medicines 
indicated as TB treatment included herbs, casting spells, and charms. Some 
practitioners in urban site reported that TB can only be treated in hospital whereas 
respondents from peri-urban and rural sites found that TB can be treated in hospitals 
as well as with traditional medicines. Only a few practitioners in urban, and peri-
urban, but half of those in rural setting mentioned treating TB. Almost all TPs 
referred patients to the hospital for further treatment but there indicated minimal 
collaboration among the practitioners and the government or other stakeholders.  
Conclusion: Results underline the need to educate TPs on TB symptoms, causes 
and treatment. Our observations may guide future public health interventions on the 
inclusion and collaboration with TPs for better TB case finding and management.  
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5.1 Introduction 
Tuberculosis (TB) is the ninth leading cause of death worldwide, and a leading 
cause from infectious disease ranking above HIV/AIDS with 1.7 million deaths and 
10.4 million TB cases in 2016 (WHO, 2017). Despite a recent global and national 
upsurge in TB treatment success rates, the disease remains a substantial killer and 
cause of disease burden especially in sub-Saharan Africa countries (WHO, 2016). 
Additionally, TB ranks the top three cause of the global burden of disease (GBD 
2017 Disease and Injury Incidence and Prevalence Collaborators, 2018). 
Traditional medicine practitioners (TPs) are significant health care resources outside 
the formal health services provided by the government or non-governmental 
organizations and outnumber by far modern health practitioners in sub-Saharan 
Africa (UNAIDS., 2002). Evidence suggests that more than one third of TB patients 
in sub-Saharan Africa seek help from TPs before approaching modern health care 
facilities leading to delay in seeking health care, increased morbidity and mortality 
(Barker et al., 2006; Hinderaker et al., 2011b; Eliud R. Wandwalo and Mørkve, 
2000a). Moreover, TPs act as the first entry point for health care seeking for the 
majority of people after the onset of TB symptoms (Barker et al., 2006). 
Tanzania remains among the 30 countries in the world with high TB burden with 295 
new TB cases per every 100,000 population (Ministry of Health and Social Welfare, 
2013a; WHO, 2016). TB case detection strategies rely on passive case finding 
based on patients presenting themselves in healthcare facilities for diagnosis and 
treatment (Ministry of health and social welfare, 2006b; Ngadaya et al., 2008b). With 
such an approach, detection of TB cases is suboptimal due to complex pathways to 
care which often starts at TPs and not at formal health care facilities (Mfinanga and 
Mutayoba, 2008b; Mhimbira et al., 2016). Furthermore, a majority of people rely 
even primarily on traditional medicines for their primary health care requirements 
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(Brouwer et al., 1998). 
Traditional healing practice is historically among the widely used and extensively 
accepted practices in Tanzania (Mbwambo et al., 2007), however, the 
documentation of its application in relation to TB control and management is 
inadequate. To our knowledge, no qualitative study on the role of TPs in TB control 
and management has previously been done in Tanzania. Up to now, interventions 
on intensified TB case findings have largely focused on biomedical rather than 
socio-cultural factors (Das and Horton, 2015). TPs knowledge and views have not 
been investigated and their practices are not well documented. (Das and Horton, 
2015). We explored the role of TPs at an urban, semi-urban and rural site of 
Tanzania (Temeke, Bagamoyo and Ifakara districts) in the management of upper 
respiratory infection and TB related symptoms to determine if they could play a role 
in TB case finding and management.  
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5.2 Methods 
Study settings 
The study was conducted at the following three sites in Tanzania: 
Urban site (Temeke district, Dar es Salaam Tanzania) 
Temeke district of Dar es Salaam has a dense population of 1,369,000 people (The 
United Republic of Tanzania, 2013b). The main source of cash income is derived 
from the sale of food crops and from business (The United Republic of Tanzania, 
2014b). The majority of the population are Christians and Muslims. The district is 
characterized by a small number of health care facilities compared to the other two 
districts (Kinondoni and Ilala). It has 135 health care facilities with only six private 
and public hospitals. The doctor population ratio in the district is estimated to be 
1:4,074 (The United Republic of Tanzania, 2014b). In 2016, a total number of 4,495 
TB cases (all forms) were identified in this district, of which 1,760 (43%) were smear-
positive (Ministry of Health and Social Welfare, 2016a). 
Peri-urban site (Bagamoyo district, Pwani Tanzania) 
The peri-urban site of Bagamoyo is among the 6 districts of the Pwani region of 
Tanzania. The district is located at the coast, approximately 70km away from the 
commercial capital of Dar es Salaam, and has a population of 311,740 with only 
136,506 individuals in formal employment. The main source of income in the region 
is farming (57.8%) and fishing (1.9%) (Tanzania National Bureau of Statistics, 
2016c). The district is characterized by a low number of healthcare facilities and the 
doctor to population ratio is estimated to be 1:2051 (Tanzania National Bureau of 
Statistics, 2016c). The majority of the population are Muslims. Bagamoyo district is 
characterized by least number of healthcare facilities and has less than 5% TB 
notification rates per year (Tanzania National Bureau of Statistics, 2016a). 
Rural site (Ifaka district Morogoro Tanzania) 
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The rural site of Ifaka is located in the Kilombero district in Morogoro region with a 
population of about 407,000 (The United Republic of Tanzania, 2013b). Farming is 
the main source of income (Tanzania National Bureau of Statistics, 2016d). The 
district is characterized by few public and private health care facilities (Ministry of 
Health and Social Welfare, 2014b). The district has a single refferral hospital which 
is the largest healthcare facility in Kilombero district. The population is a mixture of 
Muslims and Christians (Tanzania National Bureau of Statistics, 2016b). The doctor 
population ratio in Morogoro region is 1:19,475 (United Nations, 2014).The case 
notification rate is about 5.4% in the region with 3194 notified cases in 2016 (Ministry 
of Health and Social Welfare, 2016a). 
Study population and sampling technique 
We included TPs with more than eighteen years of experience in traditional healing 
practice who reported treating upper respiratory tract infection (i.e.’ normal cough’ as 
indicated by practitioners) and TB related symptoms (coughing for more than two 
weeks, night sweats, fever, and haemoptysis (coughing up blood). The study 
population consisted of 10 TPs at each study site.  
Respondents were selected by purposive sampling with the help of the TB clinic at 
the Temeke referral hospital in Dar es Salaam, the Bagamoyo district hospital, and 
St. Francis hospital in Ifakara. The sampling procedure was considered the most 
effective approach for the identification and selection of information-rich cases, i.e. 
respondents knowledgeable and experienced in the management and treatment of 
cough and TB related symptoms (Creswell, 2014; Palinkas L et al., 2013; Patton, 
1990). 
As we were aware that most likely there were other key informants unknown to us, 
we further used snowball sampling (Biernacki and Waldorf, 1981; Browne, 2005) to 
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recruit further suitable participants. Residents and people around the study sites 
were asked about local TPs within their residence areas (Gessler et al., 1995c). 
They helped with recruitment from among their acquaintances until the required 
sample size was reached. 
Study design  
Qualitative in-depth interviews were used to investigate socio-cultural ideas and 
knowledge of TB in general, TPs approaches towards the management of coughs 
and TB related symptoms, and traditional medicines used by TPs for treatment of 
cough and TB related symptoms (Getachew et al., 2016). 
Data collection 
An interview guide was designed and, according to the accepted standards, pilot 
tested prior to data collection and modified where appropriate. The interview guide 
was developed in English and translated into the local language, Swahili. An 
interviewer with extensive training in qualitative research and in-depth interviews 
conducted the interviews in the local language. The interviews lasted 30 - 60 
minutes and were audio-recorded. Data were collected from August 2016 to March 
2017. 
Data analysis 
Data were transcribed verbatim. The transcribed data from voice recordings were 
read and re-read to gain an initial impression of the data and an in-depth 
understanding of participants' descriptions. All analyses were performed using 
MAXQDA version 12 (Verbi Software, Berlin, Germany). 
We used open coding to labelling concepts, defining and developing categories 
based on properties and dimensions of participant’s descriptions (Strauss A, 1998). 
Subsequently, codes were grouped into categories and an inductive approach (ideas 
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emanating from the data itself) as well as a deductive approach (theoretical 
understanding, literature review and researcher`s experience) was used for data 
analysis. Two independent people checked for inter-coder reliability in order to 
improve coding instructions and individual codes (Kirilenko and Stepchenkova, 
2016). The two individuals independently created codes and read randomly selected 
transcripts, one from each study site. They subsequently discussed the codes and 
resolved any disagreement arising from the codes. 
Data were analysed focusing on emerging themes, patterns, similarities and 
differences. The framework analysis method of Gale,(Gale KN, Heath G, Cameron 
E, Rashid S, 2013b) developed for the analysis of qualitative data in multi-
disciplinary research, was used for data analysis. The method was helpful in 
summarizing and reducing the data to answers the research questions.   
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5. 3 Results 
Demographic characteristics 
The demographic details of the study population are summarized in Table 13. Overall, 
we interviewed 30 TPs in three study settings. The age distribution of the practitioners 
ranged from 30 to 65 years with the exception of one practitioner being aged 75 
years. There were 8 males (80%) at urban site, 7 (70%) per-urban and 4 (40%) in the 
rural site. Ninety percent of the practitioners were Muslims compared to ten percent 
Christians and other religions. Half of the respondents in urban and peri-urban were 
full-time TPs, half part-time TPs, combining TP with other occupations like farming 
and business. Almost all in rural site were part-time practitioners, combining TP and 
farming. The respondents reported a work experience as TP ranging from a minimum 
of five years to a maximum of 32 years. A long work experience (30 years and above) 
was reported by TPs particularly in the urban. As to the level of education, more than 
half of all TPs had a primary education, none had a university degrees or a vocational 
training education. In rural site, half of the interviewed TPs had no formal education. 
Furthermore, none of the TPs had been trained as community health care workers.  
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Table 13. Demographic characteristics of the interviewed Traditional 
practitioners 
Characteristics Urban n (%) Peri-urban n (%) Rural n (%) 
Total 10 10 10 
Sex    
Males 8 (80%) 7 (70%) 4 (40%) 
Females 2(20%) 3 (30%) 6 (60%) 
Level of education    
Primary  7 /70%) 60 (60%) 50 (50%) 
Secondary 3 (30%) 1 (10%) - 
No formal education - 3 (30%) 50 (50%) 
Age    
30 years and above 10 (100%) 8 (80%) 9 (90%) 
Below 30 years - 2 (20%) 1 (10%) 
Religion    
Muslims 9 (90%) 10 (100%) 8 (80%) 
Christians or other religion 1 (10%) none 2 (20%) 
Work Experience as TP    
Range (years) 5-32 years 1-26 years 2-20 
Five years or less 1 (10%) 3 (30%) 1 (10%) 
Six years or more 9 (90%) 7 (70%) 9 (90%) 
Occupation    
Full-time TH 5 (50%) 5 (50%) 2 (20%) 
Part-time TH 5 (50%) 5 (50%) 8 (80%) 
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Mode of acquisition of the traditional healing practices 
The mode of acquisition of the traditional healing practices described by the 
practitioners falls into six major routes as displayed in Table 14. These included, 
ancestor spirits subsequent to an experienced sickness, initiation of ancestral spirits, 
training through apprenticeship/religious institutions, inheritance from a family 
member subsequent to a sickness, own decision. All reported passing through a 
combination of routes. 
 “I experienced unknown illness that made me collapse and lose consciousness 
for even four hours. I lost my work because of the condition. I had to come back 
home. My family members took me to a TP who said the ancestral spirits 
instructed that I have to inherit the job from my grandfather. I am a TP since 
then.” (male, Ifakara).  
“I inherited this work from my father after he died. (female, Temeke.) 
“I liked traditional practices since I was young. I decided to go to a religious 
institution to get some training and later I stayed with a TP for a year for further 
training.” (male, Bagamoyo). 
“The ancestral spirits wanted me to do this job. I first refused the spirits became 
furious with my decision. I eventually accepted the job and since then I have 
treated so many patients” (male, Ifakara). 
“I stayed with a TP for three months helping her and also to train for the job. I 
started practising at my home town afterwards.” (female, Temeke). 
In the urban site, most reported inheriting the practice from a family member (7 out of 
10), contrasting to rural and peri-urban sites, where the majority stated to have 
become a healer initiated by ancestor spirits upon recovery from a sickness. Few 
practitioners in urban and peri-urban reported acquiring the practice through training 
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(apprenticeship/religious institutions), whereas none reported this in rural site. Only 2 
stated to have become TPs by their own decision.  
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Table 14. Modes of acquisition of the traditional healing practice (multiple 
answers possible) 
Mode of acquisition 
 
Urban  Peri-urban  Rural 
      
Ancestor spirits subsequent to an 
experienced sickness 
5 (50%)  6 (60%)  8 (80%) 
Inheritance from a family member 
 
7 (70%)  4 (40%)  4 (40%) 
Initiation by ancestral spirits 1 (1%)  4 (40%)  5 (50%) 
Training through Apprenticeship/ 
religious institutions 
3 (30%)  3 (30%)  1 (10%) 
Inheritance from a family member 
subsequent to sickness 
1 (1%)  2 (2%)  3 (30%) 
Own decision 1 (1%)  1 (10%)  - 
Health problems frequently treated 
The interviewed TPs treated a number of health problems. Apart from different 
coughs and TB, these included: epilepsy, seizures, infertility, stomach diseases, 
witchcraft, fever, mental disorders, diabetes, pneumonia, malaria as well as different 
types of cancer. Treatment for health problems did not differ much among the TPs 
from the three study sites with the exception of cancer that was treated only by one 
TPs in the rural site. None explicitly reported treating HIV.  
A male traditional healer from Bagamoyo stated: 
“I treat mental disorders, women infertility, sexually transmitted disease, 
different types of coughs and even TB.”  
“I have successfully treated epilepsy, mental disorders, seizures and malaria to 
mention a few. All patients that I treated are in good health.” (female, Ifakara).  
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TP knowledge on cough symptoms and TB 
TPs in the three settings had limited knowledge on cough and TB related symptoms. 
They identified three distinct types of coughs. They referred to them as ‘normal 
cough’, ‘asthmatic cough’ and ‘TB cough’. Symptoms of a ‘normal cough’ were 
described as a dry cough without shortness of breath which lasted for some few days. 
Symptoms of ‘asthmatic cough’ included a productive cough that lasted for a longer 
period of time, and went along with fever as well as high body temperature.  
‘TB cough’ was described by respondents as a productive cough accompanied by 
yellowish, thicker sputum. They also linked cough to TB in case of its co-occurrence 
with tiredness, difficulty in breathing, changes of skin and hair colour, and loss of 
consciousness. When asked about TB symptoms, only one TP in the urban setting 
could list more than half of the TB symptoms which include weight loss, haemoptysis, 
coughing for more than two weeks as well as fever. Some TPs, particularly in peri-
urban, could not explain TB symptoms since they claimed not to have treated anyone 
with TB. 
"I have never treated anyone with TB therefore, I am not aware of what the 
symptoms are” (female, Bagamoyo). 
“I know three TB symptoms. The first one is coughing for a long time, second is 
tiredness and the last is changes in skin and hair colour.” (male, Ifakara). 
Knowledge of TB causes and TB transmission 
More than half of the respondents were able to describe that TB is transmitted 
through air from one person to another. 
A female respondent in the urban setting said: 
“I know that TB is transmitted through air. If someone coughs without covering 
his mouth, he can transmit the disease” (female: Temeke). 
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Another TP in the rural reported that TB is transmitted through air or if an infected 
person eats or sleeps with those who are not infected: 
“I think TB is transmitted through air when someone coughs or even when you 
eat with someone who has TB; you can get the disease.” (female: Ifakara). 
The TPs could not differentiate the causes and risk factors for TB. There were 
different concepts with regard to the cause of TB among the TPs in the three sites. 
Half of the TPs in the urban site reported that TB is caused by dust, alcohol intake, 
cigarette smoking, and staying or working in crowded places such as buses and 
marketplaces. None of the TPs in the urban associated TB with witchcraft or evil 
spirits.  
A male practitioner from the urban site explained it this way: 
“It is not true that TB is caused by either witchcraft or evil spirits. TB is caused by 
cigarette smoking and sometimes dust.” (male, Temeke). 
Contrasting to this, some TPs in peri-urban and rural settings believed TB was caused 
by witchcraft and evil spirits and two respondents from peri-urban and rural sites 
claimed that TB was caused by evil spirits. 
“Evil spirits can cause TB. It is another type of TB.” (female, Bagamoyo). 
Furthermore, only three TPs in the rural site said it was caused by bacteria. However, 
they could not mention the specific type of bacteria.  
“I know that TB is caused by a certain bacteria though I don’t know the name of 
the bacteria.” (male, Ifakara) 
Other common causes mentioned in all sites were: a dirty environment, dust, drinking 
unboiled milk, inheritance and a combination of other diseases like asthma and HIV.  
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Knowledge of TB and HIV 
We asked TPs if it is a must for a TB patient to have an HIV infection. TPs in rural site 
had a better knowledge of the relationship between TB and HIV than those in the 
urban and peri-urban. The majority in the rural site disagreed with this concept (8 out 
of 10):  
“It is not necessary for a TB patient to have HIV. Although these are co-
infections, still I believe it’s not necessary to have TB and HIV at the same 
time.” (male, Ifakara). 
In contrast, 5 out of 10 TPs in the urban and 4 out of 10 TPs in peri-urban agreed that 
a confirmed TB person must also have HIV. 
Approaches to TB treatment 
We observed an interesting pattern in the three study areas regarding TB treatment. 
In the urban, six out 10 TPs claimed that TB can only be treated in the hospital. None 
of the TPs thought to be able to treat and cure the disease, but only to relieve the 
symptoms. 
A male respondent put it this way when asked: 
“None of us TPs can treat TB. We can only give herbs to alleviate TB 
symptoms. TB can only be cured in hospitals. There are some herbs that can 
treat a normal cough but not TB.” (male, Temeke). 
In the rural site 3 TPs mentioned that TB could be treated in hospitals but saw also a 
role for traditional medicine:  
“TB can be treated in the hospital but also with traditional medicines if hospital 
treatment fails. We sometimes receive patients who could not be cured with the 
treatment in hospitals. If I treat them with my herbs, they get completely cured.” 
(male, Ifakara). 
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Likewise, 4 out of 10 TPs in peri-urban site claimed that traditional medicines can 
work if only the disease was caused by evil spirits. 
“TB can be treated by traditional medicine only if the disease was caused by 
evil spirits.” (male, Bagamoyo). 
Additionally, fear of being diagnosed with TB at the hospital was also mentioned as a 
reason for the patients seeking health care from a TP than in hospitals and other 
healthcare facilities. 
 “Sometimes patients are afraid of being diagnosed with HIV at the hospital; 
that is why they visit us.” (female, Temeke). 
Traditional diagnosis of upper respiratory tract infections (‘normal cough’), 
asthma and TB 
Three different diagnostic procedures were described to be used by the TPs, include 
divinations (inquiring from the spirits and supernatural powers), laboratory test 
results from the hospital, and symptoms mentioned by the patients. The diagnostic 
procedures were said to be used either as a single procedure or in a combination. 
We found that TPs in rural site who claimed to use divination as a diagnostic 
procedure far outnumbered those in urban and peri-urban (6 out of 10).  
“I inquired from the spirits regarding the health problem of the patient. The 
spirits informed me that the patient has TB.” (female, Ifakara). 
“When a patient comes for treatment, I usually consult my spirits regarding the 
patient’s problem. Immediately I know what the health problem is. If it is not 
witchcraft, I instruct the patient to visit the hospital.” (male, Ifakara). 
Only one TP in urban and one TP in peri-urban claimed to use divination as means 
of diagnosis for cough and TB related symptoms. 
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Diagnosis based on patient’s symptoms was more common in urban and peri-urban 
settings. The TPs said they usually ask the patient first before they decide whether it 
was normal cough, asthma or TB. 
“I asked the patient regarding her symptoms before I could decide how to treat 
her. This is how I diagnose the different kinds of coughs.” (male, Temeke). 
"I let the patient explain his problems and I listen carefully. Afterwards, I may 
advice the patient based on his explanations on whether to visit the hospital or 
to use traditional medicines. I don't use divinations or spirits for diagnosis of 
cough problems.” (female, Temeke).  
Diagnosis by hospital reports was frequently used by the TPs in urban and peri-
urban sites. The patient is asked for the laboratory results before treatment. 
 “I rely on laboratory results obtained from the hospital. I ask the patient to first 
get checked in a hospital. Afterwards, I can decide on how best to treat the 
patient.” (male, Temeke). 
 “Most of my patients visit hospitals first before coming here. This gives me a 
clear direction on how to treat them based on the diagnosis made at the 
hospital. “(female, Bagamoyo). 
Treatment of coughs and TB related symptoms 
Treatment approaches of a cough and TB were similar among the three study sites. 
All TPs reported using different traditional medicines for the treatment of either 
cough or TB related symptoms. These included: herbs (plant roots and leaves) that 
were either in powdered or liquid forms. Other traditional medicines included: honey, 
vinegar, lemons, garlic as well as ginger. Moreover, spells and charms, as well as 
spirits and divination were mentioned as part of treatment.  
Variations in the views on treatment of TB were apparent in the three study sites. 
When asked if they could treat TB, only 2 TPs in urban and 3 TPs in peri-urban 
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agreed that they could do so TPs in the urban and peri-urban sites said that for TB 
patients, they only give some traditional medicines that can be used for a shorter 
time in order to alleviate pain before making referrals to hospitals for further 
treatment.  
“Once I suspect that I cannot treat the cough, I usually give the patients some 
herbs to relieve pain before I refer the patient to the hospital. If you send the 
patient away without any treatment, he might feel that you don’t care. In 
addition, it’s considered unethical in THs practices”. (male, Temeke). 
On the other hand, half of the respondents in the rural site said they treat TB and 
that they had previously treated TB patients with successful treatment outcomes.  
“I have never treated a TB patient before; however. I have some traditional 
medicines that can treat TB once I get a patient.” (Ifakara, female). 
Number and gender of treated patients 
The number of patients treated did not differ in the three study sites. On average, 
TPs reported treating two to five patients daily with coughs and TB related 
symptoms.  
TPs in the urban site reported treating more females than males. Only two 
respondents reported otherwise. When asked about underlying reasons, a male 
respondent said:  
“I treat more females than males. Females are weaker compared to males and 
encounter more health problems than males. The biological and physical 
make-up of a female makes her more vulnerable to health problems than a 
male.” (male, Temeke).  
Similarly, 6 out of 10 TPs in peri-urban reported treating more females than males; 
however, their given explanations differed from those in urban site 
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“Females believe more in witchcraft than males. Whenever women encounter 
health problems, they think they are bewitched. This is the reason why females 
visit TPs more than males. It also might be because of a lack of financial 
resources, as TPs are cheaper compared to healthcare provided in hospitals.” 
(female, Bagamoyo). 
In contrast, almost all TPs in the rural site (7 out of 10) reported treating both females 
and males.  
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Patient’s admission to the treatment rooms 
While none of the TPs in urban and only one in peri-urban reported admitting 
patients during treatment, in the rural site, half of the respondents reported to do so. 
Different reasons were given for this. In the rural site, TPs mentioned distance and 
the patient’s condition as the reasons for admitting patients. Patients who lived far 
from the TPs and who were weak due to illness were admitted more often compared 
to others. However, patients with TB and other health conditions (e.g. fever, stomach 
problems) are admitted to a single room according to their gender.  
“I admit patients who come from far and those that are physically weak. I have 
separate rooms for males and females. Patients sleep together regardless of 
their health problems.” (female, Ifakara). 
Referrals to the hospital  
We found that almost all TPs in the 3 study sites reported referring patients for 
further treatment if they could not provide treatment or if their treatment did not help. 
However, the majority of the respondents claimed to have changed their medication 
before the referrals were made. Three respondents, one from each study site, 
reported to refer patients to another TP if they could not provide treatment. 
“I change the medication before I refer the patient to another TP once I receive 
feedback that the treatment did not work. If traditional medicines from the other 
TP fail, then we can refer the patient to the hospital for further treatment.” 
(male, Bagamoyo). 
TPs were asked how long it takes them before referring patients for further 
treatment. While those in urban and peri-urban settings indicated a minimum of 3 
days and a maximum of 7 days, TPs in the rural setting took a minimum of 3 days 
and a maximum of 2 weeks to refer patients for further treatment. 
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“I prescribe traditional medicines for seven days. If the condition does not 
improve and the patient is getting worse, I immediately refer the patient to the 
hospital for further treatment.” (male, Temeke). 
Costs of treatment 
Three different explanations were provided by the TPs with regard to why they 
charge their patients. One reason for charging patients was that the payment 
received was used for obtaining an official treatment licence from the government. 
Others received payment to cover admission costs, while others used the payment 
to cover travel expenses to other regions to collect the traditional medicines. 
TPs in all study settings commonly admitted that charging patients was not the main 
interest of their work but rather observing a positive treatment outcome for a patient. 
All TPs mentioned patient satisfaction with the provided treatment before asking for 
a payment. 
“Asking for a reimbursement from a patient is not the foremost priority. The 
patient has to get well first before I can ask for payments. Some of the patients 
are financially incapable of paying for their treatment. I treat even such 
patients. 
It’s very unfair to reject a patient because he cannot pay. Gods are not pleased 
with such behaviour” (male, Temeke). 
Furthermore, costs of treatment varied significantly among the study settings. In 
urban site, the minimum costs ranged from ten thousand Tanzania shillings to a 
maximum of seventy thousand Tanzania shillings (4.5 USD to 32 USD). In peri-
urban site from a minimum of two thousand to a maximum of fifty thousand (1 USD 
to 23 USD) and in the rural site from a minimum cost of two hundred shillings  to a 
maximum of fifty-five thousand Tanzania shillings (0.08 USD to 25 USD). The 
amount of treatment costs depended on the type of treatment. In addition, more than 
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half of the TPs in the rural site accepted payment in kind (i.e sugar, rice and maize) 
compared to only three in peri-urban and none in the urban. 
“I accept all kinds of payments. If the patient does not have cash, he can bring 
something else e.g. rice or sugar. For others who cannot afford payment in 
cash, I receive even payment in kind.” (female, Bagamoyo). 
Costs for treatment were lower than those charged by hospitals and other healthcare 
facilities. The minimum payment could range from six thousand to a maximum of 
twenty five thousands Tanzania shillings for TB diagnosis for a single visit. 
Collaboration with the government and other stakeholders 
When asked about any collaboration with the government, only 3 TPs in the urban, 2 
in rural and none in peri-urban said they would collaborate. Those who do 
collaborate in the urban reported to attend different seminars on TB events 
organized by the ministry of health in collaboration with other stakeholders. A TP in 
the rural reported to attend a seminar on TB to attend seminars organized by the 
government on other diseases such as HIV/AIDS but not TB.  
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5.4 Discussion 
Findings from this study provide an insight into the current role of TPs in managing 
cough and TB related symptoms. Knowledge about cough and TB related symptoms 
were limited and varied across settings. Dust, witchcraft, smoking, alcohol abuse 
and living or working in crowded places e.g. in buses and in marketplaces were seen 
as causes of TB. TPs in the urban and rural sites had a mixed knowledge about how 
TB is transmitted and some in peri-urban could not respond to this question at all. 
Diagnosis for cough and TB related symptoms based on divinations (inquiring from 
the spirits and supernatural powers), laboratory test results from the hospital, and 
symptoms mentioned by the patients. The majority of the TPs accepted that effective 
TB treatment could only be obtained in hospitals. TPs in all study sites referred 
patients to the hospital for further treatment. Treatment costs ‘normal cough’ asthma 
and TB related symptoms ranged from a minimum of 200 to a maximum of 50 
thousand Tanzania shillings (to 24USD). 
We found that TPs reported treating a vast majority of diseases with traditional 
medicines and divinations as documented elsewhere (Gessler et al., 1995b). This 
finding highlights that TPs are an influential group in the primary health care system 
and can undoubtedly contribute to the health of the community. This underscores a 
need to involve TPs in national healthcare systems through effective training so they 
can support disease control strategies in the community. Furthermore, on average, 
TPs reported treating two to five patients daily with coughs and TB related 
symptoms. This finding is alarming and requires some attention since it may 
increase TB transmission in the community. 
In this study, almost all of the TPs could mention how TB was transmitted. However, 
the majority lacked the ability to identify presumptive TB cases. Only one TP could 
mention about half of the TB symptoms. This indicates a limited knowledge of TB 
137 
symptoms among the TPs, as similarly documented elsewhere (Brouwer et al., 
1998). Consequently, this might intensify the TB transmission cycle in the community 
since the TPs will not be able to identify and immediately refer patients to hospitals 
for further treatment. Public health interventions should focus on educating this 
important group in the community particularly on TB symptoms in order to control 
further TB transmission in the community. 
We found that a majority of the healers did not have a clear knowledge of the causes 
of TB. While those in the urban related TB to cigarette smoking and overcrowding, 
their counterparts in the peri-urban and rural sites had different views and related the 
disease to evil spirits. Only 3 TPs in the rural site mentioned bacteria as a cause of 
TB. Our results confirm observations made in other studies that have documented 
perceptions of TB causes. Knowledge is usually higher in urban settings compared 
to rural settings in TB patients and in the normal population (Haasnoot et al., 2010; 
E. R. Wandwalo and Mørkve, 2000). This finding should be carefully reflected upon 
as assumptions like TB is caused by evil spirits complicates the health-seeking 
behaviour and increases delay for patients who seek care from TPs.  
Acknowledgement by some TPs that TB can be treated only in hospital underlines 
the importance of harnessing such information among these practitioners as 
beneficial for the patients. The TPs could be trained to become TB treatment 
supervisors, an approach accepted by many TB patients (Banerjee et al., 2004; 
Wilkinson et al., 1999). Subsequently, the approach could assist in reducing the rate 
of loss to treatment follow-up and pre-treatment follow-up, a substantial health 
problem in low-income countries particularly in Africa (MacPherson et al., 2014a). 
Diagnosis of normal coughs and TB was based on divination, laboratory results from 
hospitals and symptoms, no diagnostic measures (such as microscopy or Xpert) 
were used by TPs. This approach may undermine TB control measures. Some TPs, 
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especially those from urban and peri-urban, indicated to rely on the diagnostics of 
hospitals, but the time that elapses until they refer their patients may be too long. 
This leads to delay in diagnosis and consequently in seeking health care treatment 
at the appropriate healthcare facilities. TPs should be properly educated on the 
importance of proper, early TB diagnosis at healthcare facilities with optimal 
diagnostic tests.  
Moreover, other TPs practiced herbal treatment and few used charms and the 
casting of spells. Using herbs for treatment of various diseases has a long history in 
African indigenous culture (Cunningham, 1993). Some of the respondents reported 
using both western remedies and traditional remedies. Our findings are similar with 
findings from treatment of malaria and HIV in Tanzania where the TPs and the 
patients reported to use both western and traditional remedies (Gessler et al., 
1995a; Moshabela et al., 2017).  
Females were more frequent among the TPs patients than males. TPs gave as an 
explanation that women are weaker, more likely to believe in witchcraft and less able 
to afford the costs of treatment in health facilities. As documented elsewhere, the low 
cost associated with TPs treatment makes it easier for women to access their 
services in comparison to men (Eastwood and Hill, 2004a). Our findings are also 
consistent with those from another study documenting that females made use of TPs 
more than males (WHO, 2006).  
Furthermore, half of the practitioners in the rural site reported admitting patients from 
a long distance and who were weak due to illness. These patients were also 
admitted in the same treatment rooms, regardless of their health conditions and 
disease. This finding is alarming and should be further examined since social 
proximity among people has been documented as a risk factor for TB (Lienhardt et 
al., 2003). 
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Costs for treatment varied in the three study settings. They were rather low and 
affordable for the majority of patients, and some TPs treated their patients for free. 
This might be one of the explanations why patients prefer to seek help at TPs rather 
than in other health care facilities e.g.in hospitals. Our findings are consistent with 
findings in Gambia whereby patients sought healthcare at TPs as they were not able 
to afford treatment costs at other healthcare facilities (Eastwood and Hill, 2004a). 
Public and private health facilities should explore ways to mitigate costs for seeking 
healthcare in the marginalized population so that this group can afford care at 
optimal healthcare facilities.  
Our results indicate that there exists very minimal collaboration among the TPs with 
the government or other stakeholders. One exception is, at least for some TPs, that 
they rely on the diagnostics of health facilities. This finding highlights the need for 
strengthening the partnership between the government and the TPs in Tanzania. It 
might motivate the TPs not only to refer patients for further treatment, but also to be 
aware of TB in general. Additionally, TPs could sometimes act as supervisors for the 
TB patients if given a chance as documented elsewhere (Banerjee et al., 2004; 
Wilkinson et al., 1999). 
To the best of our knowledge this study is the first one to examine the roles of TPs in 
the management of TB in Tanzania. It is also the first study to investigate and 
contrast the practices of TPs in urban, peri-urban and rural areas of Tanzania. Our 
study is not without limitations. TPs might have displayed social desirability towards 
the interviewer and provided answers that they thought were likely to be favoured by 
the interviewer. However, we had assured the respondents that there were no wrong 
or right answers and that all their response were highly acceptable and valuable. 
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5.4.1 Conclusion 
Findings from this study highlight insights into the possible role of TPs in TB 
management. They confirm the limited knowledge of TB among TPs. Further, it 
points out the different treatment practices including the use of herbs, divinations 
and use of charms and spells. Although referrals to hospitals for further treatment 
are found to be a common practice among the TPs, they but occur with delays. 
Results from this study underline the need to educate TPs on TB symptoms, causes, 
timely diagnosis and appropriate treatment to enable them for their inclusion and 
collaboration for a better TB management.  
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Abstract  
Introduction: At least one third of the tuberculosis (TB) patients in sub-Saharan 
Africa visit traditional healers (THs) before visiting modern healthcare facilities for TB 
treatment. We explored the role of THs in TB management in urban, per-urban and 
rural settings of Tanzania. 
Methods: We included 90 THs, 30 from each study site and collected data on 
knowledge of symptoms and causes of TB, costs for TB treatment and calculated 
distance in meters. Cost distributions were described by their medians and 
interquartile ranges. 
Results: The median age was 41.4 years (interquartile range [IQR] 37.5-49.7) and 
54 (60%) were men. 5 (17%). 50% of the healers in peri urban and rural sites had 
low knowledge on TB causes. 24 (80%) in the rural setting reported to use charms 
and spells for treatment of cough and TB related symptoms compared to 12 (40.0%) 
in the urban setting and 17 (56.7%) in peri-urban. Maximum median costs for TB 
treatment in urban site were USD 4.61 [IQR 2.30-6.91] similar to peri-urban and 
6.91[2.30-11.53] in the rural site. 37% of the THs in the rural site admitted patients 
during treatment compared to 10% in the urban and 16% in peri-urban (p=0.03). 11 
(36.7%) of the healers in peri-urban resided < 1000 meters from a hospital 
compared to 28 (93%) in urban site and the rural site 24 (80%). There was a 
significant association between collaboration with the government and referring 
patients to hospital for further treatment (p =0.01). 
Conclusion: THs had limited knowledge on cough and TB related symptoms. 
Treatment practices differed among the healers and costs for treatment were lower 
compared to formal treatment. THs should be educated on the importance of early 
and timely TB diagnosis and the collaboration between the healers and the 
government should be improved for better TB control.  
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6. 1 Introduction 
Despite recent global and national increase in tuberculosis (TB) treatment success 
rates the disease remains a substantial killer especially in Sub-Saharan Africa 
countries particularly where HIV prevalence is also high (WHO, 2018). In such 
settings TB accounts for almost 40% of adult deaths where as in half of these cases 
the disease remains undiagnosed until death (Gupta et al., 2015). These results 
might be attributed to health seeking behaviour and access to health care among TB 
patients (WHO, 2018, 2017). In addition, they might be attributed to visits to health 
care providers with sub-optimal or no diagnostic capacities e.g. traditional healers 
(THs) for the first consultations before reaching facilities with TB diagnostic 
capacities (Barker et al., 2006). Furthermore, access to health care facilities is 
sometimes difficult for the presumptive and TB patients due to several factors such 
as geographical accessibility, suitability of the health services and the financial 
constraints (Barker R. et al., 2002; Kasse et al., 2006). Such factors may lead to the 
utilization of the THs than other health care providers (Eastwood and Hill, 2004a). 
Almost 80% of the people living in Africa rely on traditional healing system for their 
primary health care requirement in spite of introduction to western treatment (WHO, 
2000). Evidence suggests that THs are significant health care resources outside the 
formal health care services, and far outnumbered modern health care providers 
particularly in sub-Saharan Africa (UNAIDS., 2002). Additionally, at least one third of 
the TB patients in these settings visit THs before visiting modern healthcare facilities 
(Banerjee et al., 2000; Barker et al., 2006). 
Tanzania still remains among 30 countries with high TB burden with 295 TB cases 
per 100,000 population (Ministry of Health and Social Welfare, 2013a; WHO, 2017). 
TB case detection is mainly done by passive case findings, by patients with TB 
symptoms presenting themselves to the health care facilities for diagnosis and 
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treatment (Ministry of Health and Social Welfare, 2013b). With such approach, the 
pathway towards diagnosis and TB treatment involve more than one health care 
provider and visits to THs which can lead to delay in diagnosis for TB patients 
(Hinderaker et al., 2011b; Said et al., 2017; Eliud R. Wandwalo and Mørkve, 2000a). 
Traditional healing practices have co-existed since the colonial age and the number 
of the THs outweigh that of the modern practitioners in Tanzania (UNAIDS., 2002). 
The practice is broadly used and widely accepted in the country (Mbwambo et al., 
2007), however, the documentation of its application towards TB management is 
scarce. To better understand the role of THs in management and TB control, we 
explored the role of THs in TB management in urban, peri-urban and rural settings of 
Tanzania.  
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6.2 Methods 
Study settings 
The study was conducted in the following three study sites 
i. Temeke district, Dar es Salaam Tanzania (urban site) 
Temeke district has a dense population of at least 1.4 million people (The United 
Republic of Tanzania, 2013a). The site has the least health care facilities compared 
to other districts (Ilala and Kinondoni) with six hospitals, eight health centers and 121 
dispensaries (The United Republic of Tanzania, 2014a). The doctor population ratio 
in the district is estimated to be 1:4,074 (The United Republic of Tanzania, 2014a). 
In 2016, 4,495 TB cases (all forms) were notified of which 20% were notified in 
private health care facilities (Ministry of Health and Social Welfare, 2016a).  
ii. Bagamoyo district, Pwani Tanzania. (peri-urban site) 
Bagamoyo is among the six districts in Pwani region approximately 70km away from 
the commercial capital of Dar es Salaam with a population of about 311,740 people 
(The United Republic of Tanzania, 2013a). The district is characterized by least 
number of healthcare facilities with one public hospital. The doctor population ratio is 
estimated to be 1:2051 (Tanzania National Bureau of Statistics, 2016a). The region 
has less than 5% TB notification rates whereas it notified a total of 2,271 cases (all 
forms) in 2016 (Ministry of Health and Social Welfare, 2016a). 
iii. Ifaka district Morogoro Tanzania (rural site) 
The rural site is located in the Kilombero district, Morogoro region, in South central 
Tanzania with a population of about 407,000 people (The United Republic of 
Tanzania, 2013a). The district is also characterized by few healthcare facilities and 
has a single referral hospital which is the largest healthcare facility in Kilombero 
district (Tanzania National Bureau of Statistics, 2016b). The case notification rate is 
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about 5.4% in the region with 3194 notified cases in 2016 (Ministry of Health and 
Social Welfare, 2016a).  
Study population 
THs with experience in traditional healing system were included in the study from 
August 2017 to January 2017 until the required sample size of 90 THs (30 THs in 
each study site) was reached (Figure 12 ). Inclusion criteria were, i) ≥18 years of age 
at recruitment ii) Treated upper respiratory tract infection (i.e normal cough as 
indicated by healers) and TB related symptoms (ie coughing for more than two 
weeks, haemoptysis, night sweats and fever) and, iii) reported to treat TB. THs were 
identified with the help of health care providers from the TB clinic in Temeke referral 
hospital Dar es Salaam, Bagamoyo district hospital in Bagamoyo and Chronic 
Disease Clinic of Ifakara (CDCI) in St Francis hospital Ifakara. We excluded healers 
who did not provide consent.  
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Rural setting
n = 42
Traditional healers recruited between August 2016 until January 2017 
n = 110
Urban setting
n = 33
Peri-urban setting
n = 35
Did not consent
n = 3
Did not consent
n = 5
Did not consent
n = 12
Eligible n = 30 Eligible n = 30 Eligible n = 30
Total Included in the study n = 90
 
Figure 13. Flowchart of the study population. Participants were enrolled until the final 
target of 90 THs (30 healers in urban, peri-urban and rural site) was reached 
Data collection and definitions 
Interviews 
THs were interviewed with a structured questionnaire and we collected data on 
socio-demographics, THs knowledge on cough and TB, as well as treatment of 
cough and TB related symptoms. The interviews were carried out with a research 
officer with extensive experience in conducting research. Data were recorded on 
tablets using the OpenDataKit (ODK) application (Steiner et al., 2016).  
Geographical Information System (GIS) data 
We collected geo-coordinates data using Android tablets (Samsung) from the three 
study sites. The data included THs households (working places) health care facilities 
as pharmacies, dispensaries, hospitals (public and private), and healthcare centres. 
The Tanzania region shape file was obtained from the Tanzania National Bureau of 
Statistics (NBS). We used ArcGIS version 10.5 (Esri; Redlands, USA) to produce the 
map. 
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Definitions 
A TH was defined as a person who is recognized by the community in which he lives 
as competent to provide healthcare by the use of plants, animals or other mineral 
substances and other methods based on socio-cultural and religious backgrounds  
as well as knowledge, attitudes and beliefs that are predominant in his/her 
community (Kubukeli, 1999; WHO, 1977). 
Traditional medicine was defined as the sum total of the knowledge, skill, and 
practices based on theories, beliefs, and experiences indigenous to different 
cultures, whether explicable or not, used in the maintenance of health as well as in 
the prevention, diagnosis, improvement or treatment of an illness (WHO, 1977; 
WHO traditional medicine strategy. 2014-2023, 2013). 
Statistical analysis 
We performed descriptive analyses to summarize the data and used Chi square test 
of association to assess differences between groups in categorical variables. We 
used the threshold of a p-value less than 0.05 for decision on statistical significance. 
We also computed medians and Interquartile ranges (IQR) on the costs for service 
provision as reported by the healers in the study sites. Furthermore, we used 
household ownership of items to generate wealth index, based on the existing 
literature (The United Republic of Tanzania, 2013a). Subsequently, we categorised 
the study participants into five quintiles of social economic status as documented in 
other settings (Kuwawenaruwa et al., 2015; Ministry of Health and Social Welfare, 
2016b; Vyas and Kumaranayake, 2006). The first quintile presents THs with lower 
social economic status (poorest) while the second presents the poor, and the last 
quintile non-poor (the rich) THs. All statistical analyses were performed using Stata 
version 14.0 (Stata Corporation, College Station, TX, USA). 
Assessment of knowledge on TB symptoms and TB causes 
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We combine knowledge questions on TB causes (i.e. bacteria, dust, witchcraft, prior 
illness, and unknown causes) and TB symptoms (i.e. cough, fever, night sweats) to 
form an index. Consequently, we used the index to categorise THs into three main 
categories (high, medium and low knowledge). The categories included THs with 
poor knowledge ranging from 0-3 score, medium knowledge from 4-6 score and high 
knowledge from 7-10 score. The index to asses knowledge were calculated based 
on other similar studies  (Kigozi et al., 2017; Uiso et al., 2006). 
Analysis of distance to the near healthcare facility 
We calculated the Euclidean distances in meters as a linear distance between the 
TH’s household (working place) and the nearest health care facility (pharmacy and 
hospitals) in all the three study sites. The nearest facility tool in Arch GIS was used to 
obtain the distance from the TH’s household and the near healthcare facility. We then 
imported the results of the Euclidean distances into Stata software and calculate the 
average distance between the THs household and the near healthcare facility.  
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6.3 Results 
Demographic characteristics 
We analysed data of 90 THs, 30 participants in each study site. The median age was 
41.4 years (interquartile range [IQR] 37.5-49.7) and 54 (60%) were men (Table 15). 
Older THs were found more in rural site comparing to urban and per-urban settings 
(median age 44.3 years, [IQR 35.5-51.8] vs 42.2 years [IQR 37.5-59.2] in urban and 
median age 38.7 years [IQR 33.4-44.7] in peri-urban. Overall, more than half of the 
respondents had primary level of education 60 (66.7%) and were Muslims 80 (88.9%). 
While most of the THs in rural were part time practitioners combining TP with farming 
19 (63.3%), majority in urban and peri-urban practised full-time 18 (60.0%) and 17 
(56.7) respectively. 27 (30.0%) of the THs heard about TB information from family 
members and friends. Overall, 57 (63.3%) of the practitioners treated two patients 
daily. 11 (45.8%) of the practitioners in peri-urban treated more than two patients daily 
while 9 (10.0%) of the healers in urban treated more than five patients daily.  
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Table 15. Demographic characteristics of the traditional healers 
 
Variable 
 
All n (%) 
 
Urban n (%) 
 
Peri-urban n 
(%) 
 
Rural n (%) 
 
     
 
Age in years median 
(IQR) 
 
41.4 (35.5-49.7) 
 
42. (37.5-59.2) 
 
38.7 (33.444.7) 
 
44.3 (35.5-51.8) 
Age groups     
24-34 16 (17.8) 4 (13.3) 8 (26.7) 4 (13.3) 
35-44 36 (40.0) 12 (40.0) 14 (46.7) 10 (33.3) 
45-54 18 (20.0) 5 (16.7) 4 (13.3) 9 (30.0) 
>55 20.0 (22.2) 9 (30.0) 4 (13.3) 7 (23.3) 
Sex     
Females 36 (40.0) 11 (36.7) 7 (23.3) 18 (60.0) 
Males 54 (60.0) 19 (63.3) 23 (76.7) 12 (40.0) 
Level of education     
No education 21 (23.3) 4 (13.3) 8 (26.7) 9 (30.0) 
Primary education 60 (66.7) 21 (70.0) 18 (60.0) 21 (70.0) 
Secondary education 9 (10.0) 5 (16.7) 4 (13.3) 0 
Religion     
Muslims 80 (88.9) 27 (90.0) 27 (90) 26 (86.7) 
Christians 10 (11.1) 3 (10.0) 3 (10.0) 4 (13.3) 
Household income     
≤300 USD per month 75 (83.3) 25 (83.3) 22 (73.3) 28 (93.3) 
>300 USD per month 15 (16.7) 5  (16.7) 8 (26.7) 2 (93.3) 
Occupation     
Full time  42 (46.6) 18 (60.0) 17 (56.7) 7 (23.3) 
Partly businessman 22 (24.4) 9 (30.0) 9 (30.0) 4 (13.3) 
Partly farmers 26 (28.9) 3 (10.0) 4 (13.3) 19 (63.3) 
Wealth Quintile     
Poor –households 18 (20) 1 (5.6) 6 (33.3) 11 (61.1) 
Second 18 (20) 2 (11.1) 3 (16.7) 13 (72.2) 
Middle 18 (20) 4 (22.2) 8 (44.4) 6 (33.3) 
Fourth 18 (20) 11 (61.1) 7 (38.9) - 
Non-poor households  18 (20) 12 (66.7) 6 (33.3) - 
Sources of TB 
information 
    
Health worker 21 (23.3) 9 (42.7) 6 (28.6) 6 (28.6) 
Family 
member/friends 
27 (30.0) 5 (18.5) 9 (33.3) 13 (48.1) 
Radio/newspaper 13 (14.4) 4 (30.8) 5 (38.4) 4 (30.8) 
School 15 (16.7) 8 (53.3) 4 (26.7) 3 (20.0) 
Others (Gods, MDH) 14 (15.6) 4 (28.6) 6 (42.8) 4 (28.6) 
Number of patients 
treated in days 
    
0-2 57 (63.3) 22 (38.6) 13 (22.8) 22 (38.6) 
3-4 24 (26.7) 6 (25.0) 11 (45.8) 7 (29.2) 
≥5 9 (10.0) 2 (22.2) 6 (66.7) 1 (11.1) 
IQR, interquartile range, MDH Management development health, USD United States dollar equivalent 
to 2168 at the time of data collection 
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Knowledge on TB symptoms and TB causes. 
Overall only 13 (1.4%) of the THs had high knowledge of TB symptoms (Table 16). 
The rural site had slightly high proportion of THs with high knowledge of TB symptoms 
5 (17%) compared to those in urban and peri-urban. While more than half or the 
healers in the urban site had medium knowledge on TB symptoms 26 (86.7%), 
similarly to the healers in peri-urban 21(70.0), a low proportion of healers with medium 
knowledge was observed in the rural site 14 (46.7%). A high proportion of healers 
with low knowledge on TB symptoms were observed in the rural site 11 (37%). 
Only 15 (16.7%) of the healers has high knowledge on the causes of TB. Half of the 
healers in peri-urban 15 (50%) and half in the rural site 15 (50%) had low knowledge 
on TB causes almost similar to the healers in the urban site 12 (40%). 
 Table 16. THs Knowledge on TB symptoms and causes 
 
Variable 
 
All n (%) 
  
Urban n (%) 
  
Peri-urban n (%) 
  
Rural n (%) 
Knowledge on TB 
symptoms 
       
High knowledge1 13 (14.4)  4 (13.3)  4 (13.3)  5 (16.7) 
Medium knowledge2 61 (67.8)  26 (86.7)  21 (70.0)  14 (46.7) 
Low knowledge3 16 (17.8)  -  5 (16.7)  11 (36.7) 
Knowledge on TB 
causes 
       
High knowledge 15 (16.7)  6 (20.0)  5 (16.7)  4 (13.3) 
Medium knowledge 33 (36.7)  12 (40.0)  10 (33.3)  11 (36.7) 
Low knowledge 42 (46.7)  12 (40.0)  15 (50.0)  15 (50.0) 
1 
High knowledge scores ranging from 7-10 
2 
Medium knowledge scores ranging from 4-6 
3
Low knowledge score ranging from 0-3  
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Traditional management of cough and TB related symptoms 
All THs used herbs to treat cough and TB related symptoms (Table 17). In the urban 
setting, 26 (86.7%) of the healers treated patients with substances (i.e. garlic, honey) 
compared to 23 (76.%) in peri-urban setting and 18 (60.0%) in the rural setting. More 
than half of the practitioners 24 (80%) in the rural setting reported to use charms and 
spells for treatment of cough and TB related symptoms compared to 12 (40.0%) in the 
urban setting and 17 (56.7%) in the rural setting. Other treatments (ie bathing 
patients, use of holy water were commonly mentioned in the peri-urban site 18 
(60.0%) compared to those in urban and rural sites. 
Table 17. Reported practice on treatment of TB and cough related symptoms  
TB treatment and 
cough symptoms 
All n (%) Urban n (%)  Peri-urban n (%)  Rural n (%) 
Herbs 90 (100) 30 (100)  30 (100)  30 (100) 
Charms, spells 
and lying of hands 
53 (58.9) 12 (40.0)  17 856.7)  24 (80.0) 
Substances 
(garlic, ginger) 
67 (74.4) 26 (86.7)  23 (76.7)  18 (60.0) 
Others (bathing, 
holy water) 
43 (47.8) 11 836.7)  18 (60.0)  14 (46.7) 
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Costs of treatment for cough and TB related symptoms. 
Overall, the maximum median costs for treatment of cough or TB related symptoms 
was 4.61 [IQR 2.30-6.91] (Table 18). For the TH in the urban site, the maximum costs 
until the end of treatment were USD 4.61 [IQR 2.30-6.91] while the minimum were 
USD 0.92 [IQR 0.46-2.30]. Similarly, the maximum costs in peri-urban were 4.61 [IQR 
2.30-6.91] and the minimum costs were USD 0.92 [IQR 0.46-2.30]. In the rural site, 
the maximum costs were 6.91[2.30-11.53] and the minimum costs stood at 1.38 [IQR 
0.92-2.30]. For other diseases like malaria, pneumonia, and evil spirits, the maximum 
median costs of treatment were USD 13.37 [IQR 6.91-23.06] and the minimum costs 
were 2.30 0.9 [IQR 2-2.30].  
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Table 18. Costs (in USD) for treatment from THs perspective 
Costs  All  
median (1QR) 
 Urban 
median (1QR) 
 Peri-urban  
median (1QR) 
 Rural  
median (1QR) 
Maximum TB 
treatment1 
4.61 (2.30-6.91)  4.61 (2.30-
6.91) 
 4.61 (2.30-
6.91) 
 6.91 (2.31-
11.53) 
Minimum TB 
treatment 
0.92 (0.92-2.30  0.92 (0.46-
2.30 
 0.92 (0.92-
2.30 
 1.38 (0.92-
2.30) 
Maximum single 
consultation2 
3.23 (2.30-4.61)  4.61 (4.61-
6.91 
 3.22 (2.30-
4.61) 
 2.30 (2.30-
3.22) 
Minimum single 
consultation 
0.92 (0.46-2.30)  0.92 (0.46-
1.84) 
 0.92 (0.46-
2.30) 
 1.38 (0.46-
2.30) 
Maximum other 
diseases3 
13.84 (6.91-
23.06 
 15 .0 (9.23-
23.06) 
 10.38 (6.91-
18.45) 
 15.0 (6.92-
23.06) 
Minimum other 
diseases 
2.30 (0.92-2.30)  2.30 (0.92-
2.30) 
 2.30 (0.92-
2.30) 
 2.30 (1.38-
2.30) 
IQR, interquartile range, USD, United States Dollar (1 USD=2168 Tanzania shillings, exchange rates as of 
August 2016) 
1 
Costs for the entire TB treatment period   
2 
Cost for a single consultation with the healer 
  
3 
Costs for treatment of other diseases e.g., Malaria, diabetes  
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Admission and referral system  
We found that 37% of the THs in the rural site admitted patients during treatment 
compared to 10% in the urban and 16% in peri-urban (p=0.03). For the referrals, 67 
(74.4%) of the healers referred patients to either near hospital, a TB clinic or a 
dispensary for further treatment if they could not treat the patients. Moreover 31 
(34.4%) of the healers reported referring patients to other healers. Out of these, 14 
(46.7%) TH’s from the rural site referred patients to other healers compared to those 
in urban and in peri-urban 8 (26.7%) and 9 (30.0%) respectively. The interval until 
referral to either formal healthcare facilities (e.g. hospital) or informal healthcare 
facility (i.e. other THs) was slightly different in the study sites. While half of the healers 
in the rural site took seven days or more to refer patients for further treatment, only 9 
(30%) in urban site took seven days or more and 10 (33.3%) in the peri-urban 
reported referring patients in seven days or more (p=0.01). 
Distance from the TH to a near health care facility  
Figure 14 display the spatial distribution of the THs and the healthcare facilities. 
While the urban site is characterised by many healthcare facilities, in the peri-urban 
and rural site are characterised by few hospitals. In addition, the THs in the urban 
setting are sparsely distributed compared to peri-urban and rural sites. Generally, 
70% of the healers lived more than 1000 meters from a referral hospital. The peri-
urban setting had a lower proportion of healers who reside 1000 meters or more 
from a hospital 11 (36.7%) compared to the urban site where 28 (93%) of the 
healers lived more than 1000 meters from a nearby hospital and 24 (80%) in the 
rural site. 
The overall median total distance from the TH’s household to a near hospital was 
2072.5 meters [IQR 1362.5-3627]. For the TH’s in the urban setting, the median 
distance to the near hospital was 4602.4 meters [IQR 3227.1-5614.5] compared to 
1231.2 meters [IQR 884.1-1650.3] in peri-urban and 2418.9 meters [IQR 1759.1-
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3069.6] in the rural setting. Additionally, the total median distance to a nearby 
pharmacy was 868.5 meters [IQR 250.3-1566.4] in the three sites. In the urban 
setting, the median distance was 1425.2 meters [IQR 1132.7-1933.2] higher than that 
of the peri-urban site 235.5 meters [IQR 149.8-328.9] and somewhat low than that of 
the rural site 1353 meters [IQR 707.1-1687.9]. 
 
Figure 14. Geographical analyses of health care facilities in urban, peri-urban and 
rural sites. Panel A: Spatial distribution of healthcare facilities in the peri-urban site 
(Bagamoyo Pwani Tanzania). Panel B: Spatial distribution of healthcare facilities in the 
urban site site (Temeke, Dar es Salaam Tanzania). Panel C: Spatial distribution of 
healthcare facilities in the rural site urban site (Ifakara, Morogoro Tanzania).  
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Collaboration with the government and other stakeholders 
Overall, only 16 (17.8%) had a collaboration with the formal health care providers in 
terms of referring patients and attending programmes prepared by the government 
or other stakeholders. The proportion of healers with high collaboration was from the 
urban setting 9 (30.0%). Healers from peri-urban and the rural site had the lowest 
level of collaboration with the government or any other stakeholders 4 (13.3%) and 3 
(10.0%) respectively. We found a significant association between collaboration with 
the government and referring patients to either a hospital, TB clinic or dispensary for 
further treatment once the healer could not treat the patient (p =0.01). 
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6.4 Discussion 
We report data from a short survey on the role of TH’s in TB management and 
treatment in Tanzania. We found that sources of TB information among the healers 
were obtained more from the family members and friends. Majority of the healers 
treated two patients per day. The level of knowledge on TB symptoms and causes 
was limited among the healers. Furthermore, traditional management of TB was 
mainly through the use of herbs and the costs for TB treatment did not differ among 
the healers. All healers referred patients for further treatment. The distance between 
the healers household to a near healthcare facility was minimal. We found limited 
collaboration among the healers and the government and an association between 
having collaboration with the government and referring patients for further treatment. 
We found that, knowledge on TB causes and symptoms of TB were particularly 
limited. The most notable gap on knowledge was found on causes of TB where some 
of the healers related TB with substances like dust and other causes like witchcraft. 
Some of these beliefs have a negative effect on the spread of TB not only to the 
healers but also to the patient and community at large. This finding highlights the 
need to educate and train the TH’s on the symptoms and causes of TB. Educating the 
healers could significantly improve the health of entire community since they act as 
the first entry to the healthcare utilization for the majority of people in the community 
(Haasnoot et al., 2010). 
Different approaches were used to manage and treat TB. Majority of the healers used 
herbs for the management of cough and TB related symptoms. Use of herbs for 
treatment of diseases has a long history. Herbs have proven to have both good 
outcomes and side effects not only for TB but also for Malaria in Tanzania (Gessler et 
al., 1995a). Our results are in line with some other studies that have documented the 
use of herbs and other substances in treatment of diseases which had led to 
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substantial health outcomes as increased mortality, morbidity and poor performance 
status among the patients (Barker et al., 2006). It is important that there should be 
clear regulations on the use of herbs for treatment so as to reduce poor health 
outcomes in the community (Mbwambo et al., 2007). 
Costs of treatment were low compared to costs that patients incur at formal 
healthcare as documented in Tanzania and in Malawi (Gospodarevskaya et al., 
2014; Kemp et al., 2007). We believe that this might be one of the reasons for most 
of the presumptive and TB patients to visit traditional healers instead of other 
healthcare facilities due to the financial burden associated with treatment in 
confirmed and presumptive TB patients as documented elsewhere (Eastwood and 
Hill, 2004a). 
Distance from the healer’s household to the a near health facility (pharmacies or 
hospital) was reported to be somehow short compared to other studies that have 
documented long distance from the patients household to a healthcare facility and 
that it is attributed to poor health outcomes and a risk factor for death (Barker R. et al., 
2002; Kelly et al., 2016). Confirmed and presumptive patients often use TH’s because 
of the long distance to the healthcare facilities (Eastwood and Hill, 2004a). However, 
in our study the median distance in meters from the THs household to a hospital or 
pharmacy was somewhat shorter implying that most of the healers lived near formal 
healthcare facilities. Therefore, we believe that the utilization of THs is not only 
attributed to distance but also to factors such as stigma, beliefs that TB can only be 
treated by THs, and perceptions that TH’s treatment is short and effective (Edginton 
M. et al., 2002; Liefooghe et al., 1997; Miller et al., 2017).  
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We found that, there exists a minimal collaboration among the THs, the government 
and other stakeholders. This finding is crucial in TB case control as it highlights the 
finding substantiates the importance of including these important healthcare providers 
in the formal health care system. Such partnership may motivate the THs to act as 
DOT supervisors for the TB patients given a chance as it was found in India and 
South Africa (Banerjee et al., 2004; Wilkinson et al., 1999). 
To our knowledge, this is the first survey to explore TB management among the 
healers in Tanzania. Furthermore, it is the first study to document the costs of 
treatment from the healer’s perspective, calculate distance, and show the spatial 
distribution of the THs and the healthcare facilities in urban, peri-urban and rural 
Tanzania. 
Our findings are not without limitations. We did not collect patient’s data to compare 
the distance to the healers. We also included only a fraction of the TH’s therefore our 
sample size was small. We might have missed some information from other healers 
because of our small sample size.  
6.4. 1 Conclusion 
THs had limited knowledge on cough and TB related symptoms. Treatment practices 
differed in the urban, peri-urban and the rural settings of Tanzania. Findings from this 
study highlight the association between collaboration among the healers, the 
government and other stakeholders. It further points out to lower costs associated 
with TB treatment. These observations may guide public health interventions for 
example of educating the THs on the importance of early and timely TB diagnosis. On 
the other hand, integration and collaboration between the healers and the formal 
health care providers should be improved especially in the peri-urban and rural 
settings.  
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7 General discussion 
7.1 Summary of the key findings 
The aim of this PhD project was to examine the community determinants of health 
care seeking in relation to the socio-cultural factors and gender in Tanzania. 
Specifically, the aim was: (i) to determine the pathways and costs of care among the 
confirmed and presumptive TB patients in Tanzania; (ii) to study LDFU before TB 
diagnosis and its determinants; and (iii) to study the roles of THs5 in TB 
management comparing urban, peri-urban and rural districts of Tanzania. The 
results of these chapters are presented in details in chapter 3. The discussion and 
implications of these results are presented in the section hereafter. 
7.1.1 Main Findings 
Pathways to care in confirmed TB patients were complex compared to the 
presumptive patients. In confirmed patients, pathways involved several visits to 
health care facilities before TB diagnosis while that of the presumptive patients were 
more direct with only one or few visits to healthcare facilities before TB diagnosis. 
Confirmed and presumptive TB patients spent a median of 31% of their monthly 
household income on health expenditure for all five visits to healthcare facilities. 
Indirect costs were considerably higher than direct costs both in confirmed and 
presumptive TB patients.  
Results obtained from the intervention study indicate a patient’s delay of ≥3 weeks 
was in almost two thirds of the respondents and LDFU from the pharmacies to the 
TB clinic was observed in 44.1%. Prior consultations with THs were associated with 
patient delay but not LDFU. Gender differences were observed in patient delay and 
LDFU whereby the odds of patient delay were higher in females than in males, and 
LDFU was also higher more in females than in males.  
                                               
5
 THs used throughout the general discussion to equally stand for THS or TPs 
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THs had limited knowledge on cough and TB related symptoms, and the knowledge 
varied across settings. Treatment for both cough and TB related symptoms was 
cheaper than that of the formal healthcare providers.  Almost all practitioners 
referred patients to the hospital for further treatment. Collaboration among the THs, 
the government (NTLP) and other stakeholders was limited.  
7.1.2 Pathways to care  
It has been found that the pathways to care for both the presumptive and TB 
patients are not direct. They involve more than one healthcare provider with sub-
optimal diagnostic equipment before TB diagnosis (Shete P.B et al., 2015; Veesa et 
al., 2018; Yellappa et al., 2017). We reconstructed pathways to care up to five visits 
from the onset of TB symptoms to TB diagnosis. The confirmed TB patients have 
shown to have more complex pathways and had more visits compared to the 
presumptive patients whose pathways were direct. To the best of our knowledge, 
this is the first study to consider pathways to care among the confirmed TB patients 
comparing them to the presumptive TB patients in an urban society of Tanzania.  
Furthermore, from the analysis of the research question 1 it was observed that the 
confirmed TB patients (TB-DAR cohort) started healthcare seeking at the 
pharmacies while the presumptive patients started health care seeking at the 
hospitals. When investigating the healthcare seeking among the presumptive 
patients in our second research question on LDFU, seeking help from the 
pharmacies was considered the most important choice after the onset of symptoms. 
We could not substantiate why the confirmed TB patients from the TB-DAR cohort 
started their healthcare seeking from the pharmacies while the presumptive TB 
patients sought care first at the hospitals. On the other hand, we found in the 
analysis of the second research question (LDFU study) that presumptive patients 
started healthcare seeking at the pharmacies. However, it is clear that our results 
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indicate that the confirmed and presumptive TB patients usually consult more than 
one healthcare provider before TB diagnosis. In line with our results, a recent study 
from a prevalence survey in Tanzania showed that a majority of the presumptive TB 
patients had more than one visit to the healthcare facilities for their TB symptoms 
and some with sub-optimal TB diagnostics (Senkoro et al., 2015a). 
Gender differences have also been documented to play a role in treatment seeking 
and pathways to care (Gosoniu et al., 2008a; Thorson et al., 2000a). When 
investigating the healthcare seeking and LDFU in relation to gender differences, we 
found that women were lost more during the diagnostic period compared to men and 
the association was statistically significant (chapter 3). Furthermore, both males and 
females sought care from the religious and THs similar to other studies (Eastwood 
and Hill, 2004a). Additionally, the preferences of seeking healthcare from the 
traditional and religious healers were associated with psychological comfort and 
financial autonomy notably among women. Women who do not have financial 
autonomy usually seek care later and with healthcare providers with sub-optimal 
diagnostic equipment (Chard, 2009). This has also been noted in our intervention 
study. Women had to depend on their husbands for financial resources before 
visiting the healthcare facilities. 
Several factors that led to complicated pathways to care which eventually led to 
delay in health care seeking have been investigated including: stigma, financial 
hardships and female gender (Cai et al., 2015; Miller et al., 2017). Moreover, the 
spatial distributions of healthcare facilities and the distance from the patient 
household to the healthcare facilities have been documented to have an impact on 
healthcare utilization and treatment completion (Buor, 2003; Ibrahim et al., 2014). 
Distances from the patient’s household to the nearest healthcare facility was 
somehow shorter in our study than in the study of (Mfinanga and Mutayoba, 2008a), 
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and we did not find any association between distance and patient characteristics. 
Our results are contrary to some other results that found distance to have an impact 
on patient characteristics such as diagnostic delay (Sreeramareddy CT, Oin ZZ, 
Satyanarayana S, Subbaraman R, 2014). 
As for the use of THs during the pathways to care, our results from objective one 
(TB-DAR cohort) and those of objective two (intervention study) documented a 
difference. While there was substantial use of THs in participants our intervention 
study (chapter 3), few visits were reported from participant of the cohort (chapter 4). 
Although we could not examine the spatial distribution of healthcare facilities and 
THs for the intervention study, in the cohort study we observed that most of the 
healers lived in the periphery while most of the healthcare facilities were situated 
mainly in the urban centers. This might be among the reasons as to why the patients 
in the cohort visited THs less than those in the intervention study. In chapter 6, when 
we investigated the distance from the THs to the nearest health care facility, we 
found that the distance was shorter from the THs household to either a TB clinic or a 
hospital. This finding could partly explain the preferences of using traditional health 
practitioners are not only due to longer distances from the patients’ household to a 
nearby healthcare facility or a lack of financial resources to afford treatment in other 
healthcare facilities. As it was observed in our study, this also can be attributed to an 
individual’s own preference to either visit the hospital or a TH. It may be attributed to 
perceptions that traditional treatment may be shorter and effective compared to the 
hospital treatment as well as patients’ perceptions that the disease can be treated by 
a TH (Edginton et al., 2002; Liefooghe et al., 1997).  
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7.1.3 Delays and loss to follow-up in TB 
In this PhD project, we explored patient delay and diagnostic delay in seeking 
healthcare from the onset of symptoms until TB diagnosis with reference to WHO 
framework on diagnostic and treatment delay (WHO, 2009). Patient and diagnostic 
delay have consequences not only to the patient but also to the surrounding 
community. At the individual level, delay advances the disease stage and worsens 
treatment outcome while at the community level, the patient can be infectious to the 
close contacts. It is documented that untreated TB patients can infect approximately 
up to 20 people annually (Dheda, 2018). 
Delay in healthcare seeking in this PhD project was lower compared to other studies 
(Hinderaker et al., 2011b; Mfinanga and Mutayoba, 2008a; Storla et al., 2008). 
However, we have confirmed that patient and diagnostic delay were substantial and 
still required some attention. In our intervention study it became clear that patient 
delay in health care seeking was associated with female gender, visits to THs and 
behaviour factors as smoking and alcohol abuse. Our study expands on the earlier 
findings documenting the factors associated with delay in healthcare seeking in 
Tanzania and in sub- Saharan Africa in general (Mfinanga and Mutayoba, 2008a; 
Ngadaya et al., 2008a; E. R. Wandwalo and Mørkve, 2000).  
Although we did not investigate the association between diagnostic delay and other 
factors than gender and poverty status in our first research question where we used 
data from the TB-DAR cohort, a study done in the same cohort did not find any 
association between gender and diagnostic delay (Said et al., 2017). Additionally, 
many studies have focused on patient and diagnostic delay however; there is little 
documentation on patient and diagnostic delay among the large population of the 
presumptive TB patients. Our study is the first to assess patient delay in presumptive 
TB patients in an intervention study in Tanzania. 
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When investigating LDFU in our intervention study, we found that women were more 
likely to be LDFU, and prior illness was positively associated with LDFU. When we 
stratified our analysis by gender, the odds of LDFU were higher among women 
without reaching statistical significance in the gender specific-estimates (chapter 4). 
Females were more concerned with the financial burden imposed on their spouses 
because of their illness and hence, many became LDFU. Results from a systematic 
review on pre-treatment loss to follow-up in middle and low income settings 
indicated a pre-treatment loss to follow-up ranging from 6% to 38%, particularly in 
Africa. Additionally, males were more LDFU compared to females (MacPherson et 
al., 2014a). These findings are contrary to our findings where females were more 
LDFU than males. Therefore, further studies are needed to substantiate our findings. 
Our study is the first to shed some light on the loss to LDFU among the presumptive 
TB patients which is the larger population seeking care for TB symptoms. 
7.1.3 THs and TB in Tanzania 
From this PhD work, it became clear that THs have a role to play in management of 
TB. Furthermore, THs have shown to be highly accepted and trusted healthcare 
providers in the society (Brouwer et al., 1998; Mbwambo et al., 2007). To our 
knowledge, we are reporting findings from the first study to be conducted in 
Tanzania on the role of THs in management of TB. Authors who describe the role of 
THs in TB management note that although THs are an important part of the 
healthcare provision in East Africa, documentation on their roles in the diagnosis and 
management of cough and TB related symptoms is scarce (Brouwer et al., 1998). 
We have explored in the three districts of urban, peri-urban and rural Tanzania how 
practitioners diagnose and manage cough and TB related symptoms but also on the 
THs knowledge of TB symptoms, causes and transmission. We found that more 
than half of the practitioners knew how TB is transmitted but the knowledge of TB 
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symptoms and causes were somewhat limited and varied in the three study settings. 
Similararly findings a study conducted in Simanjiro Tanzania found variations on 
knowledge among the THs on TB symptoms and referrals for further treatment 
(Haasnoot et al., 2010). 
One common similarity in all study areas is the willingness of the practitioners to 
refer patients to hospitals for further treatment if they could not treat them 
themselves. More attention should be paid to this finding as it could help in 
strengthening TB case findings in the community when the healers would refer the 
patients either for diagnosis or for further treatment. In turn, it will help in reducing 
TB transmission in the community. It is also clear that THs can help not only in 
managing TB but may help in serving as DOT supervisors as documented 
elsewhere (Wilkinson et al., 1999).  
Spatial distribution of THs in the three study settings showed that overall 70% of the 
practitioners lived more than 1000 meters away from a referral hospital. The 
proportion of practitioners living more than 1000 meters was notably higher (80%) 
for THs in Ifakara compared to Temeke and Dar es Salaam. While our findings on 
distance might be shorter compared to other studies, this finding is important 
especially with regard to patient referral for formal treatment. Patients may not be 
able to have access to the formal health care providers’ example hospitals even 
after referrals by the TH because of the long distance. As noted by (Barker R. et al., 
2002), distance might be a risk factor for death and poor performance status among 
patients living far from the health care facilities. 
7.1.4 Costs of TB care. 
As presented in chapter three, costs of care in confirmed and presumptive TB 
patients were substantial, specifically the indirect costs. Even though presumptive 
and confirmed TB patients encountered substantial costs during care seeking (Kemp 
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et al., 2007; Veesa et al., 2018), few studies have documented the costs of care 
among the presumptive TB patients. Furthermore, it has been documented that the 
costs of care are usually higher during the pre-diagnosis phase than the diagnosis 
and treatment phase (Ukwaja et al., 2012). The higher indirect costs in our study 
were attributed to by income reduction specifically in confirmed patients and other 
indirect costs (i.e. costs for supplements and vitamins). Our results confirm findings 
from a study in Zambia that documented higher indirect costs than direct costs 
among confirmed TB patients (Aspler et al., 2008) 
We have confirmed that presumptive and confirmed TB patients spent almost 30% 
of their monthly household income on health expenditure for the five visits. This is 
substantial for a population where the majority are employed in the informal sector 
with no sickness benefits or health insurance (Barter et al., 2012a). What we found 
was similar to the findings of (Shete P.B et al., 2015) which documented patients 
incurred up to 28% of their monthly household income on health expenditures. 
However, that study only documented the costs of care among the presumptive TB 
patients. These findings point towards the importance of further investigation of the 
costs of care among not only the confirmed TB patients but also among the 
presumptive TB patients in settings with a high TB burden. 
Analyses stratified by sex and poverty status indicated that poor men with confirmed 
TB had lower direct costs compared to poor women and costs differed slightly 
among the poor men and women for the presumptive TB patients. Our results are 
somewhat similar to results obtained in Malawi (Kemp et al., 2007) that documented 
higher costs among men than women although they did not stratify the costs of care 
according to poverty status. Further research is needed especially in sub-Saharan 
Africa where few data exists to substantiate our findings.  
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7.2 Strengths and limitations 
7.2.1 Overall strengths 
Innovations in medical and treatment regimens are unlikely to substantially improve 
TB control without the contribution from socio-cultural determinants of health to 
successfully implement programmatic interventions (Mason PH, Degeling C, 2015). 
Socio-cultural determinants of health seeking behaviour are key aspects in TB case 
detection and disease control, but largely understudied in Tanzania and elsewhere 
in sub-Sahara Africa (Senkoro et al., 2015a). Furthermore, one of the END TB 
strategy’s key principles is Pillar 1, which focuses on early diagnosis of TB, 
unhindered access to services and engaging patients in care (WHO, 2015b). 
Therefore, health care seeking plays a key role in disease prognosis, case detection, 
and proper utilization of health facilities, diagnostic procedures, and programme 
awareness of health options. This PhD project has shed some light on the role of 
socio-cultural determinants of health as well as healthcare seeking by examining 
pathways to care and costs of care basing on gender and poverty status. 
Furthermore we have explored the role of THs on TB management and control as 
well as explaining delay and LDFU in presumptive and TB patients.  
A further strength of this project is the opportunity to investigate pathways to care 
not only in confirmed patients but also in presumptive TB patients. Different patient 
pathways to care are an important part in recognition of public health interventions in 
TB control. This PhD project is important because so far, most studies have been 
focusing on patients who are diagnosed and on treatment, rather than the large 
presumptive population seeking care for TB symptoms (Shete P.B et al., 2015). 
Finally, most studies addressing loss to follow-up (LTFU) consider TB patients in 
treatment, negleting the larger group of people with presumptive TB symptoms who 
have not yet been diagnosed and not yet started treatment.  
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7.2.2 Added benefits of gender perspective in TB 
As mentioned throughout this PhD project, the role of gender in TB is taken into 
account: investigating the health-seeking behaviour including delay in seeking care, 
LDFU, as well as costs of health-care seeking from onset of symptoms to TB 
diagnosis. Understanding gender differences is important since sex and gender are 
both important determinants of health. Biological sex and socially constructed 
gender interact to produce differences not only to ill-health but also on the health- 
seeking behaviour and health outcomes for both men and women (WHO, 2005a). As 
(Johansson et al., 2000b; WHO, 2005a) clearly point out, there are very few studies 
on health care seeking in TB that ascertain gender differences. Sex and gender 
have been acknowledged as factors of importance in understanding patterns of 
diseases as well as providing insights into TB prevention programs and TB control 
(Chan-Yeung et al., 2002). Despite the widespread recognition of these differences, 
they have not adequately been addressed (Chan-Yeung et al., 2002; Diwan and 
Thorson, 1999). The strength of our study is that we report gender differences in 
healthcare seeking from the onset of TB symptoms together with the costs of care 
until TB diagnosis for both confirmed and presumptive TB patients. We believe our 
results are not only useful and potential in future TB research but also make a 
significant contribution to the literature. 
Data from the intervention study offered a unique opportunity to investigate LDFU 
while reflecting on gender differences where very little data exist. This work may 
further inspire research investigating gender differences especially building on the 
intervention studies. 
7.2.3 Added benefits on role of TH in TB management and control 
As explained in section five, THs are important healthcare providers in African 
communities apart from the formal health care system, yet there is limited 
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information regarding their role (Gessler et al., 1995b). Different perspectives on TB 
and approaches used in TB management from urban, peri-urban and rural Tanzania 
are addressed including: knowledge of the THs on causes and TB transmission, 
management of cough and TB related symptoms, costs of TB treatment, as well as 
collaboration with either the government or other stakeholders. By investigating the 
role of THs, we were able to reveal some important findings. Knowledge of the THs 
concerning TB was limited and different ways were used in managing cough and TB 
related symptoms. Referrals for further treatment depended on the effectiveness of 
the prescribed traditional medicines, and women visited THs more than men. 
Additionally, surveying the role of THs is important in understanding different 
mechanisms which can be used to decrease delay in the community but also help in 
positive treatment outcomes since THs may act as DOT supervisors (Wilkinson et 
al., 1999). 
Additionally, there are fewer studies that have investigated the role of THs in TB 
management especially in Tanzania. Findings from this study might serve as the 
basis of information for future projects/research to evaluate the potential for the 
contribution of THs and their remedies to improve TB situation in Tanzania. 
7.2.4 Limitations 
As we retrospectively collected data on pathways, delay and costs of care, we relied 
on self-reporting of delay in seeking care. Reporting errors are is likely to happen. 
For the LDFU study, presumptive and confirmed patients had to recall the number of 
days since the onset of symptoms until first health care seeking. Patients may 
underreport the delay because of unfriendly fear of reaction from the healthcare 
providers. As expressed in our findings from the qualitative research. On the other 
hand, confirmed and presumptive patients had to report retrospectively the costs of 
care from the onset of symptoms to TB diagnosis. This may have introduced 
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overestimation or under estimation of costs. Additionally, patients could overestimate 
costs of care thinking they will be compensated. Such inconsistences have been 
reported in other similar studies (Said et al., 2017; Ukwaja et al., 2013b). However, 
we tried to reduce this by relying on experienced clinical workers with extensive 
knowledge on data collection to interview the patients. Secondly we used 
visualisation charts to reconstruct the pathways to care. 
Since we mainly focused on delay among the confirmed and presumptive TB 
patients rather than delay from the perspective of the healthcare provider, a possible 
limitation is in answering the broader question on the delay caused by the health 
systems (health system delay /provider delay).  
We were able to estimate costs of care only in urban settings and not in the rural 
settings where the majority of the marginalized population is found. For the 
marginalized population these costs could be pronounced if the patients may have 
spent a higher proportion of their household income on health care compared to the 
patients in the urban population (Russell, 2004). Therefore, inclusion of the rural 
setting in our study might have provided a more comprehensive assessment. 
Tanimura et al (2014) also found considerable variations in the financial burden of 
TB both between individuals in the same setting and between settings. Moreover, 
we were only able to only investigate the costs of care from the onset of symptoms 
to TB diagnosis and not during the TB treatment and post-treatment periods. 
Additionally, we only addressed the costs of care until TB treatment in public health 
facilities. We might have missed out costs of care for the patients who had their final 
diagnosis in private health care facilities. It would be interesting for future research to 
investigate costs of health care seeking from the onset of symptoms to the post-TB 
treatment period not only in public health care facilities but also in private health care 
facilities. 
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As for the THs, our sample size was rather small (90 THs in urban, per-urban and 
rural setting) and we were not able to collect data from the patients who were treated 
with the THs. We therefore may have left out some crucial information on the patient 
side that could have contributed further to the body of knowledge. 
7.3 Implications for research 
Gender differences during pathways to care and on the costs of TB diagnosis for both 
the confirmed and presumptive TB patients are evident. Moreover, understanding 
how the poor and non-poor patients finance TB diagnosis is important (Kemp et al., 
2007; Krishnan et al., 2014). Nevertheless, to the best of our knowledge, very few 
studies have been conducted in sub- Saharan Africa on pathways and costs of care 
for both confirmed and presumptive TB patients, accounting for both poverty status 
and gender differences, from the onset of symptoms to post-TB treatment. A few 
previous studies have only focused either on presumptive TB patients without taking 
into consideration poverty status and gender differences (Shete P.B et al., 2015) or 
have only focused on costs of care taking into account poverty status and gender in 
only confirmed patients (Kemp et al., 2007). Future studies should further investigate 
the pathways and costs of TB care for both presumptive and TB patients while taking 
into account poverty status and gender differences, not only from the onset of 
symptoms to TB diagnosis but also during TB treatment and post-TB treatment. 
Moreover, were not able to estimate the costs of TB and other co-morbidities like HIV 
or diabetes. We believe that the co-morbidities may have caused higher costs in both 
the confirmed and presumptive patients. Therefore, future research should consider 
co-morbidities like HIV when estimating patient’s costs. 
The association between LDFU and female gender in our study is in contrast to 
other studies which have documented that men are more LTFU than females 
(MacPherson et al., 2014a). Odds of patient delay were higher in females than in 
males. Future studies should investigate on the gender specific barriers to health 
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care particularly those relating to social roles. As the odds for delay were higher in 
women than in men and females were more LDFU than males, the feasibility and 
usefulness of integrating TB diagnostic services with maternal and child health care 
should also be explored. 
The pathways to care in confirmed and presumptive TB patients in Tanzania is 
characterised with patients presenting themselves to the health care facilities for 
diagnosis and treatment as our findings revealed and as documented elsewhere 
(Ministry of Health and Social Welfare, 2016a). The effectiveness of active case 
findings should be investigated to complement the passive case findings. 
The finding that THs use different traditional medicines e.g. herbs that have proven 
to be successful in treatment of not only coughs but also TB related symptoms, 
warrants further research. The efficacy of traditional medicines that treat cough and 
TB related symptoms should be evaluated not only in the laboratory settings but 
also in clinical trials. 
7.4 Implications for policy and practice 
I. Improved engagement between the public and private health care 
sectors and other stakeholders. The finding that confirmed and presumptive TB 
patients have complex pathways to care and that some start health care seeking at 
private health care facilities, underscores the importance to further include the private 
health care sector in TB control strategies. As the first point of care plays a major role 
in early TB diagnosis which appears to be a major challenge in TB control, improved 
engagements and collaborations between the private and public sectors is warranted 
so as to reduce the complexities of the pathways to care among confirmed and TB 
patients. Ensuring integration among the private and public health sectors will also 
encourage referrals of patients with TB symptoms to TB diagnostic units.  
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II. Social protection against direct and indirect costs and removal or 
decreasing of user fees. We found that confirmed and presumptive patients have a 
high financial burden during health care seeking from the onset of symptoms to TB 
diagnosis. Social protection schemes are needed to reduce the economic burden of 
TB especially in marginalized populations so as to ensure universal health coverage. 
Reducing economic barriers to TB diagnosis (e.g., user fees) would guarantee early 
care seeking among the confirmed and presumptive TB patients. Other social support 
packages such as foodstuff and cash transfers should be considered.  
III. More attention should be paid to gender specific needs in healthcare. 
Delay and LDFU in our intervention study was substantial especially for women. 
Women reported seeking care at informal health care providers (e. g., THs). Given 
that women in particular reach clinical treatment services through a circuitous circle 
preferring to seek health care from THs (Johansson et al., 2000b). Although we did 
not find any association with regards to delay and LDFU among men, never the less, 
men also face barriers when assessing health care as noted in a systematic review 
on LMIC (Horton et al., 2016). Attention should be paid to both men and women 
heathcare behaviour and TB control interventions should focus on gender-specific 
patient needs. 
IV. Involvement of traditional healers in the educational activities of NTLP 
programmes. Our findings showed minimal collaboration among the THs and the 
formal health-care providers as NTLP. The THs were also ready to refer patients to 
formal health care facilities for further treatment. This underscores the need to train 
and educate THs on how to recognize symptoms of TB so that they can further refer 
patients for timely diagnosis in health care facilities. 
7.5 Conclusion  
This project is among the few to report pathways to care, costs of care, determinants 
of delay and LDFU as well as the role of THs in TB management and control in 
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Tanzania. We found that the pathways to care are complex, especially in confirmed 
TB patients compared to presumptive patients, and that all patients incurred 
substantial indirect costs from the onset of TB symptoms until TB diagnosis. The 
odds of patient delay were higher in women than men and LDFU was associated 
with women. THs had limited knowledge on TB related symptoms, limited 
collaborations with formal health- care providers and referred patients mainly for 
diagnosis further treatment. Given the importance of TB in terms of global disease 
burden, and the WHO’s ambitious goal to end TB by 2035, planning and specific 
interventions which integrate social and biomedical solutions are necessary in order 
to end the epidemic  
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Appendices  
Appendix 1. CRF 12 Pathways to care 
CRF 12: Pathway to care (Objective 1 PhD Grace) 
 Section 1 : Patients Information   
 Date of interview |___|___|    |___|___|  |___|___|___|___| DD/MM/YYYY  
 Patient ID and visit  |___|___|___|___|___|-|___|___|-|___|___|___| 
Scan from the barcode for the 
specified visit. i.e. VO1, VO2, 
VO3 
Section 2: Socioeconomic status  
 Education level  
☐ No formal education  
☐ Accomplished primary school education  
☐ Accomplished secondary school education  
☐ Accomplished college/university  
Select one  
 
How many years in total have you 
spent in school or in full time 
study? 
_________________________________ In figures 
 Current employment status 
☐ Unemployed  
☐ Petty trader  
☐ Carpenter  
☐ Business person  
☐ Student ☐ Retired /long-term disabled  
Select one  
 House ownership 
☐ Your own 
☐ Rented 
☐ Rented, but paid by somebody else  
 
 Household monthly income  
 
________________________________ 
In thousands Tanzanian 
shillings  
 Household size 
 
|__|__| 
How many people currently 
living in your household  
 
How many people older than 18 
years, including yourself, live in 
your household 
 
|__|__|  
 Household contribute  
 
|__|__| 
All household members 
(patient included) that 
contribute to living expenses 
 
How many rooms used for 
sleeping 
|__|__|  
 
How many people sleep in each 
room 
|__|__|  
 Do you own a piece of land ☐ Yes     ☐ No  
 
House has electricity 
 
☐ Yes     ☐ No  
 Floor type 
☐ earth sand ☐ cement ☐ tile ☐ other  
 
Select one 
 
Walls type 
 
☐ Grass ☐ mud ☐ sundried bricks ☐ baked bricks ☐ wood 
timber ☐ cement ☐ stones ☐ other 
Select one 
 Roof type 
☐ Grass, thatch or  mud ☐ iron sheet ☐ concrete ☐ 
asbestos ☐ other 
 
 Do you have a radio? ☐ Yes     ☐ No  
 Do you have a TV? ☐ Yes     ☐ No  
 Do you have a mobile phone? ☐ Yes     ☐ No  
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 Does your home have a 
refrigerator? 
☐ Yes     ☐ No  
 Do you have a bicycle? ☐ Yes     ☐ No  
 Do you have a motorcycle? ☐ Yes     ☐ No  
 Do you have a car or a truck ☐ Yes     ☐ No  
Section 3: Knowledge and perception of TB  
 Do you know about TB disease ☐ Yes ☐ No  
 
If yes, where did you learn about 
it 
☐ From health care worker ☐ From school ☐ from a friend 
☐ From a family member at home ☐ From media (magazine, 
radio television) ☐ Others 
Other types of learning not listed, please specify (comma 
separated) 
 
multiple answers 
 What causes TB 
☐ Bacteria ☐ Dust ☐ Contact with infected person ☐ Prior 
illness ☐ Smoking, ☐ Air borne illness 
Other causes not listed, please specify (comma separated) 
________________________________ 
 
multiple answers 
 Is TB contagious ☐ Yes      ☐ No  
 
TB is mostly commonly 
transmitted from person to person 
in which of the following ways 
☐ Blood/bodily fluids ☐ Air ☐ Food ☐ Shared objects ☐ 
Others  
Other types of transmission not listed, please specify (comma 
separated) 
________________________________ 
 multiple answers 
 
What was the first symptom that 
you encountered 
 Productive cough ☐ fever ☐ hemoptysis ☐ night sweat☐ 
chest pain ☐ weight loss ☐ abdominal pain 
  
 
Do you think anyone with TB must 
have HIV infection? 
☐1  ☐2   ☐3 ☐4  ☐5 1 strongly agree 
5 strongly disagree 
 
Do you know the importance of 
coughing in an open air 
☐ Yes     ☐ No  
 
Do you have any knowledge 
about sputum production and 
submission 
☐ Yes   ☐ No  
 If yes where did you learn 
☐ From health care worker ☐ From school ☐ From a friend 
☐ From a family member at home ☐ From media (magazine, 
radio television) ☐ Others 
Other types of learning not listed, please specify (comma 
separated) 
________________________________ 
 
multiple answers 
 
Common symptoms of pulmonary 
TB includes 
  
☐ Cough ☐ Diarrhea ☐ Night sweats ☐ Fever  
☐ Nausea/vomiting ☐ Weight loss ☐ Hemoptysis ☐ 
breathlessness ☐ others 
Other common symptoms not listed, please specify (comma 
separated) 
________________________________ 
 
multiple answers 
 Is TB curable ☐ Yes        ☐ No  
 If yes How is it cured 
☐ Cough medicine ☐ Injections ☐ Tablets for TB ☐ Tablets 
Other treatments not listed, please specify (comma 
separated) 
________________________________ 
 
 
Section 3: Health care seeking behavior 
 
What was the first symptom that 
you encountered 
 Productive cough ☐ fever ☐ hemoptysis ☐ night sweat☐ 
chest pain ☐ weight loss ☐ abdominal pain 
  
 
How long have the symptoms 
been persisting 
Productive cough _______ (weeks)  Fever _______ (weeks)  
Night sweats _______ (weeks)  Hemoptysis _______ (weeks)  
Chest pain  
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_______ (weeks)  Weight loss _______ (weeks) 
 
 
Did you seek care for your 
symptoms 
☐ Yes     ☐ No  
 
When was the first contact with 
the health care facility 
_______ (weeks)  
 
Where did you seek care for the 
first symptoms that you 
encountered 
☐ Private/governmental hospital ☐ Pharmacy ☐ Dispensary 
☐ Local home remedies/non-professional friends ☐ 
Traditional healer ☐ Religious healer ☐TB clinic ☐Primary 
Health care 
Other types of health care seeking not listed, please specify 
(comma separated) 
________________________________ 
multiple response 
 
How far is the place that you first 
sought care from your home 
☐ minutes walking    ☐ minutes with transport 
_______ minutes ______ 
 
 
How far is the nearest 
government facility for TB 
diagnosis only 
☐ walking               ☐ with public transport 
   __________ minutes                    _________ (minutes) 
 
 
How far is the nearest 
government facility for TB 
diagnosis and treatment 
☐ walking               ☐ with public transport 
   __________ minutes                    _________ (minutes) 
 
 Section 4: Pathway of care (Visualization chart will be presented to the patients as a proxy) 
1
st
  
Visit 
Location 
☐ Hospital 
☐ Pharmacy  
☐Dispensary 
☐ Local 
home 
remedies/non-
professional 
friends 
☐ Traditional 
healer 
☐ Religious 
healer 
☐ TB clinic  
☐ Primary 
health care 
 
Select from 
the GPS 
Codes 
Symptoms 
Symptoms ______weeks ago 
Presumptive diagnosis made 
during the visit 
☐ Pneumonia 
☐ Bronchitis 
☐ Upper respiratory illness 
☐ TB suspected 
☐ Unknown 
☐ Other 
________________________ 
 
 
Medication 
Medication given 
☐ Amoxicillin 
☐ Ciprofloxacin 
☐ Ceftriaxone 
☐ Home remedies 
☐ Traditional medicine 
☐ Ampiclox 
☐ Cough Syrup 
☐ Cephalexin 
☐ Unknown 
☐ Other 
___________________ 
 
 
Estimated direct 
costs  
☐ Medical costs  
   Tsh 
_______________ 
☐ Transport expenses 
   Tsh ___________ 
☐ Diagnostic costs  
     Tsh ___________ 
☐ Informal payments  
    Tsh ___________ 
☐ Food expenditures 
and accommodation   
   Tsh ___________ 
☐ Unknown 
   Tsh ___________ 
☐ Other direct costs 
specify ____________ 
    Tsh ___________ 
 
Estimated indirect 
costs 
☐ Income reduction  
   Tsh 
_______________ 
☐ Decrease 
productivity 
   Tsh 
_______________☐ 
Copying Costs 
   Tsh 
_______________☐ 
Less paid labor  
     Tsh 
_______________ 
☐ Unknown 
    Tsh 
_______________ 
Other indirect costs 
specify ____________ 
 Tsh _______________ 
2st 
Visit 
Location 
☐ Hospital 
☐ Pharmacy  
☐Dispensary 
☐ Local 
home 
remedies/non-
professional 
friends 
☐ Traditional 
healer 
☐ Religious 
healer 
☐ TB clinic  
☐ Primary 
health care 
 
Select from 
the GPS 
Codes 
Symptoms 
Symptoms ______weeks ago 
Presumptive diagnosis made 
during the visit 
☐ Pneumonia 
☐ Bronchitis 
☐ Upper respiratory illness 
☐ TB suspected 
☐ Unknown 
☐ Other 
________________________ 
 
 
Medication 
Medication given 
☐ Amoxicillin 
☐ Ciprofloxacin 
☐ Ceftriaxone 
☐ Home remedies 
☐ Traditional medicine 
☐ Ampiclox 
☐ Cough Syrup 
☐ Cephalexin 
☐ Unknown 
☐ Other 
___________________ 
 
 
Estimated direct 
costs  
☐ Medical costs  
   Tsh 
_______________ 
☐ Transport expenses 
   Tsh ___________ 
☐ Diagnostic costs  
     Tsh ___________ 
☐ Informal payments  
    Tsh ___________ 
☐ Food expenditures 
and accommodation   
   Tsh ___________ 
☐ Unknown 
   Tsh ___________ 
☐ Other direct costs 
specify ____________ 
    Tsh ___________ 
Estimated indirect 
costs 
☐ Income reduction  
   Tsh 
_______________ 
☐ Decrease 
productivity 
   Tsh 
_______________☐ 
Copying Costs 
   Tsh 
_______________☐ 
Less paid labor  
     Tsh 
_______________ 
☐ Unknown 
    Tsh 
_______________ 
Other indirect costs 
specify ____________ 
 Tsh _______________ 
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3
rd
 
Visit 
Location 
☐ Hospital 
☐ Pharmacy  
☐Dispensary 
☐ Local 
home 
remedies/non-
professional 
friends 
☐ Traditional 
healer 
☐ Religious 
healer 
☐ TB clinic  
☐ Primary 
health care 
 
Select from 
the GPS 
Codes 
Symptoms 
Symptoms ______weeks ago 
Presumptive diagnosis made 
during the visit 
☐ Pneumonia 
☐ Bronchitis 
☐ Upper respiratory illness 
☐ TB suspected 
☐ Unknown 
☐ Other 
________________________ 
 
 
Medication 
Medication given 
☐ Amoxicillin 
☐ Ciprofloxacin 
☐ Ceftriaxone 
☐ Home remedies 
☐ Traditional medicine 
☐ Ampiclox 
☐ Cough Syrup 
☐ Cephalexin 
☐ Unknown 
☐ Other 
___________________ 
 
 
Estimated direct 
costs  
☐ Medical costs  
   Tsh 
_______________ 
☐ Transport expenses 
   Tsh ___________ 
☐ Diagnostic costs  
     Tsh ___________ 
☐ Informal payments  
    Tsh ___________ 
☐ Food expenditures 
and accommodation   
   Tsh ___________ 
☐ Unknown 
   Tsh ___________ 
☐ Other direct costs 
specify ____________ 
    Tsh ___________ 
Estimated indirect 
costs 
☐ Income reduction  
   Tsh 
_______________ 
☐ Decrease 
productivity 
   Tsh 
_______________☐ 
Copying Costs 
   Tsh 
_______________☐ 
Less paid labor  
     Tsh 
_______________ 
☐ Unknown 
    Tsh 
_______________ 
Other indirect costs 
specify ____________ 
 Tsh _______________ 
 
4
th
 
Visit 
Location 
☐ Hospital 
☐ Pharmacy  
☐Dispensary 
☐ Local 
home 
remedies/non-
professional 
friends 
☐ Traditional 
healer 
☐ Religious 
healer 
☐ TB clinic  
☐ Primary 
health care 
Select from 
the GPS 
Codes  
 
Symptoms 
Symptoms ______weeks ago 
Presumptive diagnosis made 
during the visit 
☐ Pneumonia 
☐ Bronchitis 
☐ Upper respiratory illness 
☐ TB suspected 
☐ Unknown 
☐ Other 
_________________________ 
 
Medication 
Medication given 
☐ Amoxicillin 
☐ Ciprofloxacin 
☐ Ceftriaxone 
☐ Home remedies 
☐ Traditional medicine 
☐ Ampiclox 
☐ Cough Syrup 
☐ Cephalexin 
☐ Unknown 
☐ Other 
______________ 
 
Estimated direct 
costs  
☐ Medical costs  
   Tsh 
_______________ 
☐ Transport expenses 
   Tsh ___________ 
☐ Diagnostic costs  
     Tsh ___________ 
☐ Informal payments  
    Tsh ___________ 
☐ Food expenditures 
and accommodation   
   Tsh ___________ 
☐ Unknown 
   Tsh ___________ 
☐ Other direct costs 
specify ____________ 
    Tsh __________ 
Estimated indirect 
costs 
☐ Income reduction  
   Tsh 
_______________ 
☐ Decrease 
productivity 
   Tsh 
_______________☐ 
Copying Costs 
   Tsh 
_______________☐ 
Less paid labor  
     Tsh 
_______________ 
☐ Unknown 
    Tsh 
_______________ 
Other indirect costs 
specify ____________ 
 Tsh _______________ 
195 
     
 
TB-PHARM STUDY  
 
DELAY IN SEEKING CARE AND LOSS TO FOLLOW UP FOR TB SUSPECTS (EMIC) 
INTERVIEW. 
    (EMIC) INTERVIEW.) 
 
    English Version5/08/2015.  
 
Ifakara Health Institute and Grand Challenge Canada.
196 
  
Appendix 2. Delay in seeking care and loss to follow up for TB suspect’s 
refereed from pharmacies questionnaire 
EMIC ID    
Date of Interview  (DD-MM-YY) 
 
Pharmacy 
1 Kiomboi 2 Mtakuja 3 Mnyamani 4.Mandela 5.Henrick 6.Buguruni 
hospital. 
 
Introduction 
" Thank you for taking your time and participate in this study. I would like to ask you a few questions 
about your background, the kind of ideas you have about the problems that brought you to the 
pharmacy and the help you have taken for it so far. There are no right or wrong answers to these 
questions. Please feel free to tell me your own ideas, what you really think about your problem. But 
first, a few questions about your background” 
Socio-economic and demographic information 
Sex and age 
 Sex F M 
 Approximate 
age (years) 
 
  
 
Household size 
Number of people living in your household  
Marital status. 
Tick one only: 
☐ 1. Never married 
☐ 2. Married 
☐ 3. Separated 
☐ 4. Divorced 
☐ 5. Living together 
☐ 6. Widowed 
☐ 7. Cannot say/ Not disclosed 
Children living in the household (0=None) 
 
 
Relationship with household head 
Tick one only:  
☐ 1. Self 
☐ 2. Spouse 
☐ 3. Parent 
☐ 4. Sibling 
☐ 5. Son or daughter 
☐ 6. Other; Specify__________________ 
Tick sex of household head:  
☐ 0. Female  ☐ 1. Male 
 
Number of children < 5 yrs 5-10 yrs 10-17 yrs 
Sons     
Daughters    
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Main occupational status 
Tick one only 
☐ 1. Agriculture 
☐ 2. Fishing 
☐ 3. Self employed 
☐ 4. Formally employed 
☐ 5. House maid 
☐ 6. House wife 
☐ 7. Casual laborer 
☐ 8. Student 
☐ 9. Not active/ retired 
☐10.Other; Specify__________________ 
 
Education attained 
Tick highest completed level: 
☐ 0. No formal education 
☐ 1. Primary education 
☐ 2. Secondary education 
☐ 3. Vocational training 
☐ 4. College education 
Years spent in education/ training:  _____years.  
Otherwise tick if you cannot say ☐  
Religion  
Tick one only: 
☐ 1. Muslim 
☐ 2. Christian 
☐ 3. Other; Specify__________________ 
☐ 4. Undisclosed 
Nationality Tick one only: 
☐ 0. Tanzanian 
☐ 1. Other; Specify__________________ 
“Is your household income usually reliable (and dependable)?” 
Tick one only. 
☐ 3. Yes 
☐ 2. Possibly 
☐ 1. Uncertain/not disclosed 
☐ 0. No 
Narrative: ______________________________________________________________________________  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
 “What main sources of income are there in your household?” 
Narrative:  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
Query for items not mentioned (except the last two), tick all that apply: 
Sources of income Own  Others 
1 Employment for cash   
2 Employment in kind   
3 Non-farm self-employment   
4 Selling agricultural produce   
5 Selling fish and seafood   
6 Rent   
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Sources of income Own  Others 
7 Remittances (money sent from outside)   
8 Other specify:         
9 Cannot say  
“How much money did you make during the last month on your own? And what about your spouse 
and other household members?” 
Narrative:  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
Query for items not mentioned, clarify if needed 
 
Monthly Income Tsh Cannot say 
1.Own   
2.Spouse    
3.Other household member   
 
Clinical History And Illness experience. 
I will now ask you about the problem that led you to seek help. Later, 
I will ask you about what has been helpful for it in the past and what you feel 
might now be helpful. While doctors have special ways of understanding illness, 
people like yourself also have their own ideas, which may be different from what 
doctors think. It will help us to help people with problems like yours by 
understanding how your problem has affected you, what it means to you, and what you do to get help 
for it.” 
 
Open Ended Enquiry 
1.1 “What is the problem for which you sought help: Please tell us about it.” 
 Narrative: _____________________________________________________________________________  
 ______________________________________________________________________________________  
Patterns of distress (associated symptoms and impact on life) 
In addition to the problem that you have mentioned, are there any other symptoms that that have 
troubled you or that you are concerned about? 
Narrative:  _____________________________________________________________________________  
 ______________________________________________________________________________________  
Tick all that apply 
Physical symptoms tick 
1. Cough  
2. Fever  
3. Chest Pain  
4. Blood in sputum  
5. Breathlessness  
6. Loss of appetite  
7. Weight Loss  
8. Side effects  
9.Other physical Symptoms 
____________ 
 
 
1.2 Effects on life 
“How does this problem (do these problems) affect your life? 
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Narrative:  _____________________________________________________________________________  
 ______________________________________________________________________________________  
Perceived causes 
2.1 “Each of us may explain our health or health problems in various ways. What do you think has 
caused this problems?”  
Summarize the respondent’s ideas about causes in the respondent’s own words: 
Narrative:  _____________________________________________________________________________  
 ______________________________________________________________________________________  
“Based on the patient’s account, mark perceived causes in the “spon” column that are reported 
spontaneously in response to the open-ended question 
Continue by probing for any perceived causes not yet mentioned from the major subgroups listed 
below. Screening each item, mark additional perceived causes reported in response to “probe.” 
   
Perceived Cause Spon Probe 
1 Food   
2 Water   
3 Alcohol   
4 Smoking   
5 Air borne illness   
6 Heredity   
7 Contamination   
8 Sexual Contact   
9 Climate   
Perceived Cause Spon Probe 
10 Dust   
11 Contact with infected 
person 
  
12 Prior Illness   
13 Evil eye, sorcery   
14 Demons or Gods   
98 Others,  
Specify _______________ 
  
99 Can not say   
 
2.2  
 
If patient has mentioned more than one cause of the problem, inquire further: 
“Which of these causes that you have mentioned (or perhaps something else) do 
You now consider the most important cause of your problem?” 
 
Narrative:  _____________________________________________________________________________  
 ______________________________________________________________________________________  
Code single most important perceived cause from the above list of perceived causes   
 
Health seeking. 
2.3 “We realize that you have come here for help, but many people who come here have also 
sought help from many other sources also. This is certainly understandable and not something 
you should be embarrassed about. We would like to know what kinds of help you have sought 
out before coming here for this particular problem? Please tell us about all the things you did 
and people you consulted for help since the beginning of this problem." 
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Narrative:  _____________________________________________________________________________  
 ______________________________________________________________________________________  
For each of the following sources of help, mark whether patient reported use, either spontaneously in 
response to the open-ended query or in response to probe. Help Seeking List. ______________________  
 
Help Seeking list. Spont Probe 
1. Home remedies, self-care, 
family, or non-professional 
friends 
  
2. Drug stores (Pharmacies)   
3. Private or governmental 
hospital 
  
4. Traditional healer   
Help Seeking list. Spont Probe 
5. Primary health care center 
(dispensary) 
  
6. Religious healer   
7.This Clinic   
8.TB clinic   
9.  Other   
 
2.4 “From the list of sources that you sought care, Tell me the sequence of providers in the order 
that you consulted them. How many times did you see each of them?” 
 
Sequence 1 2 3 4 5 6 7 8 9 
4. Traditional 
Healer 
         
5.Primary 
health care 
center 
(dispensary) 
         
2.Drug stores 
(Pharmacies) 
         
3.Private or 
governmental 
hospital 
         
8.TB Clinic          
 
Narrative  ______________________________________________________________________________  
 ______________________________________________________________________________________  
First Help Seeking 
Inquire about first help excluding home remedies and self-care: 
2.5 “What was the first help you sought for this problem outside your home, other than from friends 
and family?” 
Narrative  ______________________________________________________________________________  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
2 Drug store 
3 Hospital 
4 Traditional healer 
5 Primary health care center (Dispensary) 
6 Religious healer 
7 This Clinic 
8 TB Clinic 
9 Other 
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Reasons for choice 
 
2.6 “What was the main reason that led you to decide to get help from this place you went to first rather 
than some other place?” 
place you went to first, rather than some other place?” 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 __________________ “How long was it after your problem began that you went to the pharmacy for help?” 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
 
3. One day to one week 3 More than two weeks  1. Months 
 
2.7 “How many times did you go to the pharmacy to seek care?” 
 Narrative  _____________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
 
1. One Time 2. Two Times 3. Three times 4. >Three times 
 
 
2.8 “What led you to wait before seeking care at the pharmacy for your problem?” 
 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
 
 
2.9 “How did you go? By what means of transport?” 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
Tick all that apply 
1.By a daladala (bus)  
2.By feet  
3.Private car  
4.Bicyle  
5.Bajaji  
6.Other specify  
2.10 “What was the cost of travel to reach there?”   
TSh  
 
Code first help seeking type from categories in above list. 
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2.11 “What kind of treatment did you get from this provider?” 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
Tick all that apply 
1. Cough medicine  
2. Tablets  
3. Injection  
4. Tablets for TB  
5. Cannot say  
  
2.12 “Were you satisfied with the care you received?” 
 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
 
3.Satisified 2.Somehow satisfied 1Not satisfied 0 Don’t know 
 
2.13 “What did this person whom you first went to for help tell you about your 
problem? By what name did he (or she) call it?” 
Specify name, summary term, or short description in the patient's words. Provide English meaning if 
appropriate If “other,” specify term and explain here 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
Specify exact term used: _______________________   
   
 
Identified as TB?  
 
Loss to follow up (patients with presumptive TB) 
 
 We appreciate your account of the reasons and experience in using the pharmacy. Was there some 
reason, however, that you did not go directly to a TB clinic?” 
 
3.1  “Was it a strain for you to travel for health care for your problem beyond the pharmacy?” 
 
Tick one only 
3 Yes  2 Possibly 1 Uncertain 0 No 
 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
 
1 
Yes 
2 
No 
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3.2 “Did you feel embarrassed to go for further medical care after your visit to the pharmacy?” 
 
Tick one only 
3 Yes  2 Possibly 1 Uncertain 0 No 
 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 
3.3 “Did the pharmacist, or anyone else explain the importance of seeking further health care? Were 
you told clearly enough so that you could understand?” 
 
Tick one only 
3 Yes  2 Possibly 1 Uncertain 0 No 
 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 _____________________________________________________________________________________  
 
3.4 “Did you have any concern that your family might not like it, or might not support you if you went for 
further help in the hospital?” 
 
Tick one only 
3 Yes  2 Possibly 1 Uncertain 0 No 
 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 
3.5 “Has getting further help beyond the pharmacy added to the burden of your illness on your family?” 
 
Tick one only 
3 Yes  2 Possibly 1 Uncertain 0 No 
 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 
3.6 “Were you afraid the doctors or health staff might tell you that you have TB if you went to the health 
facility?” 
 
Tick one only 
3 Yes  2 Possibly 1 Uncertain 0 No 
 
Narrative  ______________________________________________________________________________  
 _____________________________________________________________________________________  
 
Concluding advice from patient 
4.1 Do you have any ideas or suggestions about what might make it easier for people with symptoms 
like yours to  get the help and treatment they need?”  
 
Narrative  ______________________________________________________________________________  
204 
 _____________________________________________________________________________________  
 
Interviewer (name/signature)  
Recorder (name/signature)  
Narratives translated & typed (date)  
Controlled (date/initials)  
1
st
 Data entry (date/initials)  
2
nd
 Data entry (date/initials)  
 
Additional comments from the interview team 
 
Notes concerning the participant’s interest and the quality of the interview, and other noteworthy features 
and details of this interview: 
 _____________________________________________________________________________________  
 __________________________________________________________________________________________________________  
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Appendix 3. Traditional healers Quantitative questionnaire 
Traditional healers (systematic questions) 
 Section 1: Contact Information   
 Date of interview |___|___|    |___|___|  |___|___|___|___| DD/MM/YYYY  
 
Name of the 
traditional healer 
 
Select from the GPS 
Codes (if available) 
______________________________________
________________ 
 
 
Place of work 
 
 
Select from the GPS 
Codes (if available) 
☐ Temeke      ☐ Ifakara     ☐ Bagamoyo 
 
______________________________ (Sub 
district/street/ten cell) 
 
Section 2: Traditional medicine and practices 
 
Have you treated 
anyone with coughing 
or other symptoms 
suggestive of TB  
☐ Yes     ☐ No  
 
Type of medication 
given to patients with 
cough symptoms/TB 
☐ Medicinal plants (herbs) specify name 
(Select from the menu) 
________________________________ 
☐ holy water and laying of hands ☐ Casting 
spell and use of poppets ☐ Charms  
Other types of treatment not listed, please 
specify (comma separated) 
________________________________ 
 
 
 
How many patients 
with cough symptoms 
do you see in a day 
________no of patients  
 
How long does it take 
to treat each patient 
________ no of days 
 
 
 
 
How long does the 
patient stay at your 
place for treatment on 
average 
________Weeks  
 How many sessions ________sessions  
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do you usually have 
with the patient during 
the treatment period 
 
If the treatment does 
not work what do you 
usually do? 
 ☐ Referral to the hospital ☐ Referral to the 
pharmacy ☐ Referral to a nearby dispensary ☐ 
Change of medication type and practice ☐ 
Referral to a more experienced traditional 
healer  
Other ________________________________ 
 
 
 
After how long do you 
refer the patient for 
other treatments (on 
average)  
 ________Weeks  
 
Do you sleep in the 
same house with a 
patient if you admit 
them for treatment 
☐ Yes     ☐ No  
 
Do the cough/TB 
symptoms improve 
after treatment 
☐ Yes     ☐ No  
 
How long does it take 
for the cough 
symptoms to improve 
(on average) 
________Weeks  
 
How long does it take 
for the patient to be 
completely cured (on 
average) 
________Weeks  
 
How much do you 
charge for a single 
session with the 
patient 
_________________________ Tsh (on 
average) 
 
 
How much do you 
charge in total for 
treatment to a single 
patient 
 
_________________________ Tsh (min / max 
range) 
 
 
Do you do your work 
in open environment?  
☐ Yes     ☐ No  
 
Do you treat any 
other diseases apart 
from cough / TB 
symptoms 
☐ Yes     ☐ No  
 
What type of 
diseases do you treat 
☐ Malaria ☐ HIV and STI`s ☐ Pneumonia ☐ 
Typhoid  
Others ________________________________ 
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 Name of Interviewer     
 Initial / Date             /  
  
 
How far is the nearest 
government facility for 
diagnosis only 
☐ walking               ☐ with public transport 
   __________ minutes                    _________ 
(minutes) 
 
 
How far is the nearest 
government facility for 
diagnosis and 
treatment 
☐ walking               ☐ with public transport 
   __________ minutes                    _________ 
(minutes) 
 
 
Have you ever had 
discussion with the 
government regarding 
your treatment 
practice 
☐ Yes     ☐ No  
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Appendix 4. Traditional healers: Qualitative questionnaire. 
INTERVIEW GUIDE FOR TRADITIONAL HEALERS 
Introduction 
Hello. Thank you for taking your time and agreeing to participate in this interview. We will ask 
you some questions concerning your treatment practices and your ideas on health problems in 
your community. Please feel free to respond according to what you understand. There are no 
wrong or right answers. We would like to know your ideas and opinions. The information that 
you will give us will be tape recorded and kept confidential. We will assign you a special number 
to use as alternative of your name, to maintain confidentiality. This information will help us to 
know treatment practices and your knowledge concerning health problems in your community. 
This will then help us to inform and suggest measures to the national and international 
guidelines regarding the health problems in your community.   
A:Traditional practices and Illness Perception 
 Kindly tell us, when did you start working as a traditional healer? 
 Where did you learn about traditional practices and treatment? 
 What are the common health problems affecting your community that you treat? Kindly 
tell us all health problems you treat. 
-If s/he mention cough probe kindly explain what you know about all kind of cough 
problems and its symptoms. 
 What is the background of the patients that you treat (probe. Economic status, level of 
education, sex, marital status) 
 Do you only treat people with cough symptoms or any other diseases? 
 If so what kind of disease you treat. 
 If someone with a sever cough comes to see you, what do you do step by step? 
 How do you identify the reasons for a cough? Can you give examples for reasons and 
respective treatment options? 
 How many patients with cough symptoms do you see and treat in a day? 
 How do you treat the patient? Why? What kind of drugs do you use? Please explain 
step-by-step 
 How long does the treatment last? 
 If the patient does not get better after the treatment  what do you do? Kindly explain 
everything that you do. 
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 Do you refer the patient for some other kind of treatment if the treatment fails? Please 
explain Where/ When and how 
 Do you charge any form of payment for treatment? If yes what do you usually charge? 
(probe money, payment in kind) 
B: Understanding of TB 
 Do you know a disease called TB? If yes, please explain what you know 
 Where did you get the information about the causes, symptoms and treatment of 
TB? 
 Probe: from health care worker, from the health care facility/TB clinic from 
school, from a family member, from a friend, from media ie magazine, radio 
television, from a fellow healer, (Others specify)  
 Do you know what causes TB 
 Do you know how TB is transmitted from one person to another? 
 If someone develops TB symptoms what do you think should he/she do? Please 
explain step by step.  (Probe: hospital, pharmacy, dispensary, traditional healer, local 
home remedies, primary health facilities). Is it useful to use different health 
providers? Which ones? Why?  
 Have you treated anyone with TB in the past? 
 If yes, what did you do? Please explain. 
 Do you think anyone with TB must have any other disease (probe, HIV, 
Pneumonia, Malaria) 
C: Collaboration among traditional healers and the government 
 Have you ever had discussion with the government regarding your treatment 
practice? 
 Is there any collaboration between you and the government? If yes what kind of 
collaboration. 
Do you get any form of threat or mistreatment by the government regarding your work as a 
traditional healer?  
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